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I N D E X
1.  TOTAL MOTHERS ATTENDING Totals 2012
Mothers who have delivered babies weighing >500 grams 8846
Mothers who have delivered babies weighing <500 grams {including
miscarriages} 1551  
Hydatidiform Moles * 27  
Ectopic Pregnancies 123  
Total Mothers Delivered 10397
*This figure includes complete & Partial Hydatidform Moles 
2.  MATERNAL DEATHS Totals 2012 
Maternal Deaths 2
3.  BIRTHS Totals 2012 
Singletons 8653 
Twins                                                                                                         364 
Triplets                                                                                                          24 
Quadruplets                                                                                                   0 
Total Babies Delivered weighing> 500 grams 9041
4.  OBSTETRIC OUTCOME Totals 2012
Spontaneous Vaginal Delivery 53% 
Forceps 4% 
Ventouse 14% 
Caesarean Section 29% 
Induction of Labour 28% 
Breech Deliveries included in spontaneaous vaginal delivery
5.  PERINATAL DEATHS Totals 2012
Antepartum Deaths 38    
Intrapartum Deaths 4    
Stillbirths 42  
Early Neonatal Deaths 26
Late Neonatal Deaths 9
Congenital Anomalies 24         3
D U B L I N M AT E R N I T Y H O S P I TA L S
C O M B I N E D  C L I N I CA L  D ATA
6.  PERINATAL MORTALITY RATES                                                      Totals 2012
Overall Perinatal Mortality Rate per 1,000 Births 7.5  
Perinatal Mortality Rate Corrected For Lethal Congenital Anomalies 4.9
Perinatal Mortality Rate Including Late Neonatal Deaths 8.5       
Perinatal Mortality Rate Excluding Unbooked Cases 7.3
Corrected Perinatal Mortality Rate Excluding Unbooked Cases 4.6   
7.  AGE OF WOMEN
Nullips Multips             Total Mothers  Delivered>500g 
<20 yrs 213 34 247
20-24 yrs 659 369 1028
25-29 yrs 1031 1025 2056
30-34 yrs 1307 1772 3079
35-39 yrs 577 1373 1950
40+ yrs 141 345 486
Total 3928 4918 8846
8.  PARITY
Totals 2012   % from Total Mothers  Delivered >500g 
Para 0 3928 44.4%
Para 1 3013 34.1%
Para 2-4 1796 20.3%
Para 5+ 109 1.2%
Total 8846 100% 
9. COUNTRY OF BIRTH & NATIONALITY
2011 % 2012 %
Irish 5957 65.35% 5693 64.36%
EU 1929 21.16% 1948 22.02%
NonEU 1217 13.35% 1188 13.43%
Unknown 13 0.14% 17 0.19%
Total 9116    100.00% 8846   100.00%
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10. SOCIO-ECONOMIC GROUP
Socio-Group 2010 % 2011 % 2012 %
1 536 6.22% 647 7.10% 622 7.03%
2 1926 22.36% 2034 22.31% 2018 22.81%
3 1452 16.86% 1569 17.21% 1498 16.93%
4 577 6.70% 563 6.18% 506 5.72%
5 595 6.91% 596 6.54% 603 6.82%
6 328 3.81% 381 4.18% 344 3.89%
7 2380 27.63% 2469 27.08% 2334 26.38%
8 1 0.01% 1 0.01% 1 0.01%
9 3 0.03% 1 0.01% 2 0.02%
10 816 9.47% 855 9.38% 918 10.38%
TOTAL 8614 100.00% 9116 100.00% 8846 100.00%
11. BIRTH WEIGHT  
Weights Totals 2012      
500 - 999 gms 69 
1,000 - 1,499 81 
1,500 - 1,999 132 
2,000 - 2,499 368 
2,500 - 2,999 1,168
3,000 - 3,499 2,844
3,500 - 3,999 3,086 
4,000 - 4,499 1,104
4,500 - 4,999 177
>5,000 12
Total 9041
12. GESTATIONAL AGE   
Nullips Multips Totals 2012 
<26 weeks 16 10 26 
26 - 29 weeks + 6 days 30 28 58 
30 - 33 weeks + 6 days 67 69 136
34 - 36 weeks + 6 days 210 176 386
37 - 41 weeks + 6 days 3628 4595 8223
42 + weeks 11 6 17
Total 3962 4884 8846
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13. PERINEAL TRAUMA AFTER ALL VAGINAL DELIVERIES (Numbers & Percentages)
Nullips Multips  Totals 2012
Episiotomy & Extended Episiotomy 1306 262 1568
20.7% 4.2% 24.9%
First Degree Laceration 261 783 1044
4.1% 12.4% 16.6%
Second Degree Laceration 753 1118 1871
11.9% 17.7% 29.7%
Third Degree Anal Sphincter/Mucosa 157 54 211
2.5% 0.9% 3.3%
Fourth Degree 4 3 7
0.06% 0.05% 0.1%
Other { Lacerations/Grazes not 195 239 434
requiring sutures} 3.1% 3.8% 6.9%
Intact 147 1026 1173
2.3% 16.3% 18.6%
Totals 2823 3485 6308
44.8% 55.2%
14.  THIRD DEGREE TEARS *  
Nullips Multips Totals 2012 
Occurring Spontaneously 71 38 109
Associated with Episiotomy 23 0 23
Associated with Forceps 24 5 29
Associated with Ventouse 48 13 61
Associated with Ventouse & Forceps 18 0 18
Associated with O.P. position 15 2 17
*Total 3rd Degree not listed as some women have a 3rd degree Tear with Both Episiotomy &
Instrumental Delivery.Table 13 has totals listed.
15.  PERINATAL MORTALITY IN ANTEPARTUM NORMALLY FORMED INFANTS
Nullips Multips Totals
Utero-Placental Insufficiency 7 5 12
Cord Accident 1 4 5
Infection 1 2 3    
Abruption 0 2 2
Prematurity 1 0 1
Unexplained 4 2 6  
Total 14 15 29
Autopsy Totals
Autopsy Rate  17/29 58.9%
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16.  PERINATAL MORTALITY IN CONGENITALLY MALFORMED INFANTS
Nullips Multips      Totals 2012
CNS Lesions 3 0 3
Cardiac 2 0 2
Renal 1 0 1
Chromosomal 2 9 11            
Diaphragmatic Hernia 0 1 1
Other 4 2 6  
Totals 12 12 24
17.  EARLY NEONATAL DEATHS
Nullips Multips Totals 
Congenital 6 5 11
Prematurity / Infection 8 4 12
Other 2 0 2
Unexpected 1 0 1
Totals 17 9 26
Full Autopsy 10/26
Autopsy Rate  38%
Overall Full Autopsy total for all Perinatal Deaths    33
Overall Autopsy Rate 48.5%
18.  HYPOXIC ISCHAEMIC ENCEPHALOPATHY
Grades Grade 1   Grade 2             Grade 3  
16 4 7
19.  SEVERE MATERNAL MORBIDITY
Nullips Multips Totals 
Massive Obstetric Haemorrhage     7 11 18
Emergency Hysterectomy 1 6 7     
Transfer To ICU/CCU 7 7 14
Uterine Rupture 0 1 1    
Eclampsia 0 0 0
Pulmonary Embolus 0 2 2
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20.  FINANCIAL INFORMATION: Non-capital income and expenditure account
For the year ended 31 December 2012
2012 2011
€'000 €'000
Cumulative non-capital deficit/(surplus) 
brought forward from previous year 136 66
Pay
Salaries 48,153 46,837
Superannuation and gratuities 4,624 4,291
Total Pay 52,777 51,128
Non-Pay
Direct patient care 5,100 5,309
Support services 4,379 4,177
Financial and administrative 3,253 3,436
Total Non Pay 12,732 12,922
Gross expenditure for the year 65,645 64,116
Income (20,963) (19,001)
Net expenditure for the year 44,682 45,115
HSE Funding notified for the year (43,647) (44,979)
Deficit for the year carried forward 
to following year 1,035 136
8
91
Introduction
by the master
2012
The Master
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I N T R O D U C T I O N
2012was the second busiest year in the history of the hospital.11,000 women booked for maternity care.  8, 846 motherswere delivered of 9,041 babies greater than or equal to
500g.  This was a slight reduction of approximately 3% on the previous year,
but the extraordinarily high level of activity is maintained evidenced by the
fact that over one 24 hour period in late December there were 42 deliveries.
This level of activity is unsustainable, particularly when simultaneous
emergencies occur and it is a credit to the hospital front line staff that the
safety levels are maintained.  The HSE and the Department of Health have
been notified on multiple occasions during the year of the intolerably high
levels of activity and the clinical risks that arise and we will continue to
address this issue with our funders.  The corrected perinatal mortality rate for
the year was 5.0 per 1,000 and the caesarean section rate is maintained at a
constant level of 29%.  This has remained virtually unchanged for the last
number of years. 
2012 marked a sad year for the hospital with the sudden tragic death of Mr.
Ken Grundy, our Laboratory Services Manager.  Ken was a hugely valued
member of the laboratory team who over the years had put in an enormous
amount of work into making the lab a world class facility.  He will be sadly
missed by all his friends and colleagues at the Rotunda.
There were a number of significant retirements during the year including
Bernie Beirne Assistant Director of Midwifery, Margaret Sheridan Specialist
Midwife on the Mental Health Team, Eilish McDonnell, Head of the Social
Work Department, Dr. John Gillan Consultant Histopathologist and Professor
Joe Walshe, Consultant Nephrologist. In addition there were a large group of
staff from across the hospital who retired as part of the early retirement
package from the HSE.  This loss of very experienced staff obviously has had
a big impact on the hospital with additional strain put on the departments
that have been left with reduced staffing levels.  I wish them all a long and
happy retirement.
There were a number of new consultant posts filled during the year.  Dr.
Fionnuala NiAinle commenced as consultant adult Haematologist between
the Mater and ourselves.  Dr. Afif El-Khuffash and Dr. Breda Hayes were new
appointments to the Neonatal Services and Dr. Roisin Ni Mhuircheartaigh
was appointed jointly between the Rotunda and the Mater as a consultant
anaesthetist.  Mr. John O’Loughlin was appointed as the Laboratory Services
Manager and Ms. Anne McLellan took on the role of Director and Academic
Affairs in September 2012.  I would like to welcome all of our new staff to the
hospital and wish them well in their posts.
I N T R O D U C T I O N
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There was also a very significant retirement from the Joint Maternities
Committee, Dr. Miriam Hederman O’Brien stepped down as Chair of the Joint
Maternities in September 2012.  Miriam had played an enormous role in
keeping maternity services on the political agenda and will be sadly missed.
I wish Miriam well in her retirement.
The Department of Health Report into the practice of Symphysiotomy was
produced in July 2012.  The report on the final outcome of the site for the New
National Children’s Hospital was released in late 2012.  The outcome of this
report was extremely disappointing for the Rotunda given the expectation
following 2008 KPMG report where the Rotunda was due to tri-locate with
the new Mater Adult Hospital and the New Children’s Hospital on the Mater
site.  A lot of time, effort and significant resources had been put into putting
the case for the Rotunda to be part of this tri-location and this has been a
significant set back for the hospitals strategic plans.  We will continue to work
with the HSE and the Department of Health in trying to improve the
infrastructure of the hospital and provide facilities to deal with the huge
increase in the level of activity that has occurred over the last 5 to 6 years.  
The Charter Day Lecture was given by Professor Sir Arulkumaran.  His lecture
‘Fetal surveillance – A tragedy – Is it time to act’ was very well received. The
Hospital held a staff ball in the Four Seasons Hotel to mark the tercentenary
of the birth of the Hospitals founder Dr. Bartholomew Mosse.  The ball was
attended by over 370 staff and partners and was a great success.  The annual
Remembrance Service for patients who have been bereaved was held in the
Pro-cathedral on the 18th November and was as always extremely well
attended.
Under the auspices of the North Dublin Hospitals Group the Rotunda hosted
a North Dublin Hospitals Research Day on 29th November to showcase
collaborative research between our Hospitals.  This was very well attended
and plans are currently being made for a second meeting to be held in mid
November of 2013. 
The Friends of the Rotunda continue to provide hugely valuable support for
research within the hospital. Their annual golf classic was again held in
Milltown Golf Club and as always this was a very successful social and fund
raising event.
The Hospital Management Team worked extremely hard and diligently
during another difficult year to bring the hospital close to budget.  However
this was only achieved with a series of one off savings and next year promises
to be an even more difficult year with further budget cuts signalled. 
The Board of Governors of the Hospital continue to take a very keen interest
in the running of the hospital and take their role of governance extremely
seriously.  The recommendations which arose from the HIQA report into
Tallaght Hospital were published in 2012 and the Board has undertaken a self
assessment review against these recommendations.  This has led to a number
of actions for the Board and for the Executive Management Team.  The tragic
death of Savitha Halapanavar in Galway late in the year will no doubt lead to
further recommendations in relation to maternal health care and the
hospital will undertake to self assess against any recommendations that
emerge from the investigations into this sad event.  Over the last couple of
years there have been significant improvements in the area of governance
with improvements in the risk management process, clinical audit,
education, research, revision of terms of reference of hospital committees and
revision of the organisational structure.  The appointment of the Clinical
Director to assist the Master has been hugely helpful.
In my previous reports I have always commented on the fact that the job of
Master would be impossible without the enormous support and
commitment of my consultant colleagues from all specialties and all of the
junior hospital doctors, but especially the Assistant Masters.  All of our
medical staff put in an enormous effort into to ensuring the hospital remains
safe.  Due to the huge numbers of patients that are being put through the
system we still have too many simultaneous emergencies which pose a
significant clinical risk and this has not changed since my report last year.
Our midwifery and nursing colleagues bring an extraordinary level of skill
and commitment to their jobs and it is due to their tireless efforts that we are
able to maintain good quality care to our patients.  However there is no doubt
that a midwife to patient ratio of 1:50 is completely inappropriate for any
busy tertiary referral unit and this is something that will have to be
addressed.  The clinical services of the hospital are backed up and supported
by an incredibly dedicated group of hospital staff who assist in the delivery of
care to our patients and together they ensure that the environment that we
work in is maintained to the highest possible standards and they deserve
huge credit for the hard work that they do.  The Hospital Executive
Management Team and Senior Management Team worked extremely hard
all year to ensure the hospital ran as efficiently as possible.  Unfortunately
next year will be just as tough.  
Lastly I would like to thank my colleagues who had contributed to the annual
report and assisted in its compilation, particularly Dr Sharon Cooley.  I would
also like to thank Mary and Anne in the Master’s Office for their continued
support in putting the report together and for their assistance in making the
job of Master just that little bit easier.  
I N T R O D U C T I O N
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Statistical Tables
&
Summaries
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Y E A R S 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012
Babies
Born 6790 6731 6804 7325 8456 8799 8912 8792 9319 9041
Perinatal
Deaths 58 
+ 12* 61 + 13 * 61 + 10* 50 + 13 * 66 + 10 * 64 + 7* 56+ 5* 69+5* 59+2* 66+2*
Perinatal
Mortality
Rate
10.3 11 9.8 8.6 9.0 8.1 6.8 8.4 6.5 7.5
Mothers
Attending 7,577 7,290 7,518 8,036 9,290 9,655 9,709 9,594 10547 10397
Maternal
Deaths 2 1 0 0 0 1 2 3 3 2
Caesarean
Section
%
28.2 26.6 25.6 27.7 27.1 26.2 28.5 27.9 29 29
Forceps/
Ventouse
%
16 16.5 15.3 16.8 17 20 19.8 20.5 19.4 18
Epidural
% 46 48 46.7 47 47 49 49.2 46.6 46 48
Induction
% 18 19 19 20 20 21 23.27 27 29 28
* Unbooked
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C O M PA R A T I V E  R E S U L T S  F O R
1 0  Y E A R S
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S T A T I S T I C A L  S U M M A R I E S
1.  TOTAL MOTHERS ATTENDING Totals 2012
Mothers who have delivered babies weighing >500 grams 8846
Mothers who have delivered babies weighing <500 grams {including
miscarriages} 1551  
Hydatidiform Moles * 27  
Ectopic Pregnancies 123  
Total Mothers Delivered 10397
*This figure includes complete & Partial Hydatidform Moles 
2.  MATERNAL DEATHS Totals 2012
Maternal Deaths 2
3.  BIRTHS Totals 2012
Singletons 8653 
Twins                                                                                                         364 
Triplets                                                                                                          24 
Quadruplets                                                                                                   0 
Total Babies Delivered weighing> 500 grams 9041
4.  OBSTETRIC OUTCOME Totals 2012
Spontaneous Vaginal Delivery 53% 
Forceps 4% 
Ventouse 14% 
Caesarean Section 29% 
Induction of Labour 28% 
Breech Deliveries included in spontaneaous vaginal delivery
5.  PERINATAL DEATHS Totals 2012
Antepartum Deaths 38    
Intrapartum Deaths 4    
Stillbirths 42  
Early Neonatal Deaths 26
Late Neonatal Deaths 9
Congenital Anomalies 24 
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6.  PERINATAL MORTALITY RATES                                                      Totals 2012
Overall Perinatal Mortality Rate per 1,000 Births 7.5  
Perinatal Mortality Rate Corrected For Lethal Congenital Anomalies 4.9 
Perinatal Mortality Rate Including Late Neonatal Deaths 8.5       
Perinatal Mortality Rate Excluding Unbooked Cases 7.3 
Corrected Perinatal Mortality Rate Excluding Unbooked Cases 4.6   
7.  STATISTICAL ANALYSIS OF HOSPITAL POPULATION
AGE AT DELIVERY 2006 2007 2008 2009 2010 2011 2012
<20 4.7% 4.7% 4.7% 3.8% 3.5% 3.0% 2.8%
20-24 16.5% 16.2% 14.8% 14.6% 13.1% 12.4% 11.6%
25-29 24.7% 24.7% 25.7% 24.7% 24.6% 23.6% 23.2%
30-34 29.8% 30.5% 30.2% 31.6% 31.6% 33.6% 34.8%
35-39 19.2% 19.9% 20.5% 21.3% 22.2% 22.5% 22.0%
>=40 4.0% 4.0% 4.1% 4.0% 5.0% 4.9% 5.5%
PARITY 2006 2007 2008 2009 2010 2011 2012
0 46.3% 46.9% 48.9% 47.3% 45.5% 45.5% 44.4%
1 30.0% 30.9% 29.3% 31.2% 32.3% 32.8% 34.1%
2-4 22.3% 20.8% 20.8% 20.4% 21.1% 20.7% 20.3%
5+ 1.4% 1.4% 1.0% 1.1% 1.1% 1.0% 1.2%
BIRTHWEIGHT 2006 2007 2008 2009 2010 2011 2012
(grams)
500-999 0.8% 0.8% 0.6% 0.5% 0.6% 0.5% 0.7%
1000-1499 0.9% 1.0% 1.1% 0.9% 0.7% 0.8% 1.0%
1500-1999 1.4% 1.6% 1.6% 1.6% 1.4% 1.6% 1.5%
2000-2499 3.9% 4.2% 3.7% 3.4% 4.0% 3.8% 4.0%
2500-2999 13.5% 13.0% 13.4% 13.6% 13.1% 13.8% 12.9%
3000-3499 32.9% 33.1% 33.0% 33.5% 32.1% 32.4% 31.5%
3500-3999 32.4% 31.7% 32.3% 34.4% 32.9% 33.0% 34.1%
4000-4499 12.0% 12.5% 12.2% 10.0% 12.7% 11.8% 12.2%
4500-4999 2.0% 2.2% 2.0% 1.9% 2.3% 2.1% 2.0%
>5000 0.2% 0.2% 0.3% 0.2% 0.2% 0.2% 0.1%
GESTATION 2006 2007 2008 2009 2010 2011 2012
(Weeks) 
<26 weeks 0.3% 0.3% 0.3% 0.2% 0.3% 0.2% 0.3%
26 - 29 weeks + 6 days 0.7% 0.8% 0.6% 0.6% 0.6% 0.8% 0.7%
30 - 33 weeks + 6 days 1.4% 1.7% 1.5% 1.4% 1.4% 1.3% 1.5%
34 - 36 weeks + 6 days 4.4% 4.6% 4.1% 4.1% 4.3% 4.4% 4.4%
37 - 41 weeks + 6 days 90.4% 90.1% 90.9% 92.6% 92.8% 93.2% 93.0%
42 + weeks 2.6% 2.5% 2.5% 1.1% 0.6% 0.2% 0.2%
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NOTES ON PERINATAL MORTALITY
1. The overall rate applies to all babies weighing greater than or equal to 
500g who were stillborn or died in the first seven days of life (68).
2. The uncorrected perinatal mortality rate is calculated when 2 transfers 
from other hospitals are excluded.  Later bookers are considered as booked cases.
3. The corrected perinatal mortality rate is the uncorrected perinatal deaths
(66) less the number of congenital abnormalities (24) = 42.  This gives an 
uncorrected rate of 7.3 and a corrected rate of 4.6.
4. There was 4 intrapartum deaths. Two were known Trisomy 18, one was a 
placental abruption and the fourth was an extremeley premature breech 
2nd twin.
STILLBIRTHS
Stillbirths 42
Congenital Malformation 13
Placental 12
Cord 5
Abruption/Rupture 2
Infection 3
Prematurity 1
Unexplained 6
F E T A L  L O S S
T h e  M a s t e r
18
Congenital ( 13 )
1. Age 19. Primigravid.  Booked at 16 weeks gestation.  Body stalk
abnormality subsequently confirmed at the anatomy scan at 23 weeks
gestation.  Hospital based care, under the care of the Fetal Medicine Team.
Review at 26, 32 and 34 weeks gestation.  Presented with an intrauterine
fetal death at 38 weeks gestation.  Assisted breech delivery of an infant
weighing 1.43 kg.  Cause of death lethal fetal anomaly. PM declined.
2. Age 34. Para 1+1.  Previous term delivery and 1st trimester loss.  No
contributory medical or surgical history.  Booked at 15 weeks gestation.
Arnold Chiari malformation diagnosed at the anatomy scan at 20 weeks
gestation and scan features suggestive of spina bifida and moderate
ventriculmegaly, abnormal heart view.  Amniocentesis undertaken.
Confirmed Trisomy 18.  Hospital based care with subsequent review at 21, 24,
28, 36 and 38 weeks.  Intrauterine fetal demise at 38+5 weeks.  Stillborn female
infant weighing 1.62 kilograms.  Cause of death Trisomy 18.  PM declined.
3. Age 32. Para 2.  Two previous full term uncomplicated normal deliveries.
Booked at 11 weeks gestation.  Short long bones identified on the fetus on the
anatomy scan at 22 weeks gestation.  Subsequent fetal medicine review
identified a growth restricted infant with normal liquor.  The possibility of
aneuploidy was discussed and declined.  Review at 25 weeks, 29
polyhydramnios was identified and amniocentesis discussed and declined.
At 31 and 32 weeks worsening polyhydramnios and an amniocentesis amnio
drainage was undertaken with a diagnosis of Trisomy 18.  Subsequent review
at 34, 35 and 36 weeks gestation.  Induction of labour at 37 weeks gestation.
Subsequent vaginal delivery of a female infant weighing 1.81 kilograms.
Agpars 0 at 1 and 0 at 5.  Cause of death Trisomy 18.  PM declined.
4. Age 35. Para 0+0.  Booked at 11 weeks.  Previous history of HTN, no
treatment.  Booking BP 140/92.  Referred to Medical Clinic at 14 weeks –
Labetalol 100mg bd commenced, increased to tid at 18 weeks. Regular
CANC – seen at 28, 32 and 34 weeks.  Presented at 38+1with irregular pains
and reduced fetal movements.  BP 137/103, ++ proteinuria.  IUD confirmed.
ARM, meconium Grade III.  Forceps delivery, with 3rd degree tear, of
stillborn male infant weighing 3.04 kgs.  Loose nuchal cord x 1.  TORCH and
Thrombophlia screen negative.  Post mortem. Cause of death Trisomy 21.
5. Age 35. Para 0+1.  Booked at 12 weeks gestation with certain dates and di-
chorionic di-amniotic pregnancy was diagnosed.  No significant medical
history.  Pregnancy induced hypertension at 31 weeks gestation.  Commenced
on Labetalol.  Admitted at 31 weeks gestation with decreased variability in
twin 1 and decreased fetal movement.  Steroids administered.  Routine fetal
ultrasound in accordance with the twin guideline.  At 31 weeks gestation high
output cardiac failure identified in fetus 1 with tricuspus regurgitation and a
diagnosis of a vein of Galen aneurism.  Subsequent fetal demise at 31 weeks
and 5 days gestation of fetus 1 secondary to heart failure.  Elective caesarean
section at 34 weeks gestation of a stillborn male infant weighting 1.42
kilograms and a live male infant weighing 2 kilograms with Apgars 9 at 1 and
10 at 5.  Cause of fetal demise twin I vein of galen aneurism.PM declined. 19
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6.  Age 38. Para 3.  First delivery emergency caesarean sections at 41+6 weeks,
second pregnancy stillborn male infant delivered weighing 3.1 kilograms at 40+6
weeks, third pregnancy elective caesarean section at 38 weeks.  Booked at 11
weeks gestation where mono-chorionic di-amniotic pregnancy was diagnosed.
Subsequent follow-up in accordance with the twin protocol and review at 16, 20,
22, 24, 26, 28 and 30 weeks.  Subsequent short femur identified in fetus 2 and a
decision for amniocentesis was made on both twins.  Trisomy 21 identified in
both infants with a small AVSD identified in Twin 1 and talipes in Twin II.
Subsequently emergency caesarean section at 34 weeks gestation for fetal
bradycardia in twin I and an intrauterine demise in twin II.  Twin I was a male
infant weighing 2.55 kilograms, Apgars 0 at 1 and 0 at 5 and 10 at two minutes of
age.  Twin II, a male infant weighed 2.6 kilograms and was a fresh stillbirth.  Early
neonatal death in twin 1.  Cause of death Trisomy 21. PM declined.
7.  Age 41. Para O.  Booked at 11 weeks. IVF pregnancy. MCDA twins confirmed.
Normal anatomy scan at 21 weeks and follow-up in accordance with the multiple
pregnancy protocol.  At 27 weeks gestation mild ascites and a pericardial effusion
were noted in twin II. No growth discordance.  Admitted with elevated blood
pressure.  In-patient care for the remainder of the pregnancy.  Negative infection
screen. The possibility of a small a sacro teratoma. Suspected Ballantyne
syndrome in the mother due to hydrops in one of the foetuses necessitated
delivery at 28 weeks gestation in association with demise of the hydropic fetus.
Twin I femal infant weighing 1.14 kilograms, Apgars 5 at 1 and 8 at 5 minutes of
age.  Twin II fresh stillborn female infant weighing 1.81 kilogram, Apgars 0 at 1
and 0 at 5.  Post-mortem showed evidence of congenital megakaryoblastic
leukaemia in association with Trisomy 21 Mosaic in twin II.  Trisomy 21
Mosaicism also confirmed in twin I.  Cause of death congenital megakaryoblastic
leukaemia with a background of Trisomy 21 Mosaicism.
8.  Age 33. Para 1. Booked at  another hospital . Previous 40 weeks elective LSCS, 4.25
kg.   20 week scan sacrococcygeal teratoma.  25+4 polyhydramnios teratoma
12x10x9.  MRI :cystic masses, old haemorrhage, extension into pelvis.  26+4
absent flow.  27+3 IUD – LSCS.  PM – cause of death sacrococcygeal teratoma.
9. Age 26. Para 0.  Booked at 8 weeks.  Seen at 14+3, 20+3, 21+3 weeks.  Hydrops
? T18.  21+3 amniotcentesis: normal karyotyple.  Reviewed by Fetal Medicine
at 23 weeks. 26+1 severe hydrops Parvo/Torch –ve.  27+3 IUD diagnosed.  SVD
stillborn female infant weighing 0.83 kg. PM.  Congenital Anthrogyphosis
multiplex, possible contributing congenital myopathy.  Placenta normal.
Cause of death lethal fetal anomaly.
10. Age 31. Para 1+1.  One previous full term uncomplicated normal delivery and a
subsequent trimester loss.  Background history of anaemia.  Booked at 11 weeks
gestation and an ultrasound confirmed the estimated date of delivery.
Combined antenatal care.  Intra-thoracic mass identified on the anatomy scan
at 19 weeks gestation.  Fetal medicine review.  Extra thoracic and intra thoracic
components.  Fetal Medicine follow-up at 20, 23 and 27 weeks.  Normal
karyotype . MRI booked for 32 weeks.  Presented at 27+3 weeks with decreased
fetal movement.  Intra-uterine fetal demise confirmed.  Labour induced.
Stillborn female infant weighing 1.5 kilograms delivered at 28 weeks gestation.
PM showed evidence of a large congenital cystic lymphangyoma with a
massive haemorrhage into the lymphangyoma leading to fetal anaemia and
hypoxia and resulting fetal death.  Cause of death fetal anomaly.
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11. Age 36. Para 2+1 (2 vag births). Booked at 14 weeks.  20 weeks fetal heart
dextroposition, vsd.  Amnio – T18.  Seen at 30, 32, 35 and 37 weeks.  IOL at
37+4.  Breech delivery of a stillborn female weighing 1.81 kg. PM declined.
Cause of death Trisomy 18 – lethal fetal anomaly.
12. Age 26. Para 0+1.  Booked at 8 weeks.  Methadone therapy.
Oligohydramnios at 17 weeks.  Scan at 16, 17, 19, 20, 23, 26, 29, 32 weeks.  At
20 weeks – no left kidney and right kidney abnormal.  Anhydramnios from
20 weeks.  34+1 sol, footling breech, stillborn delivered 1.1 kg infant. PM –
Sirenomelia.  Cause of death lethal fetal anomaly.
13. Age 42. Para 6+4.  Booked at 12+4.  Three previous LSCS, 1 previous MCDA
pair – miscarriage at 12 weeks.  BMI 26.85.  Anatomical survey at 21+2
weeks – EFW <5th centile, CPC, 2VC, unilateral Talipes, a VSD.
Amniocentesis performed – Trisomy 18.  Presented in labour at 31 weeks
gestation, IUD noted.  Breech delivery of a stillborn female infant
weighing 720g.  PM declined.  Cause of death Trisomy 18.
Placental  ( 12 )  
1. Age 28. Para 0+0.  Booked at 12 weeks. Primary infertility x 5 years,
spontaneous conception.  History of thrombocytopenia – booking
platelets 146, repeat platelets at 16 weeks 96.  Coagulation clinic at 26
weeks – platelets 160.  Presented at 27 weeks and 3 days with no fetal
movements for 2 days.  Pregnancy induced hypertension diagnosed.   IUD
confirmed.  Mifepristone/misoprostol IOL.  Stillborn female infant
weighing 830g delivered, Nuchal cord x 1.  PM done.  Cause of death
placental insufficiency.
2. Age 36. Para 0+0.  Booked at 12 weeks.  Recurrent first trimester bleed from
5/40 – 14/40.  First trimester screening reassuring.  Normal 20 weeks
ultrasound.  Regular combined antenatal care.  Presented at 38+5 with 12
hours history of reduced fetal movements.  IUD confirmed.
Mifespristone/misoprostol induction of labour.  SVD stillborn female
infant weighing 2.6kg.  Nuchal cord x 5.  Manual removal of placenta –
bicornuate uterus.  Thrombophilia and TORCH screen negative.  TFTs and
HbA1c normal.  PM: no congenital anomaly. Placenta: diffuse chronic
villitis of unknown aetiology. 
3. Age 32. Para 2+1.  Transferred from another hospital at 28+3 weeks with
PET.  Past obstetric history of one first trimester miscarriage, a placental
abruption at 32 weeks – LSCS, NND, subsequent elective LSCS at term.
History of SLE: skin and joint involvement.  Anti-Ro positive.  BP 129/93 –
97, significant proteinuria, creatinine 81.  USS – oligohydramnios, EFW <
5th centile, normal dopplers.  Plan for delivery next morning following
corticosteroids and MgSO4.   Developed abdominal pain, tachycardia –
suspected abruption. Emergency LSCS.  Stillborn male infant delivered
weighing 950g.  Placental abruption confirmed, EBL 1000mls.  Coroners
PM: no congenital anomaly. Thrombophilia negative. Cause of death:
placental abruption (background of PET & SLE).
4. Age 35. Para 0+0.  Previous myomectomy.  Primary infertility x 8 years.  3rd
cycle IVF.  Booked at 15 weeks.  Scan revealed 4 centimetre wall fibroid.
Regular CANC.  Presented to ER at 34+6 with non-substantial antepartum
haemorrhage and abdominal pain.  USS confirmed IUD.  Mifepristone IOL.
Stillborn male infant delivery weighing 2.11 kgs.  TORCH and Thrompbophilia
screen negative.  Postmortem – normal.  Placental histology – retroplacental
haemorrhage.  Cause of death retroplacental haemorrhage.
5.  Age 28. Para 1.  Previous emergency LSCS for failed induction at term and pre-
eclampsia.  Booked at 9 weeks gestation.  Normal anatomy scan at 19 weeks.
Combined antenatal care.  Subsequently noted to be small for gestational age
at 32 weeks gestation with a fetal weight less than the 5th centile.  Admitted for
fetal surveillance at 32+2 weeks gestation.  Blood pressure 138/79.  Significant
proteinuria of 1.72 grams per litre in 24 hours.  Subsequent fetal demise.
Induced.  Stillborn female infant weighing 1.41 kilograms delivered.  PM
declined.  Persistent pre-eclampsia in the early postnatal period.  Cause of death
chronic utero placental insufficiency secondary to maternal pre-eclampsia.
6. Age 27. Para 2.  One previous assisted delivery at term and a subsequent
caesarean section in the following pregnancy for breech pregnancy.  Booked
at 20 weeks gestation.  Smoker.  Size consistent with dates.  Normal anatomy
scan at 23 weeks gestation.  Subsequent fetal growth scan at 27 weeks
gestation showed normal fetal growth.  Presented with severe headache at 28
weeks gestation with recurrent episodes of headache throughout the
pregnancy.  Normotensive at each review however proteinuria developed at
26 weeks gestation.  Subsequent ambulance admission at 30 weeks and six
days with severe abdominal pain. Fetal heart pulsation was absent on
attendance and diagnosis of placental abruption was suspected.  Ultrasound
showed a fetal heart rate of less than 60 and a category 1 caesarean section
was undertaken.  A male infant weighing 1.49 kilograms was delivered.
Apgars 0 at 1 and 0 at 5.  1.8 litre blood loss intra-operatively with a large retro-
placental clot identified.  Cause of death placental abruption.  Fresh retro-
placental haemorrhage identified on histology.  PM declined.
7. Age 32. Para 1.  Booked at 13 weeks.  One previous LSCS at 39 weeks.  Partial
thyroidectomy in 2009.  Normal anatomy scan at 21 weeks.  At 28+4
diagnosed with polyhydramnios, growth  on 63rd centile.  Impaired glucose
tolerance.  Diet controlled.  Seen at 32 and 34 weeks.  36+6 referred with
reduced FM.  IUD.  IOL and SVD of a female infant weighing 3060g. ACLA,
APLA negative, TORCH negative. PM - normal. Placenta – severe villitis.
Cause of death severe placental villitus of unknown aetiology.
8. Age 21. Para 0.  Later booker at 23 weeks.  Very little English.  Ultrasound
at booking was consistent with dates.  Subsequently reviewed at 28 and 34
weeks gestation.  At 34 weeks gestation was noted to be small for dates
and departmental ultrasound was requested.  Presented 24 hours later
with an intra-uterine fetal demise.  In spontaneous labour.  Vaginal
delivery of a stillborn male infant weighing 3.7 kilograms. Coroners PM
excluded congenital malformation.  Placental examination showed
chronic utero-placental insufficiency and a small placenta and an un-
occlusive thrombus in the umbilical vein. Cause of death utero-placental
insufficiency with a super-imposed cord accident.22
9. Age 35. Para 0.  History of insulin dependent diabetes mellitus since age 12.
Booked at 7 weeks gestation.  Hospital based multi-disciplinary care.
Subsequent review at 9, 11, 16, 20, 26, 28, 30 and 34 weeks gestation.  Did not
attend for three appointments during the course of her antenatal care.
Normal first trimester screen.  Normal anatomy scan and appropriate
grown fetus throughout the course of her pregnancy.  Presented at 35 weeks
gestation with an intrauterine fetal demise.  Induced.  Stillborn male infant
weighing 2.36 kilograms delivered.  PM declined.  Placental histology
showed evidence of chronic utero-placental insufficiency.  Cause of death
placental insufficiency secondary to maternal insulin dependent diabetes.  
10. Age 22. Para 1+2.  Previous term SVD and two first trimester losses. Smoker.
EPAU 11 weeks – normal scan.  Booked at 17 weeks.  Anatomy scan at 22
weeks.  Presented at 24+2 with pv bleed, no fetal heart pulsation.
Mifepristone induction, SVD at 24+6.  Female infant weighing 610g. ACLA
–ve, TORCH –ve, thrombophilia screen negative.  PM declined.  Histology –
chronic uteroplacental insufficiency with 80% placenta infarction.
Increased coiling index.  Cause of death placental infarction.
11. Age 20. Para 0+0.  Booked at 11+4 with uncertain dates.  Recurrent UTIs.
Advised MSU at each visit.  Anatomical survey at 20+3 days – NAD.  DNA
further appointments until 28+6 - +3 nitrates on urine stick, Hb 70g/dl –
Galfer BD advised.  MSU – Staph aureus (>100,000 orgs) script sent.
Presented to ER at 30+1 weeks with irregular pains. NIL. CTG reactive.
Steroids given, discharged home on po Flucloxacillin and Galfer BD.  Re-
presented to ER at 32+5 with irregular lower abdominal pains and no FM x
2 weeks.  On review BP 110/68, fundus measured 26 cm, no FH auscultated.
IUD confirmed by Registrar on-call.  Breech presentation, patient
distressed with pains.  Transferred to DS.  Delivered stillborn male infant
weighing 1.25 kg.  PM declined. LFTs, TFTs, HbAIC, APA.  Placental histology
consistent with severe uteroplacental insufficiency.  Cause of death
placental insufficiency.
12. Age 31. Para 0.  Booked at 13 weeks. History of hypothyroidism, on Eltroxin.
Booking bloods otherwise normal.  Negative anatomy scan at 21 weeks.
Regular attender at clinic.  Attended the Emergency Room at 27 weeks
with reduced fetal movements.  Scan confirmed IUD.  Medical induction of
labour. Assisted breech delivery of a male infant weighing 800g.  PM
negative for congenital malformations.  Placental examination revealed
severe chronic utero-placental insufficiency.  Cause of death hypoxia
secondary to severe chronic utero placental insufficiency with 90%
placental infarction.  
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Cord  (5 )
1. Age 29. Para 0.  No significant medical history.  Booked at 11 weeks
gestation.  Ultrasound confirmed gestation.  Low lying placenta noted at
20 weeks.  Normal anatomy scan.  Hospital based care.  Subsequently
presented with abdominal pain at 29 weeks gestation.  Re-attended three
days later with a fetal demise.  Labour induced and a male infant 1.59
kilograms was delivered. PM excluded congenital anomalies.  Placenta
examination showed a hypocoiled cord.  Cause of death cord accident.
2. Age 35. Para 1, previous SVD.  Booked at 12 weeks.  Seen at 19, 28, and 33
weeks.  At 37 weeks AC > 95th centile – planned IOL at 40 weeks.  39+1 IUD.
At delivery loose loop of cord round leg, meconium grade II.  IUD bloods
normal.  Female infant weighing 3.64 kilograms. PM – no obvious fetal
abnormality identified.  History showed an increased coiling index on the
umbilical cord with thrombus formation.  Cause of death cord accident.
3. Age 36. Para 1.  Booked at 12 weeks. Previous SVD.  Seen at 12, 20, 29, 33, 36,
38, 39 and 40 weeks.  Anatomy scan NAD.  Seen at 40+ - IOL booked.  Seen
at 41+1 SOL 8 cms. SVD of stillborn female infant weighing 3.89kilograms.
PM – normal.  Placenta – normal. Cause of death probable cord accident. 
4. Age 33. Para 1.  Previous ventouse delivery at term.  Booked at 13 weeks.  Seen
at 27, 34 and 38 weeks.  Normal anatomy scan.  Self referral at 39 week
gestation in labour.  No FH.  SVD, stillborn male infant weighing 3590g.  Mec
grade II. Bloods normal. PM – normal.  Placenta – hypercoiled with non-
occlusive thrombus in artery & vein.  Cause of death cord accident.
5. Age 39. Para 2.  Previous emergency caesarean section at 35 weeks and
successful VBAC at 40+6 weels.  History of PIH and PET.  Smoker. Booked at
8 weeks.  30 weeks c/o pain.  Seen at 34, 39 and 40+1 weeks.  Presented at
40+4, CTG normal.  ARM, meconium grade 2/3.  FH post ARM  95, difficult
ausculation.  Crash LSCS.  Macerated male, 3.4 kg.  PM – normal.  Placenta –
cord accident.  Cause of death cord accident.
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Infect ion  (3 )
1. Age 35. Para 3.  Booked at other hospital.  Anomaly scan at 21+2 – fetal
hydrops, elevated PSV on MCA Doppler.  USS at 21+6.  IUD confirmed the
following day at 22 weeks.  Medical IOL.  Stillborn hydropic male infant
weighing 800g. Parvovirus confirmed. PM: no congenital anomaly. Cause of
death: non-immune hydrops due to acute parvovirus B19 infection.
2. Age 32. Para 0+0.  Booked at 12 weeks. Abnormal GTT at 28 weeks, commenced
on diet.  USS at 34 weeks, all well, EFW 82nd centile.  Antenatal visits at 27, 35 and
37+5 (BP 140/90).  Presented at 38+5 with 1 day history of no FM.  IUD confirmed.
Admitted.  Pregnancy induced hypertension diagnosed, Labetalol commenced.
Prostin IOL.  SVD, stillborn female infant weighing, 2.78kg. PM and placental
histology – ascending infection and retroplacental haemorrhage.
3. Age 39. Para 1.  SVD 36+2.  Booked at 12 weeks.  IVF twin pregnancy.
Haemochromatosis carrier. 16 weeks DCDA, growing well.  PROM at 22
weeks.  Delivered twin I cephalic, 435g.  Twin II female 570g, footling
breech delivered 10 days later still born.  PM declined.  Cause of death an
acute chorio-amnionitis.
Abruption/Rupture  (2 )
1. Age 31.  Para 1 +1.  Booked at 15 weeks. Antenatal care at 28 and 32 weeks
gestation.  Presented at 32+5 with abdominal pain.  BP 131/91, proteinuria
+++.  USS confirmed IUD.  Mifepristone given, admitted in view of BP.
Reviewed two hours later with increasing abdominal pain.  Clinical
abruption.  Oxytocin IOL.  Stillborn male infant weighing 1.88 kg delivered.
PPH 1200mls.  No PM.  Cause of death abruption.
2. Age 29.  Para 3. Late booker at 30 weeks. Two previous term deliveries and one
previous LSCS, successful VBAC in the third pregnancy.  Rhesus negative.
Presented with pains at 40+5 weeks.  Discharged home.  Subsequently
presented in labour at 41 weeks gestation.  Bradycardia at full dilatation.
Emergency caesarean section.  Stillborn female infant delivered weighing
3.73 kilograms.  Ruptured uterus noted at the time of caesarean section with
800 mls intra-operative blood loss.  PM declined.  Placental examination
normal. Cause of death fetal demise secondary to uterine rupture.
Prematur ity  ( 1 )
1. Age 35.  Para O.  Booked at 12 weeks.  DCDA IVF pregnancy. On Eltroxin and
Prednisolone until 12 weeks.  Plasminogen Activator heterozygous
deficiency.  Scan at 14 weeks – NAD.  Scan at 17 weeks – cyst 7x10 cms.  Scan
at 20 weeks – NAD.  20+5 PROM, Twin I oligo, Twin II LV normal.  22+1 EFW
< 5th centile Twin I, Twin II normal. Delivered twin I stillborn female infant
at 23 weeks, 540g.  23+6 MgSO4 given.  Twin II delivered 24 weeks 690g, live
born male infant, Apgars 8 at 1 and 10 at 5.  Transferred to NICU.  PM. Twin
I cause of death prematurity.  Twin II late neonatal death secondary to
complications of prematurity. 25
Unexplained  (6 )
1. Age 46.  Para 0+0.  Booked at other Hospital.  Booking bloods normal.
Combined first trimester screening at Rotunda.  T21 risk 1:340 (background
1:17), T18/12 risk 1:91 (background 1:30).  Declined diagnostic testing.  21 week
anatomy scan - normal fetal anatomy, but 12x8cm fibroid.  Planned elective
LSCS in another hospital.  IUD diagnosed at 35 weeks.  Transferred to
Rotunda.  MRI – broad ligament fibroid below fetal presenting part.  LSCS
male infant weighing 1.05 kg.  Macerated breech cord tightly coiled.  PM
declined. Postnatal – elevated TPO antibody and elevated HbA1c.  Cause of
death unexplained.
2. Age 22. Para 0+0.  Booked at 17 weeks.  Smoker 1-2 per day.  Seen in
Midwives Clinic at 28, 32 and 36 weeks.  SGA fetus identified at 36 weeks.
USS confirmed IUD.  Mifepristone/misoprostol IOL.  Stillborn male infant
delivered weighing 2.19kg.  TORCH and Thrombophilia negative.  Post-
mortem declined.  Cause of death unexplained.
3. Age 35. Para 0. Booked at 13 weeks gestation with a singleton pregnancy.
Ultrasound confirmed gestation. History of hyperthyroidism, on
Neomercazole. Combined multidisciplinary antenatal care. Seen at 27 weeks,
30 weeks, 33 weeks, 37 weeks. Complained of generalised itch at 37 weeks.
Liver function tests checked and were normal. Subsequently presented at 39
weeks with decreased fetal movement and intrauterine fetal demise was
confirmed. Labour was induced. Stillborn male infant, 3.75kgs, delivered.
Normal liver function tests at delivery and uthyroid on medication. Negative
thrombophilia screen. The post-mortem was negative for congenital
anomalies and the placenta appeared normal. Cause of death: unexplained
4. Age 33. Para O.  Booked at 12 weeks.  Seen at 16,20,25 and 29 weeks.  19 week
anatomy scan normal.  25+2 normal growth, low lying placenta.  30+4
AC,5th centile/ LV + Doppler normal.  IUD diagnosed at 32+4
weeks/Anhydramnios 1210g. Bloods AST 69, ALT 89. PM – no obvious fetal
abnormality.  Placenta normal.  Cause of death unexplained.
5.  Age 27. Para 1, previous SVD at term. Smoker.  Booked at 12 weeks.  SGA
identified at anatomy scan. Combined care.  Seen at 28 and 34 weeks.  37+1
referred with no fetal movements x 2 days, IUD diagnosed.  IOL – SVD, male
infant weighing 2700g.   Declined PM.  Bloods normal.  Increased coiling
index in cord.  No thrombus identified.  Cause of death unexplained.
6. Age 42. Para 3+1.  Three previous term deliveries.  Prior history of
gestational diabetes.  Booked at 13 weeks gestation and fetal size was
consistent with dates.  Glucose tolerance test booked for 28 weeks
gestation.  Showed evidence of impaired glucose tolerance which was
controlled with diet.  Subsequently presented at 34 weeks gestation with
flu like illness and decreased fetal movements.  Intrauterine fetal demise
was diagnosed.  Subsequent vaginal delivery of a female infant weighing
1.87 kilograms at 34 weeks gestation. PM declined.  Placental examination
showed no obvious cause for the fetal demise.  Hyperthyroidism identified
postnatally.  Negative thrombophilia screen and negative for acute
rubella, toxoplasmosis or CMV.  Cause of death unexplained.26
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EARLY  NEONATAL  DEATH
Neonatal  Deaths 26
Congenital Malformations 11
Prematurity/Infection 12
Meconium Aspiration 1
Hypoxia 1
Unexplained 1
Congenital  Malformation  ( 1 1 )
1.  Age 31. Para 0+0.  Booked at 11 weeks.  USS at 21+6 weeks – anhydramnios,
? left multicystic kidney/cystic mass, right kidney not visualised.  Short
long bones, small thorax.  Regular USS – findings unchanged.  Counselled
re poor prognosis.  Presented to ER at 34 weeks in labour.  Assisted breech
delivery of live born male infant weighing 2.18 kg, Apgars 2 at 1 and 1 at 5
minutes.  Limited PM.  Cause of death: Potter sequence.
2.  Age 37. Para 1.  Referred from other hospital at 32 weeks.  Polyhydramnios.
Prenatal diagnosis Clinics at 32 weeks U/S – Polyhydramnios with
duodenal atresia.  Amniocentesis: T21.  33 weeks obstetric cholestasis.  At
35 weeks US – IUGR with reversed EDF.  EFW < 5th centile.  Admitted for
IOL.  Forceps delivery of male infant weighing 2.14 kg.   Early NND on day
4.  Coroners PM. Histology: increased coiling index.  Cause of death
Trisomy 21.
3.  Age 35. Para 0+0.  IVF.  DCDA twin pregnancy.  Booked at 13 weeks.
Anomaly USS – NAD.  14% growth discordance.  Regular uncomplicated
antenatal care until 33+4.  Itch, elevated BP 166/93, no protein.  Admitted
and commenced on Aldomet.  LFTs normal.  BP stabilised and discharged
home after 3 days.  Reviewed at 34+4.  Fall off in growth in Twin II.  Plan
for FAU one week later.  USS at 35+3 – oligohydramnios both twins.
Normal UA dopplers.  Admitted.  Commenced steroids.  35+6 cervix
favourable for IOL.  Twin I female infant weighing 2.46kg delivered,
Apgars 4 at 1 and 5 at 5 minutes.  Twin II forceps delivery of a female
infant weighing 2.1 kgs, Apgars 1 at 1 and 1 at 5. Twin II early NND at 1 ½
hours.  Coroners PM.  Cause of death Arthrogryposis. 
4. Age 30. Para 3+0.  Booked at 13 weeks.  Anomaly scan at 21+3 –
diaphraghmatic hernia with mediastinal shift.  PND scan confirmed left
sided diaphraghmatic hernia containing stomach and bowel.  LHR 0.9.
Amniocentesis performed.  Regular ultrasounds.  IOL at 39+6.  Ventouse
delivery of live born male infant weighing 3.5 kg.  Apgars 5 at 1, 6 at 5 and
6 at 10.  Cord pH 7.41/7.42.  Lived x 12 hours.  PM declined. Cause of death
congenital anomaly.
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5.  Age 21. Para 0+0.  Booked at 13 weeks – MCDA twin pregnancy.  USS at 13+6 –
twin II prominent bladder with small adjacent cystic structure.  Scan at 16+3 –
twin II bilateral ventriculomegaly and oligohydramnios, bladder normal.  Scan
at 18+3 – similar findings, ? abnormal perineum with cystic structure.
Oligohydramnios.  USS at 20+3 – Twin II Anhydramnios.  Poor prognosis
explained.  24+6 – polyhydramnios, Twin I.  Admitted for inpatient monitoring.
Discharged home at 25+3.  Readmitted at 28+3 for daily monitoring.  Elective
LSCS at 34+2.  Twin I live born male weighing 2.77kg. Apgars 9 at 1, and 10 at 5.
Twin II live born male weighing 2.14kg, Apgars 6 at 1 and 8 at 5.  RIP day 1.
Placenta normal. PM: VACTERL Syndrome.  Cause of death lethal fetal anomaly.
6. Age 34. Para 0+1.  USS at 10 weeks  – dichorionic triamniotic triplets.  USS at
22 weeks ? Hypoplastic left heart.  Fetal echo confirmed HLHS in one of the
monochorionic twin pair.  IUGR in this triplet with AEDF from 28 weeks.
Admitted for daily monitoring from 28+1.  Discharged home at 29+3 for
outpatient monitoring with daily CTG and Dopplers.  Presented in labour at
30 weeks.  LSCS.  Triplet I 890g, Apgars 3 at 1 and 6 at 5.  Triplet II 1.15kg.  Apgars
5 at 1 and 8 at 5.  Triplet III 1.55kg.  Apgars 9 at 1 and 10 at 5.  Triplet I HLHS
Palliative care.  RIP. PM declined. Cause of death fetal anomaly.
7. Age 28. Para 1.  Previous emergency LSCS preterm for pregnancy induced
hypertension.  Medical history of polycystic ovaries and epilepsy.  Booked at 13
weeks gestation.  Singleton fetus consistent with dates.  Normal anatomy scan
at 20 weeks gestation.  Planned for serial fetal ultrasounds in view of chronic
maternal illness.  Appropriately grown infant at 26 weeks gestation and 30
weeks gestation. Planned for glucose test in light of the polycystic ovarian
syndrome and two abnormal readings on the glucose tolerance test with a
diagnosis of impaired glucose tolerance controlled with diet.  Presented to the
Emergency Room at 31+5 days gestation with reduced fetal movements.  Fetal
bradycardia identified at admission.  Category 1 caesarean section.  Live born
female infant weighing 2.4 kilogram.  Apgars 0 at 1, 1 at 5 minutes of age and 4 at
10 minutes of age.  Subsequent neonatal death day 1 of age. PM showed Trisomy
21 and congenital megakaryoblastic leukaemia.  Cause of death Trisomy 21.
8. Age 33. Para 1.  Previous term uncomplicated normal delivery.  No
significant contributing medical history.  Booked at 11 weeks with a di-
chorionic di-amniotic pregnancy confirmed.  Subsequent follow-up in
accordance with the multiple pregnancy protocol.  Isolated plural effusion
noted in twin II at 19 weeks gestation.  Amniocentesis discussed but
declined.  Marked increase in the hydrothorax of twin II noted at 23 weeks
gestation and a short femur was noted at 24 weeks gestation.  Associated
media stinal shift secondary to the hydrothorax and cardiac review
organised.  Fetal cardiac function appeared normal.  Hydrothorax
resolving from 25 weeks gestation with a normal scan at 26 weeks
gestation.  Presented with threatened preterm labour at 29 weeks
gestation.  Steroids administered.  Subsequent emergency caesarean
section.  Twin I – live born male infant weighing 1.43 kilograms, Apgars 9
at 1 minute and 9 at 5 minutes.  Twin II was a male infant weighing 1.34
kilogrrams, Apgars 6 at 1 minute and 6 at 5 minutes of age.  Twin II
karyotype showed Nonne’s Syndrome.  Neonatal death: cause Nonne’s
syndrome and prematurity. PM declined.
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9.  Age 38. Para 3.  First delivery emergency caesarean sections at 41+6 weeks,
second pregnancy stillborn male infant delivered weighing 3.1 kilograms
at 40+6 weeks, third pregnancy elective caesarean section at 38 weeks.
Booked at 11 weeks gestation where mono-chorionic di-amniotic
pregnancy was diagnosed.  Subsequent follow-up in accordance with the
twin protocol and review at 16, 20, 22, 24, 26, 28 and 30 weeks.  Subsequent
short femur identified in fetus 2 and a decision for amniocentesis was
made on both twins.  Trisomy 21 identified in both infants with a small
AVSD identified in Twin 1 and talipes in Twin II.  Subsequently emergency
caesarean section at 34 weeks gestation for fetal bradycardia in twin I and
an intrauterine demise in twin II.  Twin I was a male infant weighing 2.55
kilograms, Apgars 0 at 1 and 0 at 5 and 10 at two minutes of age.  Twin II, a
male infant weighed 2.6 kilograms and was a fresh stillbirth.  Early
neonatal death in twin 1.  Cause of death Trisomy 21. PM declined.
10. Age 28. Para 0+1.  Booked at 20 weeks.  Oligohydramnios.  22 weeks
infantile PCOS + oligo +VSD.  24+2 anhydramnios.  Scanned at 28+, 31, 34+3
weeks.  SOL, SVD at 34+5 of male infant weighing2.380kg., Apgars 6,5,2.  RIP
one hour of age. Limited PM. Cause of death lethal fetal anomaly.
11. Age 17. Para 0.  Booked at 11 weeks.  Anencephaly diagnosed at 20 weeks.
Amniocentesis: normal karyotype.  Scan at 27, 31, 34, 36, 37 and 38 weeks.
IOL: delivered as face presentation. Female infant weighing 2290g. Lived
for approx. 30 minutes.  PM declined.  Cause of death lethal fetal anomaly.
Prematur ity  /  Infect ion   ( 12 )
1. Age 30. Para 0+1 (Top at 6 weeks). Booked at 14 weeks. History of CIN –
previous LLETZ.  USS at 8 weeks (hyperemesis) – DCDA twin pregnancy.
Reviewed in twin clinic at 21 weeks – plan for cervical length at next scan.
Presented at 22 weeks with PROM.  Admitted.  Discharged home 4 days later
for outpatient management.  Presented 2 days later at 23+1 weeks in labour.
Two doses of dexamethasone.  Pains settled and transferred to GPN, 20
minutes later fully dilated.  SVD live born female infant weighing 460g,
Apgars 5 at 1 and 3 at 5 minutes.  No response to BMV in Twin I, intubated at
5 minutes without improvement, handed to parents.  NND.  Two hours later
SROM Twin II.  SVD of live born female infant weighing 530g, Apgars 7 at 1,
9 at 5 and 10.  NND.  PM declined. Cause of death prematurity.
2. Age 23. Para 0+1.  Previous 1st trimester miscarriage. Transferred from other
hospital at 23+4 weeks.  PPROM at 17 weeks.  Methadone 45 ml – ex-drug abuser.
Smoker.  23+4 growth < 5th centile, anhydramnios.  25+4 growth < 5th centile,
anhydramnios.  27 weeks meconium grade I, oblique breech. LSCS – 890g, no
liquor, Apgars 2 and 3.  Early NND on day 1. Placenta – acute chorioamnionitis.
PM declined.  Cause of death extreme prematurity and infection.
3. Age 27. Para 0+1.  Booked at 12 weeks. H/o 18+3 TOP for bladder outlet
obstruction.  EPAU at 6+5.  Scanned at 12 weeks and 17 weeks periembranous
vsd.  Offered 2nd trimester screed risk 1:450.  No vsd seen at 20 weeks.  Scan at
23weeks NAD. 24+6 c/o ? leak – nil seen.  24+6 PPROM, cont 5:10.  Temperature
37.6, pulse 102.  Cx 1 finger.  Delivered by LSCS, B.W. 830g, baby flat at delivery.
RIP in NICU on day 2. PM declined. Cause of death extreme prematurity.
4. Age 36. Para 1.  Previous uncomplicated term delivery.  No significant medical
history.  Booked at 12 weeks gestation and a singleton pregnancy consistent
with dates was identified.  Decision for combined antenatal care.  Uterine
fibroid identified in the lower segment at 23 weeks gestation, measuring 8 x 8
centimetres.   Persistent transverse lie of the fetus from 33 weeks gestation,
appropriately grown fetus.  Presented with a cephalic presentation at 39
weeks gestation and spontaneous onset of labour at 42 weeks gestation.
Spontaneous vaginal delivery of a live born male infant weighing 4.35
kilograms.  Apgars 9 at 1 and 10 at 5 minutes.  Poor fetal oxygenation noted on
the postnatal ward.  Baby admitted to NICU for observation.  Neonatal death
day 1 of age.  Diagnosis of acute broncho-pneumonia and secondary right
ventricular heart failure.  Cause of death fetal acute broncho-pneumonia
secondary to ascending infection identified on histology. Coroners PM.
5. Age 29. Para 1.  Booked at 13 weeks.  Previous SVD at 40+3 weeks.  Seen at
13, 18 and 24 weeks.  Scan at 12, 20 weeks NAD.  22+2 pv bleed – admitted.  24
weeks steroids.  Exophytic  cervical mass biopsied. 28+1 PPROM.  Prem
breech in labour 955gm. Live born female infant. Placental Toxoplasma
Gondii. Coroners PM.  Cause of death Toxoplasmosis.
6. Age 37. Para 0. Referred from another maternity hospital with ruptured
membranes at 23 weeks gestation. History of anaemia and a multiple
fibroid uterus. Admitted. Prophylactic antibiotics. Steroids administered at
26 weeks gestation. Antenatal neonatology review. Spontaneous labour at
29 weeks gestation. Transverse lie. Classical caesarean section. Liveborn
male infant delivered 1.17Kg. Apgar score 2 at 1 minute, 2 at 5 minutes and
2 at 10 minutes. Early neonatal death. 1 litre intraoperative blood loss.
Sepsis 2 days postnatally. Triple therapy antibiotics instigated. Failure to
respond to treatment. Transferred to the Mater Intensive Care Unit. PM
declined.  Cause of death ascending infection and extreme prematurity.
7. Age 30. Para 1.  Previous pre-term delivery at 36 weeks gestation.  No other
contributing medical history.  Late booker at 20 weeks gestation with a di-
chorionic di-amniotic pregnancy.  Subsequent follow-up in accordance with
the multiple pregnancy protocol.  Twin I noted to be less than the 5th centile
at the anatomy scan at 23 weeks gestation.  Twin II also noted to be less than
the 5th centile at the anatomy scan with some media stinal shift.  Prenatal
diagnosis undertaken.  Fetal anatomy appeared appropriate for gestation
with both foetuses less than the 5th centile.  Presented at 26 weeks gestation
with threatened preterm labour.  Twin I cephalic.  Dexamethasone and
magnesium sulphate administered.  Spontaneous vaginal delivery of twin I of
a male infant weighing 0.74 kilograms.  Apgars 6 at 1 and 6 at 5.  Subsequent
assisted breech delivery of a female infant weighing 0.78 kilograms.  Agpars 2
at 1 and 5 at 5 minutes.  Both infants septic in the early postnatal period, with
twin I being an early neonatal death.  PM declined.  Subsequent fetal demise
of twin II.  Histology showed evidence of extensive ascending infection with
maternal and fetal response and both placentae cultured Ecoli and
streptococcus group D.  Cause of death prematurity secondary to ascending
infection and sepsis.
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8. Age 24. Para 0.  No medical history of note.  Booked at 17 weeks gestation.
Failed to attend for anatomy scan.  Presented to the Emergency Room at 26
weeks gestation having delivered at home a live born male infant
weighing 0.89 kilograms.  Neonatal death at 17 hours of age.  Coroners PM
showed evidence of hyaline membrane disease and pneumonia.  Placental
examination showed ascending infection with maternal chorioamnionitis
and fetal response.  Cause of death prematurity with respiratory distress
syndrome and ascending infection.
9. Age 33. Para 0+0.  Booked at 14 weeks.  Cornual pregnancy from HARI.
Recurrent early pregnancy bleeding.  EPAU at 7,8, 9 and 11 weeks – all
normal.  Anomaly scan at 21 weeks normal, fibroids noted.  Presented to ER
at 26+2 with SROM and pains.  SSE – confirmed PROM.  USS – breech,
oligohydramnios, cx funnelling.  4g bolus of Mg SO4 given.  Admitted for 14
days and discharged home at 28+2 weeks for out-patient management.
Presented to ER at 30+5 weeks with irregular pains.  Not in labour.
Admitted to ward.  Mild pains all day.  Severe pains that evening.  Assessed
– fully dilated, footling breech.  Emergency LSCS.  Live born male infant,
weighing 1.78 kg, Apgars 5 at 1, 6 at 5 and 9 at 10.  Cord pH 7.29/7.30.  NND
day 1.  PM. Cause of death – hyaline membrane disease.
10. Age 38. Para O.  Booked at 13 weeks. History of IgA nephropathy as a child.
Scan at 20 weeks NAD.  Scan at 23 weeks oligohydramnios, Doppler NAD,
12th centile.  PPROM at 19 weeks.  Scan 24+1 anhydramnios, scan at 24+4
anhydramnios, BPP 8/8.  C/o pains.  Breech in vagina.  MgSO4.  SVD 630g
live born female.  Placenta: chorioamniotis.  Early neonatal death on day 2
secondary to pulmonary hypoplasia.  PM declined.
11. Age 37. Para 1.  Passed history of neonatal death at 25 weeks following
delivery for severe pre-eclampsia at 24+ weeks in another hospital.
Transferred from another institution at 24 weeks with severe pre-
eclampsia, with biophysical profile and Dopplers indicating delivery
required.  Emergency caesarean section performed.  Male infant weighing
.73kg delivered.  Apgars 0 at 1, 2 at 5.  Full cardio pulmonary resuscitation.
Transferred to NICU.  Baby died day 2.  PM declined.Cause of death extreme
prematurity.  Mother transferred to HDU.  Blood pressure subsequently
settled on treatment.  Placental histology revealed accelerated villus
maturation and retroplacental haemorrhage.
12. Age 44. Para 0+4.  Four previous 1st trimester miscarriages.  Passed
medical history of migraine, bronchitis, meningitis and degenerative discs
and hypothyroidism.Booked at 12 weeks.  Twin pregnancy.  Routine
attender for antenatal care and ultrasound scans.  Attended with PPROM
at 23 weeks.  Emergency caesarean section at 24+6 weeks.  Twin female
infants weighing 0.69 and 061 kg.  Twin I neonatal death on day 4 and
twin II neonatal death on day 56.  PM declined. Cause of death extreme
prematurity. 
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Meconium Aspirat ion  & Pulmonary  Haemorrhage  ( 1 )
1. Age 39. Para 0+2 (TOP T18 and Miscarriage).  Booked at 17 weeks.  Booking
bloods normal.  Anatomy scan normal.  Seen in ANC at 28, 31, 35, 38, 39, term
and term +.  Spontaneous labour at T+2.  Forceps delivery of female infant
weighing 3.99 kg.  pH 7.15 BE – 7.8/pH 7.26 BE – 4.0.  Baby to paeds.  Early NND.
Coroners PM.  Placenta normal.  Cause of death meconium aspiration and
pulmonary haemorrhage.
Hypoxia  ( 1 )
1. Age 29. Para 0+0.  Booked at 14+1 weeks.  BMI 28.04.  IVF pregnancy.  Two
previous failed attempts at IVF.  FTS at 12+1 – low risk of aneuploidy.  Bleeding
at 15 and 16 weeks – cervical erosion noted.  Anatomical survey performed at
20 weeks – NAD.  Attended ER with reduced fetal movements at 23 and 28+5
weeks.  Growth scan at 28/40 –EFW < 10th centile, normal UA Doppler, AFI
23.4 cm; 30/40 – EFW < 10th centile, good interval growth, AFI 12 cm, normal
UA Doppler; 33/40 – EFW 12th centile, AFI 12.6, normal UA Doppler; 35/40 EFW
<10th centile, normal fluid and Doppler; 37/40 EFW 11th centile 2.5 kg, AFI 10.8
cm, Normal UA Doppler.  Antenatal visits at 23, 26, 29, 31, 33, 35, 36, 37 weeks.
Attended ANC at 38 weeks, BP 145/80.  158/77 referred to DCU for review.
Other issue – unable to pass urine that day.  Admitted.  Trial of urination
unsuccessful – catheter inserted.  MSU C/S > 100,000 Pseudomonas
Aeruginosa.  Reviewed by microbiology.  Commenced on IV cetazonie and IV
Gentamicin.  Later that day in labour.  Category I LSCS called.  GA – LSCS, no
fetal heart documented in OT.  Hemoperitoneium noted at time of LSCS.
Transfused 5 units of RCC, 4 Octobplas and 4g of Fibrinogen. Male infant 2.58
kg, no signs of life.  Apgar 0 at 1, and 2 at 5, 5 at 10 minutes.  NND day 5.  PM
declined.  Placental histology: no clear aetiology.  Referral made to Mater for
MRI pelvis to out rule AV malformation.  Cause of death hypoxia secondary
to acute maternal blood loss.
Unexplained  ( 1 )
1. Age 30.  Para 0. History of epilepsy, however had not been requiring
medication for epilepsy for the preceding three years prior to pregnancy.
Booked at 12 weeks gestation. Ultrasound confirmed a singleton intrauterine
pregnancy and established an EDD consistent with dates. Combined
antenatal care with review at 28 weeks, 34 weeks, 37 weeks and 39 weeks.
Normal anatomy scan at 20 weeks. Presented at 40 weeks gestation in
spontaneous labour and fully dilated. Fetal bradycardia auscultated.
Spontaneous vaginal delivery. Female infant weighing 3.6kgs. Apgars 0 at 1,
0 at 5 and 0 at 10. Palliative care for baby day 6 of life. Neonatal death.
Placental examination: normal. Coroners PM: no obvious congenital
anomaly. Infection screen: negative. Cause of death: unexplained. Placental
examination: normal.
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MATERNAL MORTALITY 2
M a t e r n a l  M o r t a l i t y  
T h e  M a s t e r
1.  Age 34. Para 2+1.  Two previous vaginal deliveries uncomplicated.  Booked at
12 weeks.  Diagnosed twin pregnancy.  Scan confirmed di-chorionic di-
amniotic twins.  Regular attender at twin clinic.  Attended Mental Heath
Liaison Team.  Scan at 34+5 weeks revealed well grown healthy babies.  At
35½ weeks gestation patient went missing and was discovered RIP at the
cliffs in Howth.  A coroners PM delivered an open verdict.
2.  Age 34. Para 4.  Uneventful obstetric history and no past history of
significant medical issues.  Uncomplicated spontaneous vaginal delivery.
Female infant 3.8 kilograms.  Patient mildly hypertensive requiring
treatment.  Discharged home day 3 post delivery.  Did not attend for
postnatal check-up.  Patient brought into General Hospital by ambulance
three months post delivery with collapse secondary to cardiac arrest.  Patient
RIP.  Coroners case and inquest awaited.  
There were no direct maternal deaths in 2012.
I am reporting on this maternal death as she was a patient of this hospital, however
I will not be counting her in the maternal death figures as she died outside the
jurisdiction and will be counted in the U.K. statistics.
Age 31.  Para 3 +1.  Black African.  Past history of stillborn twins at 32 weeks
gestation in another country.  One spontaneous miscarriage at 12 weeks and
an emergency caesarean section at 39 weeks, live born 3.6 kilograms.  Past
history of multiple fibroids and past history of postnatal depression.  Booked
at 19 weeks.  Was considering elective termination of pregnancy in the U.K.
and travelled to the U.K. for same.  Patient RIP as a result of complication of
termination of pregnancy in the U.K. 
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WHO Definitions:  
Direct obstetric deaths are those resulting from obstetric complications of the
pregnant state {pregnancy, labour and the puerperium} from interventions,
omissions, incorrect treatment or from a chain of events resulting from the
above.  
Indirect obstetric deaths are those resulting from previous existing disease or
disease that developed during pregnancy and which are not due to direct
obstetric causes, but are aggravated by the Physiologic effects of pregnancy.  
Dr. Sam Coulter Smith
Master
Maternal Mortality   
Year Total Total Number of Mothers Attending
2003 2 7577
2004 1 7290
2005 0 7518
2006 0 8036
2007 0 9290
2008 1 9655
2009 2 9709
2010 3 9594
2011 3 10547
2012 2 10397
Total 14 89613
Maternal Mortality Rate       15.6/100,000
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The Rotunda continued to prospectively monitor severe maternal morbidity
during 2012. In total there were 29 patients reported on and 54 events. This
number is an increase on previous years as it reflects the expanded National
Perinatal Epidemiology Centre classification of maternal morbidity.
The incidence of severe morbidity for 2012 was 0.3%. The incidence of severe
maternal morbidity events was 0.6% (54/8846). This is because many of our severe
maternal morbidity cases had more than one severe maternal morbidity with one
patient having three separate events.
Similar to 2011 there were no episodes of eclamptic seizure. Our number of cases
with major obstetric haemorrhage fell in 2012 (from 24 to 18) which may reflect
earlier identification and improved management of cases complicated by
haemorrhage. This is despite a doubling in the number of cases requiring
hysterectomy between 2011 and 2012. Four were in women with previous
caesarean sections and three of these were complicated by placenta praevia.
Almost one third of our cases of major maternal morbidity occurred in women
above the age of 35 years (10/29) and 27.5% (8/29) were in women who were obese
or morbidly obese at booking.
Our number of cases requiring transfer for intensive care or coronary care
management more than tripled in 2012. This highlights the importance of allied
healthcare professions in providing safe maternity care. This number does not
reflect those women delivered in the Mater Misercordiae Hospital or those
women transferred for radiological investigation, medical or surgical review. 
In line with previous years we report “near-miss” cases for prompt identification
of learning points for all providing maternity care in Ireland.
Major  Maternal  Morbidity Number  of  cases  
Transfusion more than 5 units or Estimated 
Blood loss more than 2.5L or Treated 
for coagulopathy 18
Uterine rupture 1
Peripartum hysterectomy 7 (6 Rotunda and one in the Mater)
Eclampsia 0
Renal or liver dysfunction 3
Pulmonary oedema or acute
respiratory dysfunction 3
Pulmonary embolism 2
Cardiac arrest 2
Coma 0
Cerebrovascular accident 0
Status epilepticus 0
Septicaemic shock 3
Anaesthetic issue 1
ICU/CCU Transfer 14
S E V E R E  M A T E R N A L  M O R B I D I T Y
D r  M i c h a e l  G e a r y ,  D r  S h a r o n  C o o l e y
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Massive  Obstetr ic  Haemorrhage  ( 18 )
1.  Age 24. Full term normal delivery in 2009 with birth weight 4.07 kilograms.
Spontaneous miscarriage 2011 at 13 weeks gestation.  History of asthma,
anxiety and postnatal depression.  Booked at 12 weeks gestation.  EDD
confirmed by ultrasound.  Booking weight 82 kilograms.  Normal anatomy
scan at 21+ weeks gestation.  Uneventful antenatal care.  Labour induced at
41+ weeks gestation.  Haemoglobin 8.7g at time of induction.  Prostaglandin
gel x 2.  ARM.  Uneventful labour and spontaneous vaginal delivery.  Live
born female infant weighing 3.96 kilograms.  Retained placenta and manual
removal of placenta performed in theatre.  Antibiotic prophylaxis given.
Cytotec 1 grams pr and syntocinon infusion commenced.  Two hour
following MROP maternal collapse occurred on the postnatal ward,
secondary to massive PPH (2.5 litres) related to an atonic uterus. PPH protocol
commenced.  Bi-manual compression of uterus followed by syntometrine
IM and haemobate.  Syntocinon infusion continued.  One unit of O negative
blood transfused, followed by one unit of cross matched blood.  Two grams
of fibrinogen administered.  Good response to resuscitation and transferred
to HDU for further monitoring.  Responded well to conservative treatment
with good recovery.  Mother and baby discharged home on day 3.
2.  Age 29. Previous ectopic pregnancy in 2005 – right salpingectomy.  History
of anaemia and anxiety.  Booked at 14 weeks gestation.  Dichorionic
diamniotic twin pregnancy noted.  Significant growth discordance noted at
25 weeks gestation.  Intensive fetal surveillance.  Admitted at 30 weeks
gestation because of absent end diastolic flow in twin II associated with
oligohydramnios and poor interval growth.  Emergency caesarean section
two days following admission at 30 weeks because of a non-reassuring CTG.
Twin I live born male with birth weight of 1.86 kilograms.  Twin II live born
female with birth of 900g.  Posterior placenta morbidly adherent and
removed piecemeal.  Ongoing persistent bleeding from placental bed.
Haemorrhage prophylaxis instigated. Syntocinon 5 units, syntocinon 40
unit infusion, and cytotec 600 milligrams in to uterine cavity.  Extra sutures
required to placenta bed.  IM haemobate administered.  Total perioperative
blood loss 4.2 litres.  Transfused 3 units red cells.  IV antibiotic prophylaxis.
Transferred to HDU.  Recovered very well and discharged home on day 6.  
3.  Age 33. Primigravid.  Booked at 14 weeks gestation.  EDD confirmed by
ultrasound.  Heart murmur as a child.  Previous LLETZ 2006.  Father known
type II diabetic.  Uneventful antenatal care.  Normal anatomy scan at 22
weeks gestation.  Normal GTT at 28 weeks gestation.  Prostaglandin
induction of labour at 41+ weeks gestation.  Short active labour of 3 hours 34
minutes.  Spontaneous vaginal delivery of a live born male infant weighing
3.43 kilograms.  Significant PPH at time of delivery of placenta.  IM
Syntometrine given.  IV line sited.  40 unit infusion commenced.  One gram
cytotec pr given.  Foley catheter inserted.  Second IV line and Hartmanns
infusion commenced.  Clots evacuated from vagina with additional piece of
placenta and membranes.  Bleeding settled very well.  Third degree tear
identified and plan to suture in theatre.  Delay in proceeding with this, as
labour ward extremely busy.  Brought to theatre 2 hours following delivery.
At time of repair exploration of uterine cavity performed.   
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Additional piece of placenta removed. Despite prophylactic oxytocics
uterus remained very atonic post emptying of uterine cavity.
Syntometrine IM repeated.  Syntocinon infusion continued.  A further one
gram of cytotec given pr.  Estimated blood loss approximately 3 litres.
Consultant present. Rusch® balloon inserted into uterine cavity.  Third
degree tear repaired.  Transfused with 2 units of O negative blood and 3
units of cross matched blood.  Four units of octoplas given and four grams
of fibrinogen administered.  Bleeding settled and transferred to HDU.
Rusch® balloon removed 24 hours later and patient stable.  Developed
significant pyrexia on day 2 and treated with triple IV antibiotics.
Subsequently recovered well and discharged home on day 6. 
4.  Age 38. SVD at 34 weeks gestation in 2009.  Idiopathic preterm birth.
History of endometriosis in 1998.  Mother has diabetes.  Booked at 11 weeks
gestation.  EDD confirmed by scan.  Normal anatomy scan at 21 weeks
gestation but estimated fetal weight less than the 10th centile.  Fetal growth
monitored regularly.  Growth persisted along 10th centile for gestational
age.  Normal GTT at 28 weeks.  Presented at 36 weeks gestation with
contractions 1:3.  Blood pressure on admission 140/91.  CTG non-reassuring
and ARM performed.  Large volume of clear liquor noted.  Late decelerations
noted.  Cervix 2 centimetres dilated and while attempting fetal blood
sample large gush of fresh PV bleeding noted.  Clinical suspicion of
placental abruption and emergency caesarean section performed.  Live born
male infant weighing 2.04 kilograms.  Apgars 2 at 1 and 6 at 5 minutes.
Abruption confirmed.  Uterus atonic and prophylactic oxytocics given –
syntocinon 5 units IV, followed by 40 units syntocinon infusion.  One gram
of cytotec also administered to uterine cavity.  Bleeding settled but
perioperative blood loss noted as 1200 mls.  Approximately 6 hours post-
operatively patient noted to have oliguria and complained of significant
abdominal pain associated with abdominal distension.  FBC checked –
haemoglobin 6.5 grams (significant drop from pre-operative haemoglobin).
Also noted to be hypertensive.  Gelofusion commenced, patient stabilised
and decision to take back to theatre to rule out intraperitoneal bleed.  At
laparotomy approximately 1600mls of blood clot removed from abdominal
cavity.  Ongoing ooze noted from left uterine angle and sutures inserted to
good effect.  Coagulopathy noted with platelet count of 36 and reduced
fibrinogen.  Transfused 5 units RCC, 4 units FFP, 1 gram of fibrinogen, 2 grams
of Cyklokapron and one pool of platelets.  Transferred to HDU.  Also treated
with magnesium sulphate prophylaxis in view of ongoing evidence of pre-
eclampsia. Labetalol 300 qds to control hypertension.  Improved very well
over the first two days postnatally but at 72 hours post op developed
significant abdominal pain and distension.  Concern regarding bowel
obstruction both clinically and by x-ray.  Transferred to the Mater for CT
scan.  Reviewed by surgical team and decision to do laparotomy.  Caecal
volvulus noted and surgery performed to excise.  End to end anastomosis
performed.  Remained in the Mater Hospital and discharged home
approximately day 14.  Reviewed at 6 weeks postnatally and mother and
baby both doing well.
5.  Age 43. Previous elective caesarean section in 2008.  Chronic hypertension
and diabetic on insulin.  Booked at 10 weeks gestation.  EDD confirmed by
ultrasound.  Seen regularly in the diabetic clinic.  Normal anatomy scan at
20 weeks gestation.  Normal fetal echo at 23 weeks gestation.  Ongoing
normal fetal growth.  Presented at 28 weeks gestation with chest
discomfort and pain.  Myocardial infarction diagnosed.  Transferred to
Coronary Care Unit Mater Hospital. Significant right coronary artery
narrowing noted and bare metal stent inserted.  Subsequently closely
monitored in the Diabetic, Cardiac and Haematology Clinics.  Scheduled for
an elective caesarean section and tubal ligation at 38 weeks gestation.  Live
born male infant weighing 4.02 kilograms.  Apgars 9 at 1 and 10 at 5
minutes.  Bilateral tubal ligation performed.  Ongoing persistent bleeding
from left uterine angle because of extension into the broad ligament.  Extra
sutures required but difficult to control ongoing persistent ooze.  Uterine
arteries ligated.  Tissues very friable and decision made to proceed with
sub-total hysterectomy.  Perioperative blood loss 3.6 litres.  Transferred to
HDU and recovered very well.  Discharged home on day 5.  Continued with
Innohep prophylaxis.  Despite this developed bilateral pulmonary emboli
approximately 4 weeks postnatal.  Admitted to Mater Hospital and
commenced on therapeutic Innohep.  Seen for postnatal visit at 9 weeks
and was doing very well.  Ongoing follow-up in the Mater Hospital re: MI
and Pulmonary emboli.   
6.  Age 29. Primigravid.  Booked at 11 weeks gestation.  Dichorionic diamniotic
twin pregnancy noted.  EDD confirmed by ultrasound.  Uneventful
antenatal care until 28 weeks gestation when admitted with antepartum
haemorrhage.  Prophylactic steroids given.  Settled and discharged home.
Re-admitted at 30 gestation with obstetric cholestasis.  Retained in
hospital. Subsequent scan revealed evidence of placenta praevia and
therefore retained in hospital until delivery.  Elective caesarean section
performed at 36 weeks gestation.  Twin 1 live born male infant weighing
2.94 kilograms.  Twin II live born male infant weighing 2.2 kilograms.
Anterior placenta praevia at caesarean section.  Perioperative blood loss
600 mls.  Prophylactic oxytocics – syntocinon 5 units with 40 units of
syntocinon infusion.  Cytotec 600 micrograms into uterine cavity.  Ongoing
post-partum haemorrhage in recovery and therefore brought back to
theatre for a laparotomy.  Some fresh blood and blood clot noted in the
abdomen.  Significantly hypotonic uterus.  Uterine cavity carefully
explored with no obvious placenta or membranes found.  Persistent ooze
from the placental bed and extra sutures required.  Haemobate also given.
B-Lynch suture used.  Overall blood loss 2.6 litres.  Transfused three units
RCC.  Subsequently transferred to HDU.  Recovered well and discharged
home on day 5.
7.  Age 35. Primigravid.  Booked at 16 weeks gestation.  EDD confirmed by
ultrasound.  Normal anatomy scan at 21 weeks gestation.  Patients mother
known insulin dependant diabetic.  Subsequent abnormal GTT at 28 weeks
and sugars controlled well with diet.  Antenatal care otherwise uneventful.
Induction of labour at term + 10.  One dose of prostaglandin gel.  Progressed
to 3 centimetres.  Emergency caesarean section performed for non
reassuring CTG.  Live born female infant weighing 3.44 kilograms.  38
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Apgars 9 at 1 and 10 at 5 minutes.  Uterus atonic following delivery.  Five units
of syntocinon given.  40 units syntocinon infusion commenced, one gram of
cytotec placed in uterine cavity.  Continued to bleed heavily.  IM Ergometrine
given, followed by three doses of haemobate intra-myometrially.  Attempt at
insertion of Rusch® balloon. Unable to place easily due to significant
bleeding.  B-Lynch suture inserted.  Continue bi-manual compression and
second B-Lynch suture inserted.  Ongoing significant haemorrhage.  Total
blood loss approximately 5 litres and decision taken to do caesarean
hysterectomy.  Total transfusion – 2 units of O negative blood, 7 further units
of RCC, 4 grams of fibrinogen, 2 pools of platelets and 5 units of octoplas.  In
view of coagulopathy and persistent ooze abdomen packed with large swabs
and closed.  Transferred to Mater ICU.  Stable 24 to 48 hours later and pack
removed from the abdomen.  No further bleeding noted.  Patient returned to
the Rotunda HDU on day 3.  Discharged home well on day 11.
8.  Age 30. Primigravid.  Booked at 10 weeks gestation.  EDD confirmed by
ultrasound.  Normal anatomy scan 20 weeks.  Uneventful antenatal care.
Normal growth scan at 33 weeks gestation.  Presented in spontaneous
labour at 40 weeks gestation.  On admission blood pressure 165/105 and
complained of associated epigastric pain and blurred vision.  Diagnosis of
pre-eclampsia and commenced on magnesium sulphate prophylaxis.
Cervix 4 centimetres dilated and ARM performed.  Short labour of 4 hours
duration.  Forceps delivery for delay in the second stage.  Live born female
infant weighing 3.62 kilograms.  Apgars 9 at 1 and 10 at 5 minutes. High
vaginal tear following forceps delivery repaired.  Uterus atonic.  Total blood
loss 1700 mls.  On day one postnatal developed post partum HELLP
syndrome. AST and ALT grossly elevated.  Creatinine elevated, significant
drop in haemoglobin.  Abnormal fibrinogen and coagulation screen.  LDH
significantly raised.  Transferred to HDU and transfused 2 units of FPC, 1
gram fibrinogen and 2 units octoplas.  Significant secondary PPH on day 2
of approximately 1 litre.  Examination under anaesthesia.  Haemobate x 3.
Rusch® balloon inserted.  Bleeding settled.  Transfused a further three RCC.
Balloon removed 24 hours later when stable.  Bloods gradually improved
over the following three days.  Very well on day 6 and discharged home.
Reviewed at 6 weeks postnatal. Mother and baby well.  
9.  Age 38. Para 3+2.  Emergency caesarean section in 2003 at twenty-nine weeks
gestation.  Neonatal death four weeks later due to Myotubular Myopathy.
Elective caesarean section in 2005 at thirty-seven weeks gestation.  Normal
outcome.  Subsequent miscarriages associated with Myotubular Myopathy.
Emergency caesarean section in 2008 at thirty weeks gestation because of
spontaneous onset of labour.  Early reassurance scan in this pregnancy at
eight weeks gestation. EDD confirmed by ultrasound.  Uncomplicated CVS at
eleven weeks gestation.  Normal karyotype and fetus not affected by
Myotubular Myopathy. TVS at fourteen weeks gestation – cervix 25mms. In
view of previous history commenced on Progesterone injections at sixteen
weeks gestation.  Cervix remained at 25/26mms.  Normal anatomy scan at 20
weeks gestation.  Pregnancy uneventful until 34+ weeks when admitted with
non substantial antepartum haemorrhage, spontaneous onset of labour one
day later. Emergency caesarean section.
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At caesarean section significantly increased vascularity on lower segment
and uterovesical peritoneal fold.  Bladder reflected and incision made high
on the lower segment.  Grade I placenta praevia noted (not seen antenatally
on ultrasound). Live male infant delivered in good condition.  Birth weight
2.52kg.  Apgars 9 at 1 and 10 at 5 minutes.  Perioperative blood loss 2000 mls.
Third stage complete.  No obvious increased bleeding from placental bed at
closing.  Transferred to Recovery Room and stable.  Further ongoing blood
loss per vagina in Recovery Room.  Evacuated 300mls from vagina.
Decision to transfer back to theatre for assessment and Rusch® balloon was
used, initially with 2units of RCC.  Rusch® balloon inserted in theatre under
ultrasound guidance.  Haemostasis achieved.  Syntocinon infusion
continued.  Cytotec 1g PR given earlier.  Uterus very well contracted.
Remained stable with minimal blood loss in Recovery Room for about two
hours.  Bleeding recommenced.  Decision to bring back to theatre for
laparotomy.  Rusch® balloon removed.  300-400mls of blood removed from
vagina.  At laparotomy significant bleeding noted from placental bed,
particularly low down close to cervix.  Deep sutures placed in the placental
bed.  Tissues noted to be friable.  Fibrinogen decreased.  Ongoing
transfusion with RCC and Fresh Frozen Plasma and Fibrinogen. CVP and
Arterial Lines inserted.  Uterus became atonic and intramyometrial
haemabate administered.  Uterus remained atonic and haemobate
repeated.  Decision to perform total abdominal hysterectomy.  TAH
performed.  Deeper lower segment sutures noted to incorporate bladder
and removed.  Bladder repaired with 2/0 Vicryl.  Urology opinion sought
and suprapubic and urethral catheter left in for four weeks.  Intravenous
triple antibiotic cover.  Total blood loss estimated at 10L.  Total transfusion
16RCC, 10FFP, 3 pools of platelets and 4 units of Fibrinogen. Transferred to
Mater Misericordiae University Hospital ICU.  Subsequently returned to
the Rotunda Hospital on day 3 after surgery.  Discharged home on day 10.
Mother and baby well.  Cystogram on day 28 normal.  Subsequent
cystoscopy normal.  Physically well three months post-partum.
10.  Age 38. Previous ectopic pregnancy 2011.  IVF pregnancy.  Early scan
reassuring and EDD confirmed.  Booking examination normal.  Normal
anatomy scan at 21 weeks.  Admitted with antepartum haemorrhage at 23
weeks gestation.  Bulging membranes noted on admission.  Recurrent
antepartum haemorrhage over the following two days.  Blood stained liquor
two days after admission. PPROM confirmed.  Antibiotic prophylaxis given.
Steroids administered at 24 weeks gestation.  Retained in hospital for
expectant management.  Clinical evidence of chorioamnionitis at 26 weeks
gestation and decision made to do emergency caesarean section.  Live born
female infant delivered weighing 750g.  Transferred to NICU.  At delivery
liquor noted to be foul smelling.  Placenta very adherent to lower segment
on anterior and posterior uterine walls.  Placenta removed piece meal.
Significant bowel adhesions on the posterior aspect to the uterus. Atonic
uterus treated with syntocinon 5 IU, syntocinon infusion, ergometrine IM
and two doses of haemobate intra-myometrially.  Significant bleeding of
approximately 2.5 litres.  Transfused four units of blood. Bleeding controlled.
1 grams of cytotec PR.  Patient transferred to HDU. Remained septic in HDU
and covered with triple intravenous antibiotics.
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Haemoglobin < 7grams postnatally and transfused with 2 further units RCC.
Improved well and discharged home on day 9.  Readmitted on day 23 with
suspected endometritis.  Ultrasound suggestive of retained products of
conception.  Management conservatively initially but as no significant
improvement, ERPC performed.  Fragmented degenerative tissue removed.
Subsequent histology confirmed decidua only and no chorionic villi.
Improved very well following ERPC and discharged home two days later. 
11. Age 28. Primigravid. Booked at 12 weeks gestation.  EDD confirmed by
ultrasound.  Normal booking examination.  Normal anatomy scan at 21
weeks gestation.  Spontaneous onset of labour at 39 weeks gestation.  Short
labour of three hours.  Spontaneous vaginal delivery.  Live born male infant
weighing 3.21 kilograms.  Apgars 9 at 1 and 10 at 5.  Episiotomy and
significant vaginal tear.  Initial blood loss approximately 1500 mls.  Uterus
well contracted with syntocinon 5IU IV and syntocinon infusion.  Registrar
called.  Vaginal tissue quite friable.  Ongoing bleeding from vaginal area.
Transfused with three units of O negative blood.  Episiotomy and vaginal
tear repaired.  Managed with vaginal pack and catheter.  Total blood loss
over time approximately 3.5 litres.  Transfusion of 4 units RCC.  Transferred
to HDU with CVP line.  Two subsequent units of RCC (total transfusion 6
units RCC). Recovered well over the following two days.  Catheter pack and
CVP line removed on day 2 and returned to postnatal ward.  Good recovery
and mother and baby discharged home well on day 4.
12. Age 26. Para 1.  Transfer of care from another maternity hospital with a
suspected Twin to Twin Transfusion syndrome in a monochorionic diamniotic
pregnancy. Twin to twin transfusion syndrome Stage 3 confirmed and
fetoscopic laser ablation at 21 weeks gestation.  Morbid maternal obesity with
body mass index of 46 and maternal cardio-vascular collapse intraoperatively
requiring evacuation of the uterus in the maternal interest.  2L blood loss.  Two
units of emergency O negative blood, three units of cross matched blood and
1.5 litres of crystalloid and colloid transfused.  Transferred to the Mater
Intensive Care Unit following surgery once the maternal condition was
stabilised.  Transferred back to the Rotunda following extubation day 1 post
hysterotomy.  Discharged home day 6, with arrangements for followup in the
referral centre. Cardiac follow-up recommended.
13. Age 38. Para 1.  Booked at 12 weeks gestation with a dichorionic diamniotic
pregnancy.  Ultrasound confirmed gestation.  Prior history of elective
caesarean section for placenta praevia at term.  Consultant led antenatal
care.  Presented at 33 weeks with pre-eclampsia.  Worsening
symptomatology necessitated admission and delivery at 33 weeks gestation.
Delivered by emergency caesarean section.  One litre intra-operative blood
loss and haemostatic sutures required to the placental bed.  Syntocinon
infusion and cytotec administered intra-operatively.  Hypotensive post-
operatively and maternal tachycardia noted. Return to theatre for
explorative laparotomy.  Two further litres of free fluid evacuated from the
abdomen.  No obvious cause for the intraperitoneal bleed identified.  Total 3
L blood loss. Transfused four units of red cells, four units of fresh frozen
plasma and two units of fibrinogen.  Five day High Dependency Unit care.
Discharged home well with routine follow-up. Mother and baby well
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14.  Age 18. Primip.  Booked at 10 weeks gestation.  Ultrasound confirmed
gestation.  Background history of depression and methadone maintenance
therapy.  Smokes 10 cigarettes per day.  Hospital led antenatal care.  Normal
anatomy scan at 20 weeks with appropriate fetal growth.  Presented in
spontaneous labour at 40 weeks 3 days gestation.  Oxytocin commenced to
augment progress.  Maternal blood pressure noted to be elevated during the
course of labour and +2 proteinuria on urinalysis. Blood pressure stabilised.
Emergency caesarean section done at 3 centimetres dilatation for failure to
advance.  800 ml intra-operative loss and a live born male weighing 3.14
kilograms delivered with an Apgar score of 9 at 1 minute and 10 at 5 minutes.
Syntocinon 5IU and syntocinon infusion commenced. Further 1 litre blood
loss with clots evacuated from the uterus immediately postoperatively.
Atonic uterus.  In total 2 litre loss following delivery requiring 2 units of cross
matched blood, 2 fibrinogen concentrates and 2 octoplas.  Responded well to
syntocinon intravenously, syntocinon infusion, cytotec and haemobate.  On
antibiotics for a post-operative wound infection.  Discharged home well five
days post-operatively.  Mother and baby well. 
15.  Age 30. Para 2+2.  Booked at 12 weeks + 3 days gestation.  Ultrasound at
booking confirmed gestation and established her estimated date of
delivery.  Back ground history of two previous caesarean sections and two
miscarriages and a history of a possible allergic reaction to pethidine
following her first emergency caesarean section.  Additional medical
history of anxiety disorder and epilepsy.  Shared care with the GP.  Major
placenta praevia noted at 20 weeks gestation.  In addition at the time of the
20 week ultrasound some free fluid was noted in the abdomen and the
cause of which was not identified.  A review in the Mater was arranged and
a diagnostic laparoscopy was undertaken.  At the time two litres of a
haemoperitoneum was identified and two units of packed red cells were
transfused and the patient was subsequently managed expectantly. No
definitive cause for the bleed identified.  Multi-disciplinary management
in light of placenta praevia and epilepsy.  Antenatal steroids administered
at 33 weeks gestation.  MRI undertaken at 20 weeks gestation suggesting
placenta percreta extending into the bladder.  Repeat MRI was undertaken
at 36 weeks gestation on admission, again suggesting bladder wall
involvement.  An elective caesarean section undertaken at 37 weeks
gestation.  Placenta percreta confirmed following delivery of a live born
female infant weighing 3.25 kilograms with Apgars of 8 at 1 minute and 10
at 5 minutes.  Four litres intra-operative blood loss despite haemorrhage
protocol. Sub-total hysterectomy performed. Two of red cells transfused
intra-operatively and three units (1000 mls) of maternal cells transfused
following use of cell salvage.  Total 4L blood loss. Transferred to the High
Dependency Unit where there was an uncomplicated postnatal recovery.
Discharged home day 5 post-operatively following review.  
16.  Age 27. Para 1+1.  Presented originally at 6 weeks gestation in August of 2012
falling beta HCGs and features suggestive of a spontaneous pregnancy loss.
Subsequently transferred from another hospital in October of 2012 with
abdominal pain and bleeding necessitating a transfer to theatre for
laparotomy with suspicion of an ectopic pregnancy.  Declining all blood
products as a member of the Jehovah Witness faith.
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Right adnexal ectopic identified adherent to the broad ligament and right
salpingectomy performed.  Cell salvage performed used and 770 mls of the
patients own blood was transfused.  3.5 litre blood loss in total. Transferred
to the Mater Hospital intensive unit care post-operatively with abdominal
packs in-situ.  Subsequently transferred back to the Rotunda Hospital on day
8 post-operatively. Postoperative recovery complicated by a history of a
pleural effusion and a lower lobar lung collapse on day 4 post-operatively.
Haemoglobin on return was 8 grams per decilitre having reached a nadir of
3 grams per decilitre intraoperatively.  She was subsequently discharged
home on day 12 post-operatively with a haemoglobin of 8.9 grams per
decilitre.  Mother well postnatally. Multidisciplinary followup. Major
maternal morbidity. Transfer to Mater ICU.
17.  Age 29. Primip.  Booked at 14 weeks gestation. Combined antenatal care.
History of endometriosis and assisted fertility. Episodes of hypertension
during the course of her pregnancy. Resolved without medication.   Serial
fetal ultrasounds for fetal growth and maternal reassurance. Fetal growth
along normal parameters. Presented at 38 weeks gestation in urinary
retention. Spontaneous labour. Fetal bradycardia at 2cms dilatation.
Suspected placental abruption. Emergency caesarean section.
Haemoperitoneum and numerous bleeding uterine varices identified. Male
infant weighing 2.58 kilograms delivered. Apgars of 0 at 1 minute of age, 2 at
5 minutes of age and 5 at 10 minutes of age. Infant demise in the early
neonatal period.  Atonic uterus.  Extensive bleeding from the varices
requiring extension of the pfannenstiel incision. Haemostasis obtained.
Abdomen packed and the patient was stabilised. Transferred to the Mater
Intensive care unit. Intraoperative blood loss of 3.5L.  Five units of O negative
blood were transfused in conjunction with 4 units of octoplas and 4 units of
fibrinogen.  Postoperative ileus. Abdominal packs removed day 2.
Transferred back from the Mater Hospital on Day 3 postnatal and discharged
home day 8 post caesarean section. Mother well.
18.  Age 24. Para 2.  Two previous caesarean sections.  Booked at 12 weeks
gestation. EDD confirmed by ultrasound. Medical history of polycystic
ovarian syndrome and depression. Body mass index of 44. Cigarettes- 11 to 20
per day.  Anterior low lying placenta identified on anatomy scan at 22 weeks
gestation. Re-scan at 26 and 34 weeks gestation showed a central praevia
covering the cervix. Antepartum haemorrhage at 24 weeks and 37 weeks
gestation. Emergency LSCS at 37 weeks gestation. Placenta morbidly
adherent to the cervix anteriorly at the time of surgery with an intra-
operative blood loss of 3.4L and subsequent requirement for a subtotal
abdominal hysterectomy. Placenta accreta.  Live born male infant weighing
2.56 kilograms with Apgars of 8 at 1 minute and 10 at 5 minutes. Discharged
home day 5 postnatally. Mother and baby well.  
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Per ipar tum Hysterectomy (7 )
1. Age 36. Para 3. Developed pulmonary hypertension in pregnancy
secondary to a pulmonary embolus. Planned elective caesarean section at
37 weeks gestation in the Mater Hospital. Postpartum haemorrhage
secondary to an atonic uterus requiring subtotal hysterectomy. Discharged
home well Day 6. Followup in the Mater.
2. Reported in Major Obstetric Haemorrhage – No. 5
3. Reported in Major Obstetric Haemorrhage – No. 7
4. Reported in Major Obstetric Haemorrhage – No. 9
5.. Reported in Major Obstetric Haemorrhage – No. 12
6. Reported in Major Obstetric Haemorrhage – No. 15
7. Reported in Major Obstetric Haemorrhage – No. 18
Ruptured Uterus (1)
1. Age 29. Para 3. Late booker at 30 weeks. Two previous term deliveries and
one previous LSCS, successful VBAC in the third pregnancy.  Rhesus
negative.  Presented with pains at 40+5 weeks.  Discharged home.
Subsequently presented in labour at 41 weeks gestation.  Bradycardia at full
dilatation.  Emergency caesarean section.  Stillborn female infant delivered
weighing 3.73 kilograms.  Ruptured uterus noted at the time of caesarean
section with 800 mls intra-operative blood loss.  PM declined.  Placental
examination normal. Cause of death fetal demise secondary to uterine
rupture.
Transfers to the Mater Misericordia Hospital (14)
1. Age 36. Para 1 Presented to the emergency services at nine weeks gestation
with a 24 hour history of bleeding, pain and vomiting. Hypotensive,
pyrexial, hypothermic and tachycardic on attendance. Diagnosis of septic
miscarriage suspected. Poor response to antibiotics and IV fluids. The
patient was stabilised and transferred to theatre where an evacuation of
the retained products of conception was undertaken. Subsequent transfer
to the Mater Intensive Care Unit in the immediate postoperative period.
Discharged home well. 
2.  Age 28. Para 0. Monochorionic diamniotic twins diagnosed. EDD assigned.
Fetal surveillance as per protocol. Twin to Twin Transfusion Syndrome at
24 weeks gestation requiring fetoscopic laser ablation. Developed
dyspnoea and chest pain three days postoperatively. Suspected pulmonary
embolus. Desaturating on room air. Transferred to the Mater Intensive care
unit. Cardiomegaly noted on echocardiography. Dyspnoea resolved and
CTPA failed to show evidence of a pulmonary embolus. Discharged home.
Followup antenatal care in the Rotunda. Delivered by elective caesarean
section secondary to fetal growth restriction at 34 weeks gestation. Two
female infants 2.14Kg and 2.02 Kg. Discharged home well Day 5
postoperatively. Neonatal and maternal followup with cardiology. Mother
and babies well.
45
3.  Age 35. Para 0. Booked at 12 weeks gestation. EDD confirmed. No medical
history. Family history of hypertension and diabetes. Combined antenatal
care. Induction of labour and SVD at 41 weeks 5 days. No immediate postnatal
complications. Mother and baby discharged home well on Day 3 postnatal.
Presented 12 days postnatally with elevated BP and disorientated.
Commenced on Magnesium sulphate and labetalol infusions. Tachypnoea
and cerebral signs with a diagnosis of PET. Transferred to the Mater Hospital
Intensive care unit for maternal care and cranial imaging. Discharged home
well. Mother and baby well.
4.  Age 28. Para 1+0.  Booked at 11 weeks in her second pregnancy.  EDD
confirmed. On methyldopa for a background history of hypertension.
Previous preterm delivery secondary to pre-term pre-labour rupture of the
membranes at 35 weeks and 2 days gestation.  Delivered a live born male
infant weighing 2.7 kilograms.  History of hypertension secondary to renal
artery stenosis, anaemia and recurrent kidney tract infections.  Body mass
index of 32 on booking.  Base line renal profile and renal clinic referral
arranged. Hospital based consultant-led multidisciplinary care. Methyldopa
titrated to 500 mg qds by the 36th week of pregnancy and subsequent
admission at 36 weeks and four days with elevated blood pressure and an
abnormal renal profile. Blood pressure on admission was 125/100 and
labetalol 200mg 3 times a day was commenced.  Fetal bradycardia and fetal
abruption diagnosed day following admission.  An emergency Caesarean
section was performed.  A live born female infant weighing 2.51 kilograms
was delivered.  Apgars 1 at 1 and 9 at 5 minutes.  Intra-operative blood loss of
600 mls and a concealed placental abruption was confirmed.  Subsequent
postnatal care provided in the High Dependency Unit.  Intravenous labetalol
was continued and continuous maternal monitoring.  Blood pressure
stabilised on labetalol.  Renal function deteriorated over the 24 hours
following delivery. Creatinine rose from 55 to 155 in the context of oliguria.
Urea also rose from 2.5 to 7.4.  Poor response to fluid challenge and diuretics.
Renal team review requested. Further deterioration in renal function.
Provisional diagnosis of acute renal failure. Transfer was arranged to the
Renal Team in the Mater Hospital for further management and follow-up.  
5.  Age 26. Para 0+0.  Booked at 18 weeks gestation in her first pregnancy with a
personal history of sickle cell disease.  Had hospital based consultant-led care.
Presented at 29 weeks with sepsis induced sickle cell crisis.  Required transfer to
the Mater Hospital.  Crisis settled with supportive management and antibiotics.
Subsequently discharged home well. Presented at 38 weeks gestation in
spontaneous labour and had a vaginal delivery of a live born male infant
weighing 2.86 kilograms.  Apgars 9 at 1 and 10 at 5 minutes. 
6.  Age 46. Para 2.  Background history of menorrhagia, presented five days
following hysteroscopy and D&C with abdominal pain and distension, pyrexia
tachycardia and neutropenia. Suspected bowel perforation. Patient stabilised.
Surgical consult sought. Transferred to the surgical intensive care unit in the
Mater Hospital for supportive care and further management.
46
7.  Age 34. Para 0. Transferred at 31 weeks gestation in the fetal interest from
another maternity with preterm, prelabour rupture of the membranes.
Spontaneous normal vaginal delivery of a live born male infant day 1 following
transfer Infant weight 2.05 kilograms.  Apgars 9 at 1 and 9 at 5 minutes of age.
Retained placenta requiring a manual removal of placenta in theatre. In total 1L
blood loss.  Difficult MROP. Placenta removed piecemeal. Discharged home day 3
postnatal. Represented to the referral hospital two weeks postnatally with
secondary postpartum haemorrhage secondary to sepsis and retained placental
tissue. Haemoglobin of 7.9 g/dl.  She was commenced on triple antibiotics.
Examination under anaesthetic. Multidrug resistant E coli identified on culture
and ten days of intravenous antibiotics required. Discharged home well day 21
postnatally. Mother and baby well.
8.  Age 37. Para o. Referred from another maternity hospital with ruptured
membranes at 23 weeks gestation. History of anaemia and a multiple fibroid
uterus. Admitted. Prophylactic antibiotics. Steroids administered at 26 weeks
gestation. Antenatal neonatology review. Spontaneous labour at 29 weeks
gestation. Transverse lie. Classical caesarean section. Liveborn male infant
delivered 1.17Kg. Apgar score 2 at 1 minute, 2 at 5 minutes and 2 at 10 minutes.
Early neonatal death. 1l Intraoperative blood loss. Sepsis 2 days postnatally. Triple
therapy antibiotics instigated. Failure to respond to treatment. Transferred to the
Mater Intensive Care Unit.
9. Major Obstetric Haemorrhage Case 5.
10. Major Obstetric Haemorrhage Case 7.
11. Major Obstetric Haemorrhage Case 9.
12. Major Obstetric Haemorrhage Case 12.
13. Major Obstetric Haemorrhage Case 16.
14. Major Obstetric Haemorrhage Case 17.
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C O M P L I C A T E D  P O S T N A T A L  C L I N I C
D r  M a e v e  E o g a n
This clinic primarily offers postnatal review to women who sustain anal
sphincter injury at vaginal delivery. The Royal College of Obstetricians and
Gynaecologists recommend that such patients are seen in a dedicated Perineal
Clinic in order to: 
•  Discuss delivery and associated events in further detail
•  Assess for symptoms of continence compromise
•  Arrange appropriate treatment / referral
•  Advise on future deliveries
This clinic also reviews women who are pregnant again after a previous anal
sphincter injury in order to discuss options and risks in terms of mode of
delivery. It also provides care for women who have had other postnatal concerns,
including wound infection, perineal pain and dyspareunia. 
397 new patients were seen in the clinic in 2012, an increase of 70 patients
compared with 2011. The indications for their attendances are tabulated below:
Indication for Attendance Number of Patients Seen
Postnatal Third Degree Tear (includes patients 
referred from other institutions) 200
Postnatal Fourth Degree Tear (includes patients 
referred from other institutions) 12
Postnatal Perineal Infection or Pain 45
Faecal Incontinence 10
Antenatal Assessment (next pregnancy) 105
Other (incl perineal pain, dyspareunia) 25
Total 397
The largest group of patients seen were those who attended after obstetric anal
sphincter injury. 219 patients sustained anal sphincter injury in the year 2012, 212
of whom had third degree tear, while 7 patients sustained fourth degree tear
(extending to involve anal mucosa). 73.3% of women who sustained anal
sphincter injury were primigravid.  The position of the vertex was OA in the
majority (89.9%) of patients.  The modes of delivery of those who sustained anal
sphincter injury are tabulated below:
Mode of Delivery Third Degree Tear Fourth Degree Tear
SVD 108 2
Ventouse 59 2
Ventouse & Forceps 16 2
Forceps 28 1
Born before arrival 1 0
Total 212 7
Clinic review after anal sphincter injury takes place after the 6th postnatal week.
However, all patients will have been offered physiotherapy follow-up prior
to that and the clinic works closely with the Department of Physiotherapy.  A
history is taken, including continence score if there are symptoms of faecal
incontinence. Information regarding perineal healing and other postnatal
symptoms is also obtained. Appropriate treatment or referral is initiated as
required, and the clinic visit also provides an opportunity to answer questions
regarding the index delivery and to discuss mode of future deliveries.
48 patients who attended the clinic required treatment or ongoing referral (in
addition to physiotherapy, which is offered to all). The specific treatments
required are enumerated below:
Procedure/Referral Number of Patients
Removal of persistent suture material (OPD) 10
Treatment of granulation tissue (OPD) 14
Fenton’s procedure / perineal revision  (day case) 8
Perineal injection (day case) 2
Referral to colorectal service 12
I am very grateful to Ms Ann Brannigan at the Department of Colorectal Surgery,
Mater Misericordiae University Hospital for both clinic and operative support
and also to Cinny Cusack and all staff of the Physiotherapy Department at the
Rotunda Hospital for their ongoing care. 
A joint Clinical Practice Guideline by the HSE and Institute of Obstetrics and
Gynaecology on Management of Obstetric Anal Sphincter Injury was published
in April 2012. We welcome this comprehensive document to guide best practice
and to provide a basis for clinical audit. 
In 2012 we undertook a retrospective study of patients’ preference regarding
mode of delivery following previous anal sphincter injury (ASI) which also
evaluated perineal outcome following subsequent vaginal birth. This identified
an approximate 10% recurrence risk following previous third degree tear and we
find it helpful to have local results to inform practice. This work was presented
by Dr Amanda Ali at the Irish Congress of Obstetrics, Gynaecology and Perinatal
Medicine and is currently being prepared for publication. 
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YEARS 2011 2012
Total number of cases 273 249
Booked 269 245
Unbooked 4 4
Incidence against delivery 3.0% 3.0%
Eclampsia % 0.04% 0.02%
Stillbirths 4 2
Neonatal Deaths 0 0
Multiple pregnancy 22 23
Par ity  of  Pat ients  at  Del ivery
0 190 165
1 48 49
2 20 21
3 11 8
4 plus 4 6
Total 273 249
Gestat ion  of  Pat ients  at  Del ivery
< 28 weeks 8 3
28 - 29 weeks 6 5
30 - 31 weeks 8 7
32 - 33 weeks 10 11
34 - 35 weeks 21 23
36 weeks plus 220 200
Total 273 249
H Y P E R T E N S I O N  W I T H  P R O T E I N U R I A
T h e  M a s t e r  
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The rate for induction of labour for the year 2012 was 28%.  This is 1% down on the
previous year and very much in keeping with the recent trends.  The indications
for induction were broadly similar.  There were fewer inductions for diabetes
and fewer inductions for abnormal biophysical scores.  
INDUCTIONS OVER 5 YEARS
Year Nullip       % Multip      %   Total        % 
2008 1025 57% 760 43% 1785 21%
2009 1147 56% 885 44% 2032 23%
2010 1326 57% 1008 43% 2334 27%
2011 1482 57% 1134 43% 2616 29%
2012 1414 57% 1064 43% 2478 28%
INDICATIONS FOR INDUCTIONS 2012
REASONS TOTAL %
Post Dates 905 37%
Prolonged SROM 477 19%
Reduced Fetal Movements 55 2.20%
Diabetes 57 2.3%
Hypertension 261 10.5%
Heart Disease 0
IUD 22 0.9%
Anomaly 17 0.7%
Antibodies * 5 0.2%
Diminished Liquor 66 2.7%
IUGR 122 4.9%
Large Baby 33 1.3%
Medical/Social 143 5.8%
Multiple Births 21 0.8%
Other 246 9.9%
Poor Obstetric History 44 1.8%
Decreased Placental Function 3 0.12%
Poor Byphysical Score 1 0.04%
Total 2478 100%
* Anti D detected or Anti E
I N D U C T I O N O F L A B O U R
T h e  M a s t e r
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INDUCTION OF LABOUR
YEARS 2011 2012
Total Number of Cases 2616 2478
Incidence against deliveries >500 29% 28%
No. of Caesarean sections for Inductions 572 549
Stillbirths 34 24
Neonatal Deaths 4 6
METHOD OF INDUCTION
YEARS 2011 2012
ARM 240 207
ARM + Synto 543 510
Prostin + ARM + Syntocinon 677 595
Prostin + ARM 409 387
Prostin 267 268
Cytotec 25 13
Prostin + Syntocinon 197 208
Syntocinon 258 290
The caesarean section rate for 2012 was 28.7%.  This was a reduction of almost 1%
on the previous year.  The caesarean section rate for Group 1, nullips in
spontaneous labour was 10.3%, which was 1% lower than the previous year.  The
caesarean section rate for group III multips in spontaneous labour was 2.1%
which was ½ % reduction on the previous year.  Induction rates for both nullips
induced and multips induced groups 2 and 4 was identical to previous years and
there was no significant difference in any of the other groups noted. 
YEARS 2011 2012
Total number of cases 2689 2538
Incidence against 
total deliveries > 500g 29.5% 28.7%
Maternal Mortality 2 2
Primary C.S. 59.0% 58.5%
Repeat C.S. 41.0% 41.5%
Classical C.S 4 2
Tubal Ligation at C.S. 80 64
C/S Hysterectomy 3 5
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C A E S A R E A N  S E C T I O N
T h e  M a s t e r
CAESAREAN SECTION ANALYSIS
All Deliveries for 2012 8846
All Caesarean Sections 2538
Section Rate 28.7%
Group 1 - Nullip Single Ceph Term Spont Lab 199/1941
Section Rate 10.3%
Group 2 - Nullip Single Ceph Term Induced 436/1360
Section Rate 32.1%
Group 2a - Nullip Single Ceph Term CS Before Labour 161
Group 3 - Multip Single Ceph Term Spont Labour 45/2192
Section Rate 2.1%
Group 4 - Multip Single Ceph Term Induced 51/950
Section Rate 5.4%
Group 4a - Multip Single Ceph Term CS before Labour 116
Group 5 - Prev Section Single Ceph Term 905/1191
Section Rate 76.0%
Group 6 - All Nullip Breeches 152/161
Section Rate 94.4%
Group 7 - All Multip Breeches 139/153
Section Rate 90.8%
Group 8 - All Multiple Pregnancies 133/194
Section Rate 68.6%
Group 9 - All Abnormal Lies 17/18
Section Rate 94.4%
Group 10 - All Preterm Single Ceph 184/409
Section Rate 45.0%
Elective Caesarean Section Total 1245
Emergency Caesarean Section Total 1293
Total Multips 4939
Total Primips 3907
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INDICATION FOR PRIMARY SECTIONS 2012
DELIVERY METHOD INDICATION 2011 2012
Fetal Distress {Antepartum & Intrapartum} 544 498
Failure to progress 1st stage 156 121
Failure to progress 2nd stage 34 49
Breech 235 225
Abruption/APH 28 11
P.E.T. 24 26
Transverse Lie/Oblique 25 14
Pyrexia 17 16
Placenta Praevia 28 34
Poor Obstetric History 9 13
Cord Prolapse/Presentation 5 11
Disproportion & Deep Transverse arrest 1 0
Failed Forceps/Ventouse 21 24
Face/Brow Presentation 4 6
Multiple Birth 40 44
Failed Induction 76 80
Prematurity 5 7
Hypertension 32 9
Emergency CS Scheduled for Elective CS 20 10
I.U.G.R. 17 17
Maternal Request 14 20
Medical Disorders 31 37
Poor Biophysical Profile 3 1
Other 160 160
Recurring indications 3 4
Rhesus Antibodies 0 0
Previous 3/4th degree tear 31 38
Malpresentaion in labour 27 10
Total 1590 1485
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INDICATION FOR REPEAT SECTIONS 2012
DELIVERY METHOD INDICATION Elective Emergency 
Failure to progress 1st stage       0 36
Failure to progress 2nd stage       0 4
Fetal distress                      0 84
Disproportion(Malpresentation in Labour)                  0 2
Breech                              1 0
Hypertension                        8 4
Placenta praevia                    3 3
P.E.T.                              6 5
Poor obstetric history              4 2
Previous LSCS                       656 73
Previous classical CS               2 2
Multiple birth                      8 0
Abruption / APH 1 7
Failed induction                    0 7
Antepartum fetal distress           0 0
Emergency CS scheduled for elective CS 0 15
Failed forceps/ventouse             0 0
I.U.G.R.                            13 1
Medical disorders                   4 1
Transverse lie / Oblique lie 4 3
Other                               37 38
Maternal request 13 2
Prematurity 0 3
Previous 3/4th Degree tear 1 0
TOTAL 761 292
** These reasons are the  First reason for  Caesarean Section 
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CLINIC New Return Total
Attendances Attendances
 Antenatal & Postnatal 13,454 40,694 54,148
Gynaecology 4,520 7,543 12,063
Paediatrics 7,628 2,919 10,547
Endocrinology 588 2,330 2,918
Nephrology 298 421 719
Other Specialist Clinics 1,397 803 2,200
Total 27,885 54,710 82,595
O U T PA T I E N T  A C T I V I T Y  D A T A  2 0 1 2
56
3
Departmental
Reports
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OPERATION CATEGORIES
2008 2009 2010 2011 2012
Obstetrical Majors 2348 2556 2469 2745 2604
Obstetrical Minors 987 1189 1273 1287 1284
Vaginal  Surgery 574 512 677 626 710
Abdominal:Uterus 135 130 113 110 125
Abdominal:Tubes & Ovaries 281 344 360 336 309
Other procedures 2138 2170 2760 2615 2397
D E PA R T M E N T  O F  G Y N A E C O L O G Y
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THEATRE GYNAECOLOGIC  WORKLOAD 
VAGINAL SURGERY 2011 2012
Vaginal hysterectomy 45 33
Manchester repair 2 1
Pelvic Floor Repair 31 27
Vaginal Hysterectomy & AP Repair 43 53
Sacro Spinous Colpopexy 17 13
Removal of IUCD 123 94
Insertion of IUCD 359 379
Other 6 10
Total 626 710
ABDOMINAL OPERATIONS 
OF THE UTERUS 2011 2012  
Total Abdominal Hysterectomy 39 49
Myomectomy 26 29
TAH & Bilateral Salpingo-oophorectomy 27 28
Sub Total Hysterectomy 18 19
Total  110 125
OTHER PROCEDURES 2011 2012   
Laparoscopy 263 269
Laparoscopy and Dye 303 242
Hysteroscopy 257 276
D&C/H&C 723 733
UBT 67 76
EUA 60 47
Cystoscopy 8 20
Laparotomy 49 58
Excision Bartholins Cyst 21 47
Fentons 9 9
Diathermy Vulval Warts 2 2
Operative Hysteroscopy 21 6
Endometrial Ablation {Rollerball} 6 14
Laparoscopic division of Adhesions 56 44
Laparoscopic Ablation of Endometriosis/Argan 154 125
Polypectomy 81 61
TVT 7 16
Punch Biopsy of Cervix 18 11
LLETZ 152 78
Other Gynae Surgery 292 184
Other Surgery - fetal/anaesthetic 66 47
Total 2615 2365
GRAND TOTAL
Gynae (Minors & Majors) 3687 3441
THEATRE GYNAECOLOGIC  WORKLOAD 
ABDOMINAL: TUBES AND OVARIES 2011 2012   
Tubal Surgery 6 28
Laparoscopic Sterilisation 24 25
Tubal Ligation at Caesarean Section 91 64
Salpingectomy 89 82
Ovarian Cystectomy 95 82
Oophorectomy 12 14
Ovarian Biopsy 5 5
Salpingo-oophorectomy 14 17
Total 336 317
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Consultant Colposcopists DR. PAUL BYRNE (Director Of Colposcopy)
DR. TOM WALSH
DR. YAHYA KAMAL
Lead Nurse Coordinator MS. SELINA IGOE
Nurses MS. ROSE THORNE
MS. CAROLE O’ROURKE
MS. JENNIFER O’NEILL
MS. VIRGINIE BOLGER
Health Care Assistants MS. TRISH O’DONOVAN
MS. NICOLA BOYD
MS. NANCY FAGAN (RETIRED IN 2012)
Colposcopy Team Leader MS. CATHY HAYES
Administrative Support MS. SUSAN DALY
MS. ÉILIS DALTON
MS. NIAMH O’CARROLL
C o l p o s c o p y  S e r v i c e
There are four consultant led clinics each week. Each consultant led clinic is also
staffed by a trainee, some of whom are BSCCP accredited while others are
working towards their accreditation. One of our trainees, Dr Tom O’Gorman, left
the service in 2012 to take up a consultant post in Our Lady of Lourdes Hospital.
Dr Bill Boyd also left the service during the year. His sessions are now done by
Dr Yahya Kamal.  Three of our nurses are working towards BSCCP accreditation
and it is our aim in the coming year is to establish nurse colposcopy clinics. 
During 2012 there were 4722 patient visits to the colposcopy clinic, representing
a slight increase compared to the previous year. Fewer new patients were seen,
but the number of return visits was higher (Table 1).  Our DNA rate is 7% for first
visits and 10% for return visits.  These figures are below the National Cervical
Screening Programme target of <15%.
Tabl e 1. Cl inic At t endances
2010 2011 2012
New attendances 1664 1908 1563
Return visits 2568 2769 3159
Total 4232 4677 4722
Of the 1563 new referrals, 373 (24%) had smears showing HSIL (moderate or
severe dyskaryosis) Table 2.  However, 423 (27%) were referred with ASCUS
(borderline) smears. We hope that the introduction of the HPV triage test in the
near future will reduce the number of referrals with borderline smears, as these
represent a significant burden on the clinical workload.   
Tabl e 2. Cyt ol ogy on r ef er r al  of  new pat ient s (n=1563)
ASCUS LSIL HSIL ASCUSG Cl inical Ot her Tot al
Number 423 539 373 96 80 52 1563
% 27 35 24 6 5 3 100
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Fewer LLETZ treatments were done in 2012 compared to the previous year,
reflecting the reduced number of new referrals.  However, there was a
significant increase in the number of biopsies taken. This is due to the fact that
62% of our referrals had either ASCUS (borderline) smears or LSIL (mild
dyskaryosis). Our aim is to avoid treating women with low grade lesions at the
first visit, but this requires the reassurance of a biopsy-proven diagnosis (Table
3).  
Tabl e 3. Biopsies and t r eat ment s
2010 2011 2012
Biopsies 732 991 1014
LLETZ 784 914 752
Tot al 1516 1905 1966
Monthly Multidisciplinary Team (MDT) meetings are held. We are most grateful
to Dr. Eibhlis O’Donovan and her team for their support.  We recognise that these
meetings represent a significant workload for the Histopathology Department. 
During the year one of our trainees, Dr Amanda Ali completed a study on the
histological outcome in women referred with borderline glandular smears. The
findings of this study allowed us to alter and improve the way we manage these
women. Dr Ali subsequently presented her findings at the Irish Congress of
Obstetrics, Gyneacology and Perinatal Medicine.  
Towards the latter part of 2012, the HPV ‘test of cure’ was introduced. This alters
the way we follow women who have had a LLETZ treatment. Ultimately, this
should allow women to return to routine screening after having two tests. This
is good news for our patients, however it is likely to result in an increase in the
need for follow-up colposcopy visits. 
One of the rate limiting steps in allowing us to increase the number of referrals
is our limited clinical space. Our colposcopy clinic is currently located in what
was once the neonatal unit. We have two small clinical rooms, with very limited
office space. We need to increase our clinical space, both for patient comfort and
so that we can increase our clinical workload. Despite these limitations, the
clinic is running well and we continue to improve in terms of reaching the
targets set by the National Cervical Screening Programme. Credit for this goes to
all of the team for their hard work, dedication and commitment. 
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DR. D. CORCORAN , DR. A. FORAN (CLINICAL DIRECTOR), 
PROF.  N. MCCALLION, DR A. EL KHUFFASH, DR B. HAYES, 
PROF. M. D. KING, DR. S. KEANE
ADMISSIONS TABLE ( see TABLE 1) 
The neonatal unit was again busy in 2012. The total number of admissions was 1135. The
monthly occupancy rate was 83-92%, with an average of 89.30% for the year. A further
720 babies had treatment < 4 hours on the unit (septic work ups, observations, scans
etc.,) while these contacts are brief they contribute to workload of staff.
Last year the unit cared for 127 Very Low Birth Weight (VLBW) infants weighing
between 501-1500g. This year we have collaborated with the directors of the other
three tertiary neonatal centres in the country (Coombe Women and Infant
University Hospital, The National Maternity Hospital and Cork University
Maternity Hospital) to compare outcome data. All 4 centres have agreed to present
a number of common tables to make comparison easier. We have strived to have the
same tables, but limitations in time allocated to data management personnel
means we cannot produce all tables requested. We hope to have all tables for the
2013 report, if additional data management support is available going forward.
NEONATAL MORTALITY (< 28 DAYS)(TABLES 2) 
Deaths of normally formed infants receiving intensive care (see Table 2A) 
There were 19 deaths of normally formed infants in the NICU.  Eight of these infants
had a birth weight of < 750g, and a further 5 had birth weights between 750-1000g.
12 were < 27 weeks gestation.  Of the preterm deaths, 3 were due to pulmonary
hypoplasia secondary to anhydramnios. Twelve infants died in the first week of life. 
There were 7 deaths of normally formed infants of over 1500g birth weight.  One
was a baby of 30 weeks gestation (birth weight of 1780g) who had severe
pulmonary hypoplasia secondary to anhydramnios.  3 full term babies died with
severe HIE.  One baby who was found to have low oxygen saturations at discharge
(6 hours)subsequently developed severe PPHN and arrested at 36 hours in the NICU.
Post mortem revealed severe group B strep infection. Another baby had poor
feeding and encephalopathy of unknown origin, despite extensive neurometabolic
workup and a full post mortem.
Congenital Malformations (see Table 2B)
There were 16 neonatal deaths associated with congenital malformations. Three
had chromosomal disorders. One had VACTERL syndrome with imperforate anus.
One had Noonan’s syndrome associated with acute renal failure, congenital
hydrothorax and refractory hypotension.   Two had severe renal anomalies (Potter’s
sequence and infant polycystic disease). Two had diaphragmatic hernias.
D E PA R T M E N T  O F  P A E D I A T R I C S
Two had complex congenital heart disease (hypoplastic left heart, double outlet
right ventricle). One had anencephaly and one had a massive posterior fossa
tumor with hydrocephalus. Two had severe arthrogryphosis.
Neonatal Encephalopathy (see Table 3)
There were 16 babies with mild HIE (grade 1), none of whom met the criteria for
cooling. All were normal and discharged at follow up. There were four inborn
babies with moderate HIE (grade 2). All were treated with cooling (therapeutic
hypothermia), all had normal brain imaging and are normal at follow up to date.
There were seven inborn babies with severe HIE (grade 3). All were treated with
therapeutic hypothermia. Three died, three have a normal outcome to date and 1
has evolving cerebral palsy (CP). Seven babies were transferred from elsewhere for
therapeutic hypothermia.
Vermont OxfordNetwork (see Table 4)
The VON network is an international collaboration of over 800 neonatal units
worldwide. The information obtained from this database allows us to benchmark
our care of infants born < 1500g on a national and international level. The Rotunda
compares favorably to the VON across most markers of neonatal outcome,
especially late onset sepsis (8.7% vs 12.8%). This reflects a huge amount of work
from our infection control colleagues and our ANP Edna Woolhead. Since our
concerted effort at the start of 2010 we have continued to see a significant drop in
infection rates: little or no CONS and consistent rates < 10%. All late onset
infections get a full and detailed root cause analysis. However, this does not mean
we can be complacent: two babies died during 2012 from late onset sepsis, one of
which was due to pseudomonas. Following the outbreak in Belfast we had a full
internal enquiry addressing all areas where pseudomonas could potentially be
sourced (taps etc.,) to no avail. No other cases were identified, but we continue to
monitor this very closely.
Our mortality rates are higher than 2011. This is something we are auditing but is
in the context of an Irish setting where we had 12.3% of babies < 1500g, born with
a major birth defect compared to 4.7% in the VON network. Our standardized
mortality rate for 2010-2012 is 1.3 and our standardized death or morbidity for the
same epoch is 1.1.
Our rates of chronic lung disease (CLD) have consistently increased over the past 2
years. This reflected higher rates of chorioamnionitis (25% Vs12.8%); a drop in
antenatal steroid use (76%Vs 87.3%) or higher rates of multiple deliveries (41.8% Vs
27.5%). However it is something we need to address. 
We are fortunate to have consistent and experienced personnel (consultant
radiologists) doing our head scans, which ensures that even the most minor
abnormalities are identified. We are pleased to report that there were no cases of
cystic PVL in 2012 (VON 2.8%)
Fol l ow-up of  babies <1500g
All infants with birth weights </= 1500g are seen in clinics and offered formal
developmental follow up at 2 years. Our follow-up rates continue to improve, 64
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reaching 83% in 2012. Close to 40% needed some early intervention referral - the
majority (64%) requiring speech and language intervention. One of the biggest
challenges is accessing services for these children.There are long waiting times,
particularly for early intervention teams and speech and language therapy. We
thank Susan Keane for compiling this follow-up data.
COMMENTS
We are delighted to welcome two new neonatal consultant colleagues. Dr Afif El
Khuffash took up his post in September this year. He has already proven to be a
great addition to our team, bringing back advanced echocardiography skills from
his training in Toronto and an uncanny knowledge of information technology. This
will be a great asset going forward in both assessing babies heart function on the
NICU and for research. We were finally able to advertise and appoint a permanent
consultant for Prof McCallion’s original job. Dr Breda Hayes was appointed in
October 2012. Breda is a Rotunda trainee who completed her training in Boston and
has special areas of interest in newborn neurology and EEG monitoring in the
NICU, areas we wish to develop as a sub specialty interest for the unit.
At directorate level, and with the support of Dr McKenna and Pauline Treanor,
we have strived to develop a EWTD compliant Rota for our NCHDs.  The
developing role of discharge midwives has reduced SHO hours at weekends. The
neonatal unit has an approved head count of 72 WTE nurses. In 2012 the nursing
staff levels were 67.88 WTE, with maternity leave and sick leave not being
replaced. As the HSE continue to seek greater productivity and flexibility at lower
cost, our front line staff are experiencing increasing pressure of work without
the support, recognition or access to work enablers they require to sustain high
levels of performance.  
Universal newborn hearing screening was introduced in September 2012. To date
we have picked up 3 babies with significant nerve deafness. We’d like to thank
Lorraine Sibley and Patricia Williamson particularly and all the ward staff for
facilitating this new service.
Paediatric outpatients attendances remained high at 10,547, but saw a drop of
almost 15% overall from 2011 (12,032). Working with Prof King, Dr Hayes and
Physiotherapy we have streamlined the developmental follow up of very low
birth weight infants, ensuring they are assessed at 6 weeks, 4 months and 9
months corrected gestation with a formal physiotherapy assessment at 6
months corrected. This has led to a 40% reduction in POPD consultant
neurodevelopmental clinic attendances. This has facilitated a reduction in
NCHD numbers at consultants clinics, moving to a consultant-led
model.Midwifery led clinic attendances (weight checks, newborn screening
checks etc.,) remain static at circa 2,000 p.a..The challenge for 2013 is to reduce
the attendances (6,000) at the SHO clinic. 
One of our SpRs (K Gorman) published an article in the Irish medical times
suggesting a national guideline for primary care POPD referrals. With EWTD
compliance and NCHD recruitment being a challenge and a priority, the target
for 2013-2015 is to reduce unnecessary attendances by 25% over three years,
giving more responsibility to GPs, PHNs and parents themselves. Earlier
discharge means jaundice may not be detected during the hospital stay, but
DOMINO midwives carry transcutaneous bilimeters to check babies bilirubin
levels in the community.  Rolling out such bilimeters to PHNs nationally would
be a major advance in community care of the newborn. An ongoing audit of SHO
POPD attendances will take place in 2013.
The Dublin North East neonatal network (encompassing the Rotunda, Drogheda
and Cavan) continues to evolve. Quarterly education meetings continue and staff
from these units attending Rotunda Grand Rounds on an ongoing basis. An audit
of network function was undertaken by Cavan, highlighting instances where
network babies were not accepted in the Rotunda. It was decided at executive
management level that any woman booked at Drogheda or Cavan would be
considered a Rotunda patient should transfer be required. This has resulted in a
significant increase in utero transfers and OPD referrals from antenatal clinics.
Kathy Conway is helping us to capture this data accurately so we get a true
reflection of the work load undertaken by the Rotunda. 
We finally received confirmation late in 2012 that the neonatal transport will
move to 24/7 in 2013. This is a vital but long overdue service which will need
extra nurses, NCHDS and the appointment of a transport consultant to oversee
the running of this important national service. 
The Rotunda continues its active role in research, and during 2012 there were a
total of two MD candidates in the Department of Paediatrics: Drs Cecile Halling
and Michael Boyle. Funding was also secured for three further post doc research
projects and these three registrars will take up posts in 2013. We continue to
provide ongoing support for neonatal staff undertaking the post graduate
Diploma in Neonatal Nursing at the RCSI. 3 staff completed the program in 2012.
In collaboration with the RCSI the first National Masters Program for training
Nurse Practitioners in Neonatology (ANNP) took place. Professor Naomi
McCallion was instrumental in developing the ANNP program and it is
anticipated that the Rotunda Hospital will support staff wishing to undertake
the program in the near future, and continue to develop and expand the ANNP
role in the Unit.
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TABLE 2A:  NICU DEATHS OF NORMALLY FORMED INFANTS <1500g
GEST BW (g) Age Sex Mode of Apgars Principle Cause of death
(Days) delivery
24 730 2 M EMLSCS "0,2" "APH,  bilateral Grade 3 IVH, cerebellar 
haemorrhage, intensive care withdrawn "
24 530 6 F SVD "7,9" "Twin, coagulopathy, large Left grade 4 IVH"
24 600 4 F EMLSCS "5,6" "Twin, bilateral grade 3  IVH, refractory 
hypotension,acute renal failure"
24 630 2 F BREECH "3,5" "Anhydramnios from 23 weeks, intestinal  
perforation, refractory hypotension, severe 
pulmonary hypoplasia."
24 830 2 M EMLSCS "5,8" "Right Grade 4 left Grade 2 IVH, 
chorioamnionitis, RDS, care withdrawn "
24 500 23 F SVD "5,8" "Twin-twin transfusion syndrome, 
Right grade 4 IVH, PDA , acute renal failure"
24 500 20 F SVD "3,3" Terminal apnoeic event; Severe hypoxic 
ischaemic encephalopathy seen on PM
25 680 16 F SVD "3,7" "Bilateral grade 3 IVH,  late onset 
pseudomonas sepsis"
26 740 0 M SVD "6,6" "Early onset Coliform sepsis, intestinal 
perforation, bilateral grade 4 IVH"
26 785 8  days F Breech "2,5" "Bilateral grade 4 IVH, early onset coliform 
sepsis, pneumothorax, intestinal perforation"
26 890 1 M "SVD, "Hypothermia, hypotension, severe respiratory
home delivery" N/A distress syndrome and pneumonia"
27 890 2 M EMLSCS "2,3" "PPROM from 17 weeks, anhydramnios,  
contractures, severe pulmonary hypoplasia"
28 955 2 F EMLSCS APH "5,7" "PPROM at 24 week, DIC, exchange transfusion, 
PPHN, intracerebral haemorrhage intensive 
care withdrawn"
30 1780 1 M EMLSCS "5,6" "PPROM at 26 weeks, oligohydramnios, 
chorioamnionitis, RDS, acute renal failure"
37 2890 25 F SVD "7,9" "Failure to thrive, poor feeding, respiratory 
failure, encephalopathy of unknown cause"
38 2580 4 M EMLSCS "Severe neonatal encephalopathy, thalamic
abruptio echogenicity,intensive care withdrawn"
placenta "0,2"
40 3600 6 F EMLSCS "3,3" "Twin-twin transfusion syndrome, Bilateral  
grade 1 IVH, PDA , pulmonary hypertension, 
chronic lung disease"
40 3990 0 F SVD "0,0" "Severe neonatal encephalopathy, thalamic 
echogenicity,intensive care withdrawn"
42 4350 1 M SVD "9,10" "Admitted with low saturations at 6 hours, 
Severe PPHN, group B spreptococcal pneumonia "
TABLE 1 ADMISSION TO NEONATAL  UNIT 2012
 Admission From Count Percentage
Delivery Suite/Theatre 749 68.04%
Home 76 6.90%
Other Hospital 30 2.72%
Postnatal Ward 246 22.34%
Total Admission 1,101 100.00%
Admission Type Description Count Percentage
First admission 1,101 96.33%
Re-admission 42 3.67%
Total Admission 1,143 100.00%
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TABLE 2B: DEATHS RELATED TO CONGENITAL MALFORMATIONS/ DEFORMATIONS
GEST BW (g) Age Sex Mode of Apgars Principle Cause of death Inborn 
(Days) delivery /outborn
29 890 1 F EMLSCS "5,8" Hypoplastic left heart syndrome
29 1170 0 M EMLSCS "2,2" "Arthrogryphosis with severe facial deformity, 
PROM at 20 weeks with anhydramnios, 
pulmonary hypoplasia"
29 1340 6 M EMCS "6,6" "Acute renal failure, congenital hydrothorax, 
refractory hypotension, Noonans syndrome"
31 2400 0 F EMCS "0,1" "non immune hydrops, congenital 
megakaryoblastic leukemia, trisomy 21"
34 2180 0 M BREECH "2,1" "Potters syndrome, renal agenesis, 
bladder hypoplasia"
34 2140 1 M ELSCS "VACTERL syndrome, imperforate anus,
(anhydramnios) "6,8" hydrocephalus, pulmonary hypoplasia, Right
renal agenesis, left dysplastic kidney"
34 2380 0 M SVD "6,5" Antenatal diagnosis of Infant polycystic disease
with Potters sequence
34 2550 0 M EMLSCS "0,0" "twin-twin transfusion, trisomy 21, refractory 
bradycardia, hypotension, PPHN, congenital 
heart disease"
35 2140 4 Forceps "0,0" "Trisomy 21, duodenal atresia, severe neonatal 
encephalopathy"
36 2460 0 F SVD "1,1" "arthrogryphosis, oligohydramnios, 
pneumothorax, no cause identified "
37 2210 21 M EMLSCS "5,7" Right  Diaphragmatic hernia
37 3520 9 F ELLSCS "5,8" "Posterior fossa tumour and hydrocephalus, 
inoperable"
38 2290 1 F SVD "3,3" anencepcephaly
39 2330 24 M SVD "6,8" "Trisomy 18, ASD,VSD"
39 3500 1 M vacuum "5,6" "Large Left Diaphragmatic hernia, severe 
pulmonary hypoplasia, Multiple Ventricular 
Septal Defect "
39 3470 9 M SVD "9,9" "Double outlet right ventricle, coarctation,total 
anomolous pulmonary venous drainage"
69
TABLE 3: NEONATAL ENCEPHALOPATHY 
Grade Gest Mode of Apgars In/Out Therapeutic Cord 1st BE Neuro Imaging Outcome  
NE Delivery 1,5,10 MinsBorn Hypothermia Ph gas
2 41 Em Lscs "4,5,6" IN Yes 6.96 -12.3 Normal MRI d8 normal at 4 months
2 38 El Lscs "9,10" IN Yes 7.33 -7.3 Normal MRI d5 normal at 1 yr
2 40 Em Lscs "1,2,5" IN Yes 7.21 -1.7 Normal MRI d5 normal at 10 months
2 40 SVD "3,4,6" IN Yes 7.17 7.12 -7.1 Normal MRI d4 normal at 4 months
2 40 Ventouse "1,4,5" OUT Yes 6.87 -23.3 Normal MRI d7 normal at 10 months
/ forceps
2 39 SVD "2,6" OUT Yes 6.98 -13.6 MRI  - extensive profound 
*WM changes. hypoglycemia
combined endo & 
neuro f/u
3 35 Forceps "0,0,0" IN No 7.02 -12.4 CRUS d2 - abn "Withdrawal of care,
^BGT and WM RIP d4; T21"
3 40 Forceps "0,0,0" IN Yes 7.19 6.73 -19.9 CRUS d1 - abn "Withdrawal of care,
Thalami RIP d1 "
3 41 Em Lscs "0,1,2" IN Yes 6.91 -14.8 MRI d8 - Suble 
changes in BGT normal at 11 months
3 39 SVD "1,4,5" IN Yes 7.14 -15.8 MRI d5 spastic quadriparesis
- abn BGT CP .
3 38 Em Lscs "0,2,4" IN Yes 7.14 -15.7 Mri d4 - abn "Withdrawal of care,
BGT and WM RIP d5 "
3 38 Em Lscs "0,0,0" IN Yes 7 6.98 -9.2 Mri d9 - rt 
occipital 
infarction normal at 14 months
3 34 SVD "0,1,5" IN Yes 6.98 -12.5 Normal MRI d10 normal at 1 yr
3 41 Em Lscs "1,1,3" OUT No 6.82 -19 Mri d7 - parietal 
lobe changes normal at 6 months
3 41 Em Lscs "0,0,0" OUT Yes 6.8 -20.2 No "Withdrawal of care, 
RIP d2 "
3 39 Em Lscs "0,0" OUT Yes 7.12 6.7 -25.6 CRUS d2- "Withdrawal of care,
abn BGT RIP d2 "
3 41 SVD "0,3,6" OUT Yes 7 6.65 -20.6 Normal MRI d6 1 yr right hemiplegia
3 38 "SVD, "3,5,5" OUT Yes 6.95 -11.5 CRUS D2 
breech" -  severe PVL "Withdrawal of care, 
RIP d3"
*WM denotes white matter
^BGT denotes basal ganglia and thalami
TABLE 4: Vermont Oxford Network Data (VON)
Rotunda Vermont Oxford Network 2012
Infants 501-1500g Infants
n=127 501-1500g
Measure
Infant Cases % % 
Characteristics
Antenatal Steroids, All Infants 92 76.0% 87.3%
C-Section 89 72.4% 72.2%
Multiple Gestation 51 41.8% 27.5%
Any Major Birth Defect 15 12.3% 4.7%
Small for gestational age 29 23.6% 23.30%
Chorioramnionitis 29 25.0% 12.80%
Interventions and Outcomes
Apgar 1 minute < 4 20 16.4% 25.7%
Any initial rescucitation 117 95.1% 88.5%
Admission Temperature< 36.0 22 18.3% 19.5%
Mortality 19 15.8% 12.0%
Surfactant at any time 80 66.1% 60.1
Inhaled Nitric Oxide 10 8.5% 4.6%
Patent Ductus Arteriosus 
Ligation 5 4.1% 5.4%
Late Bacterial Infection 9 7.1% 8%
Coagulase Negative Staph 2 1.6% 6.0%
Fungal Infection 0 0.0% 1.0%
Any Late Infection 11 8.7% 12.8%
Necrotizing Enterocolitis 7 5.8% 5.4%
Severe Intraventricular 
Haemorrhage 4 4.0% 7.8%
Severe ROP  (Retinopathy 
of prematurity) 1 1.0% 6.0%
ROP surgery 2 1.7% 2.8%
Periventricular leukomalacia 0 0.0% 2.8%
Chronic Lung Disease 
< 33 weeks 29 29.9% 25.4%
Chronic Lung Disease (36 weeks) 27 26.70% 24%
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CONSULTANT SURGEON Mr. Paul Connolly FRCSI, FRCSOrth
ORTHOPAEDIC PHYSICIAN Dr. Hilary Lane MB, PhD
The orthopaedic service in the Rotunda hospital provides a full neonatal screening
service with an emphasis on screening for Developmental Dysplasia of the Hip
(DDH). Here we outline the DDH screening program, which has been developed in
conjunction with the Dept. of Orthopaedic Surgery, Children’s University Hospital
Temple Street.  
Rotunda Hospital Infant Developmental Dysplasia of the Hip Screening
Programme
1.) All neonates undergo clinical examination for hip instability, 
preferably by an experienced clinical examiner.
2.) A subset of neonates are selected for hip ultrasound at 6 weeks 
and hip xray at 4 months,  on the basis of the following criteria:
a. Positive family history of DDH
b. Breech presentation at birth
c. Talipes Equinovarus, Calcaneovalgus, Metatarsus Varus.
d. Oligohydramnios
e. Ligamentous laxity on clinical examination
3.) Babies who have hip instability or hip dysplasia detected on clinical 
examination or ultrasound are treated for an initial period of 6-8 weeks in
a Pavlik harness.
4.) Treatment progress is monitored using hip ultrasound at 2 weeks 
and 6-8 weeks. 
5.) If dysplasia is still present after 6-8 weeks in a Pavlik harness,
treatment is continued  for a further 6 weeks.
6.) Follow-up xrays of the hips are performed at 4, 8-10 
and 15-18 months of age.
7.) Babies are referred to Children’s University Hospital, Temple St. for 
follow-up surgery as required based on xray and clinical findings.
DEPARTMENT OF ORTHOPAEDIC SURGERY
DATA FROM THE DDH SCREENING SERVICE
2008 2009 2010 2011 2012
Total No. of babies diagnosed 
with unstable hip clinically 40 55 66 82 77
Total No. of babies diagnosed 
with dysplastic hip on ultrasound 
requiring treatment 21 14 37 39 31
Total No. of babies treated for 
DDH in Pavlik harness 
(Dysplasia and dislocation) 61 69 103 121 108
Total No. of babies referred for 
further non-operative 
intervention for DDH 4 6 7 10 13
No. of cases of DDH referred
to CUH, Temple St. for surgery 
for DDH† 29 20 12* 10* 11*
† As new cases come to light, the data is added to the birth cohort. These cases
include babies treated for unstable hip who go on to develop persistent stable
dysplasia refractory to bracing treatment, requiring Salter, Pemberton and/ or
Femoral Osteotomies.
* A fall in the number of babies requiring operative intervention is noted after
the introduction of hip ultrasound screening in the neonatal period. This was
introduced by The Master, Dr Sam Coulter-Smith, in 2010.
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D E PA R T M E N T  O F  A N A E S T H E S I A
DR MARY BOWEN, DR JOHN LOUGHREY, DR CONAN MCCAUL, 
DR NIAMH HAYES, DR ROISIN NIMHUIRCHEARTAIGH, 
DR PATRICK THORNTON.
Dr Ivan Hayes left in his capacity as locum Consultant to take up a permanent
position at Cork University Hospital. Dr Ismat ElSaigh departed to take up a
position of Consultant Anaesthetist in Qatar.  The department wish them every
success in their careers.  Dr McCaul remained as College of Anaesthetists Tutor
and Dr Loughrey as Department Chairman. Dr Patrick Thornton was appointed
temporary Consultant Anaesthetist. He has previously trained in Vancouver and
at the Heart Hospital in London. The department was delighted to welcome the
appointment of Dr Roisin Ni Mhuircheartaigh as Consultant Anaesthetist on a
permanent basis. Roisin was awarded a PhD from Oxford University in 2012. All
Consultant posts are held on a joint sessional basis with the Mater Misercordiae
Hospital.
Non-Consultant Hospital Doctors:
The Department was fortunate to avail of the opportunity to provide training in
obstetric anaesthesia for Trainees rotating on the College of Anaesthetists
national training programme. A high level of experience on behalf of the
trainees is relied upon to provide quality Anaesthesia services at the Rotunda.
The staffing consists of 5 Trainees from the National training programme, 2
other NCHD’s and one Fellow in Obstetric Anaesthesia. Dr Aisling McMahon was
the recipient of The James Gardiner Rotunda Anaesthesia medal for 2012. 
DELIVERY  SUITE  ACTIVITY
DELIVERIES UNDER EPIDURAL
2011 % 2012 %
Nulliparous 2569 70% 2571 73%
Multiparous 1582 42% 1672 44%
TOTAL 4151 4243
A wide range of analgesic options are utilised by labouring women, including
nitrous oxide inhalation, opioids and non-pharmacologic techniques such as
relaxation and TENS (transcutaneous electrical neuro stimulation). The maternal
uptake of epidural analgesia in labour are shown above and procedural activity
remains high. All parturients receive patient-controlled epidural analgesia
(PCEA). Combined spinal-epidural techniques are also employed. The small
number of parturients in whom an epidural is contra-indicated can use
remifentanil patient-controlled administration as a high quality analgesic
alternative option although the number of patients receiving this method in
2012 was 35. 
POST DURAL-PUNCTURE HEADACHE (PDPH)
In 2012, 4,243 epidurals and 1,713 obstetric spinal anaesthetics were performed. 24
women had a known dural puncture recorded at epidural placement. 13 patients
had epidural blood patches (EBP) performed and no women required repeat
procedures. 10 blood patches were post-labour epidural and 3 post-spinal
anaesthesia. 
OPERATING THEATRE ACTIVITY
ANAESTHESIA FOR OBSTETRIC AND GYNAECOLOGICAL PROCEDURES
The theatre activity across the 2 elective and one emergency operating theatres
is very high. A total of 3541 Gynaecology procedures were performed with the
majority on a day-case or 24 hour basis.
In addition the department provided anaesthesia services for 3883 obstetric
procedures incorporating Caesarean deliveries and 1284 other obstetric
procedures during 2012 at the Rotunda. An increasing number of laparoscopic
procedures are being performed including surgical management of emergency
ectopic pregnancy.  We provide a 6 day/week service at the HARI unit for women
undergoing oocyte retrieval procedures related to IVF treatments. These are
performed under a propofol-based technique with an anaesthetist present.
Mode of Delivery for Parturients who Select Epidural Analgesia
NULLIPAROUS
Mode of Delivery 2011 % 2012 %
Normal 832 32.4% 892 34.7%
Forceps 337 13.1% 286 11.1%
Vacuum 811 31.6% 843 32.8%
L.S.C.S 585 22.8% 546 21.2%
Breech 4 0.2% 4 0.2%
Total 2569 100% 2571 100%
MULTIPAROUS
Mode of Delivery 2011 % 2012 %
Normal 1150 72.7% 1258 75.2%
Forceps 58 3.7% 41 2.5%
Vacuum 222 14% 209 12.5%
L.S.C.S 151 9.5% 161 9.6%
Breech 1 0.1% 3 0.2%
Total 1582 100% 1672 100%
The obstetric outcomes of women who select epidural analgesia are compatible
with low dose techniques employed, with over 34% of primiparous women and
over 75% of multiparous women experiencing normal unassisted vaginal
delivery.
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ANAESTHESIA OUTPATIENT CLINIC
Pre-Anaesthesia assessment is performed for in-patients or on an outpatient
basis for defined referral criteria. The clinic ran weekly with a total of up to 10
attendances per week, with a total of 446 attendances. Both obstetrical and
gynaecological cases are reviewed. The service is limited to patients whose care
needs to be planned in advance of hospital admission. A specialised assessment
service for women with congenital cardiac disease is also run in conjunction
with the Mater Hospital to provide rapid multi-disciplinary assessment. Patients
with gynaecological and obstetrical pain are also reviewed on a consult basis.
PEER REVIEWED PUBLICATIONS
Hayes I, Rathore R, Enohumah K, Mocanu E, Kumar D, McCaul C. The effect of
crystalloid versus medium molecular weight colloid solution on post-operative
nausea and vomiting after ambulatory gynecological surgery - a prospective
randomized trial. BMC Anesthesiol. 2012 Jul 31;12:15. 
2: Aslani A, Ng SC, Hurley M, McCarthy KF, McNicholas M, McCaul CL. Accuracy of
identification of the cricothyroid membrane in female subjects using palpation:
an observational study. Anesth Analg. 2012 May;114(5):987-92.
3: Aslani A, Husarova V, Ecimovic P, Loughrey J, McCaul C. Anaesthetic outcomes
in obese parturients: the effect of assessment in the high-risk clinic. Ir J Med 
Sci. 2012 Mar;181(1):93-7. 
CAESAREAN SECTION  -  Anaesthesia Technique
2011
Mode of Anaesthesia Elective % Emergency %
Spinal 1250 96.2% 593 37.7%
GA 30 2.3% 201 12.8%
Epidural 7 0.5% 656 41.7%
CSE 12 0.9% 123 7.8 %
Tot al 1299 1573
2012
Mode of Anaesthesia Elective % Emergency %
Spinal 1214 96.3% 499 35.2%
GA 12 1.0% 182 12.8%
Epidural 9 0.7% 641 45.2%
CSE 25 2.0% 95 6.7%
Tot al 1260 1417
The regional anaesthesia rates for caesarean delivery are 87.2% and 99%
respectively for non-elective and elective cases. Non-elective cases include category
1-3 deliveries by Caesarean. We utilize low dose neuraxial opioid as part of a multi-
modal technique for post-caesarean analgesia.
H I G H  D E P E N D E N C Y  U N I T
DR. MARY BOWEN  CONSULTANT ANAESTHETIST
Admissions NUMBER %
Total 193
Obstetric 174 90.1
Gynaecology 19 9.8
Obst et r ic Admissions
Number % % Total
Peripartum Haemorrhage 66 37.9 34.2%
Pre-eclampsia 52 29.9 26.9%
HELLP 3 1.7 1.55%
Peripartum Sepsis 31 17.8 16%
Others 31 17.8 16%
Congenital Cardiac Obstetric Patients 7 4 2%
CONGENITAL  CARDIAC OBSTETRIC PATIENTS  (7)
1 Tetralogy of Fallot for elective caesarean section.
2 Lowe-Ganong-Lewine Syndrome. Elective caesarean section at Mater 
Misericordiae University Hospital Patient developed Post partum 
haemorrhage and required hysterectomy. 
3 Submembranous aortic stenosis. Elective caesarean section in Rotunda 
Hospital.
4 Tetralogy of Fallot, Addison’s Disease, Biliary Thrombosis, Asthma and 
Epilepsy. Elective caesarean section.
5 Transposition of Great Vessels. Elective caesarean section.
6 Dextrocardia and Coarctation of Aorta. Elective caesarean section.
7 Transposition of great vessels. Elective caesarean section. 
Ot her s (31 pat ient s)
1 Patient with histiocytosis. Caesarean section in Mater Misericordiae 
University Hospital.
2 Patient with Gitelman’s Syndrome post caesarean section in Rotunda 
Hospital.
3 Patient with Pulmonary Hypertension due to multiple Pulmonary 
Embolisms. Caesarean section at Mater Misericordiae University Hospital.
Post partum haemorrhage. Proceeded to hysterectomy.
4 Cachectic patient for Caesarean section with a low Potassium and 
Magnesium
5 Pregnant patient with Addison’s Disease
6 Tachypnoea and tachycardia post caesarean section. Found to have 
Pulmonary embolism.
7 Patient with Freidrich’s Ataxia post spontaneous vaginal delivery.
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8 Patient with history of Osteosarcoma who developed Sodium losing 
enteropathy post amputation of  lower limb. Elective caesarean section at 
Mater Misericordiae University Hospital.
9 Cornual ectopic  patient.
10 Patient with history of previous cerebellar infarct post caesarean section.
11 Severe headache with normal blood pressure. For investigations post 
spontaneous vaginal delivery.
12 Patient for  analgesia post caesarean section  (x 2 patients)*
13 Patient with Fibrotic lung disease. Caesarean section in Mater 
Misericordiae University Hospital
14 Patient who desaturated post SVD, developed  pulmonary oedema
15 Patient with IUD. Grand mal seizure following Pethidine injection
16 Patient with anaphylactoid reaction to Oxytocin.  Developed post partum 
Haemorrhage post elective caesarean section.
17 Patient for elective caesarean section for twins developed perioperative 
dysrhythmias
18 Patient for elective caesarean section with multiple antibodies in blood.  
Cell salvage required.
19 Pregnant patient developed severe headache and visual disturbances 
during caesarean section.
20 Pregnant patient with Acute Coronary Syndrome due to cocaine abuse.
21 Patient who developed Atrial Fibrillation post caesarean section.
22 Patient with pulmonary embolus post spontaneous vaginal delivery.
23 Patient with a history of Opiate allergy requiring epidural infusion  post 
caesarean section.
24 Patient who had elective caesarean section. She had an MI at 26 weeks 
gestation and two previous  caesarean sections.. Patient developed PPH 
requiring  hysterectomy.
25 Patient developed  wound dehiscence and bowel protrusion five days post 
caesarean section.  Developed bronchospasm  and subsequently pulmonary
oedema.
26 Patient arrested after spinal for Laser for Twin to Twin transfusion.
27 Patient at 23 weeks gestation, Type 2 Diabetes Mellitus with Diabetic 
Ketoacidosis
28 Patient 17 weeks gestation with Hyperemesis and Hypokalaemia
29 Caesarean section  for placenta accreta. Cardiac arrest on operating table. 
Potential Amniotic Fluid Embolus. Transferred to Mater Misericordiae 
University Hospital.
30 Patient with laser for twin to twin transfusion syndrome, developed chest 
pain and Shortness of breath.  Pulmonary Embolism /H1N1. Transferred to 
Mater Misericordiae University Hospital
31 Patient with Hyponatraemia, Hypokalemia,  Coagulopathy and  Sickle cell 
trait at 29 weeks gestation. Transferred to Mater Misericordiae University 
Hospital
Gynaecol ogical  Pat ient s (19)
Intraoperative Bleeding 6
Sepsis 2
Post Operative Analgesia. 5
History of fibromyalgia 1
Hyponatremia post roller ball procedure 1
Hypotension post laparoscopy 1
History of  cardiac disease – post hysterectomy. 1
Pulmonary oedema post laparoscopy for ectopic pregnancy. 1
Patient having TVT had intravascular injection of local anaesthetic. 1
Caesarean Hysterectomies 6
Ectopics 6
ERPC 3
INVASIVE  MONITORING
Arterial line 33 17%
CVP 8 4%
Tr ansf er s t o Mat er  Miser icor diae Univer sit y Hospital  (15)
1 Patient who had laser for twin to twin transfusion and developed chest 
pain and shortness of breath.
2 Septic miscarriage.
3 Patient became septic 6 days post hysteroscopy and Mirena insertion. Had 
perforated uterus. Required hysterectomy.
4 Patient who had TVT under spinal. Developed tachycardia and ST elevation
following LA infiltration. Chest pain in recovery. 
5 29/40 with sickle cell trait with abnormal electrolytes
6 Patient with PPH - 6 litres. Had hysterectomy
7 Patient with Hypertension,Renal artery stenosis. Had emergency LSCS 
under GA. Deteriorating renal function post LSCS
8 Patient who had Emergency LSCS for APH. Previous caesarean sections x3. 
Had Hysterectomy
9 Patient who had 2 previous caesarean section and MI at 26/40.  Had stent 
inserted. PPH at LSCS> Hysterectomy. 
10 Patient who arrested after spinal for laser for twin to twin transfusion. 
Transferred for cooling
11 Patient who had haemoperitoneum at Category I caesarean section.  Found
to have abnormal vasculature over uterus. 
12 Elelvated blood pressure and disorientation 12 days postnatally.  PET.  
Patient admitted. Transferred to Mater for management and cranial imaging.
13 Patient transferred to Rotunda Hospital from other hospital. Post Partum 
Haemorrhage + sepsis multiresistent E.coli.
14 Multifibroid uterus. Classical  caesarean section with blood loss and sepsis.
Transferred to ICU, Mater Hospital.
15 Jehovah's Witness patient with Ectopic pregnancy.  Transferred to Rotunda
Hospital from other hospital.  Major haemorrhage 2.5l. blood loss. Cell 
salvage required. Discharged to Mater ICU.
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D O V E  C L I N I C
DR JACK LAMBERT, Consultant in Infectious Diseases 
DR MAEVE EOGAN, Consultant Obstetrician and Gynaecologist
DR WENDY FERGUSON, Associate Specialist Paediatrician with the Paediatric 
Infectious Diseases Service (The Rainbow Team)
DR BARRY KELLEHER, Consultant in GI/Hepatology
DR SUZANNE CORCORAN, Consultant Microbiologist
MS MAIREAD LAWLESS, ID Liaison Midwife
MR JUSTIN GLEESON, Drug Liaison Midwife 
MS NICOLA ROGERS, Medical Social Worker
DR VALERIE JACKSON, Clinical Audit & Surveillance Scientist
INTRODUCTION
The DOVE clinic was set up to look after the specific needs of women who have
or are at risk of blood and sexually transmitted bacterial and viral infections.
This could be through drug use, unprotected sex, or any contact with infected
blood or body fluid.  
DOVE BOOKINGS IN 2012
During 2012, 227 women booked into the DOVE clinic for their antenatal care. Of
these, 
• 70 (31% of bookings) women were positive for Hepatitis B surface antigen, 
representing a decrease of 18% compared to 2011 (Fig 1). 
• 61 (27%) women were positive for Hepatitis C antibody, a decrease of 23% 
compared to 2011.
• 36 (16%) were positive for HIV infection, an increase of 33% compared 
to 2011. 
• 15 (7%) women had positive Treponemal serology, a decrease of 6% 
compared to 2011.
• 73 (33%) women were known to be on prescribed methadone programs 
Fig 1: DOVE Bookings by Year
DOVE DELIVERIES 2012
Deliveries to HIV Positive Mothers 2012
Total Mothers Delivered <500g (incl miscarriage) 1
Total Mothers Delivered >500g 30
Tot al  Mot her s Del iver ed 31
Live Infants 30
Miscarriage 3 (1 set of triplets)
Stillbirths 0
Infants <37 weeks gestation 2
Infants ≥37 weeks gestation 28
Infants delivered by Caesarean Section 18
HIV Positive Infants 0
Mat er nal  Data (n=31)
Median Age 32
Newly Diagnosed at ANS 7
Deliveries to HCV Positive Mothers 2012
Total Mothers Delivered <500g (incl miscarriage) 2
Total Mothers Delivered >500g 68
Tot al  Mot her s Del iver ed 70
Live Infants 71 (incl 3 sets of twins)
Miscarriage 2
Stillbirths 0
Infants <37 weeks gestation 14 (incl 3 sets of twins)
Infants ≥37 weeks gestation 54
Infants delivered by Caesarean Section 22
HCV Positive Infants 0
Mat er nal  Data (n=67)
Median Age 30
Newly Diagnosed at ANS 12
Deliveries to HBV Positive Mothers 2012
Total Mothers Delivered <500g (incl miscarriage) 3
Total Mothers Delivered >500g 73
Tot al  Mot her s Del iver ed 76
Live Infants 73
Miscarriage 3 
Stillbirths 0
Infants <37 weeks gestation 5
Infants ≥37 weeks gestation 68
Infants delivered by Caesarean Section 19
HBV Positive Infants 0
Mat er nal  Data (n=70)
Median Age 28
Newly Diagnosed at ANS 15
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Deliveries to Syphilis Positive Mothers 2012
Total Mothers Delivered <500g (incl miscarriage) 1
Total Mothers Delivered >500g 17
Tot al  Mot her s Del iver ed 18
Live Infants 17
Miscarriage 3 (1 set of triplets)
Stillbirths 0
Infants <37 weeks gestation 0
Infants ≥37 weeks gestation 17
Infants delivered by Caesarean Section 6
Syphilis Positive Infants 0
Mat er nal  Data (n=18)
Median Age 30.5
Newly Diagnosed at ANS 11
Deliveries to Mothers under DLM* service 2012
Total Mothers Delivered <500g (incl miscarriage) 8
Total Mothers Delivered >500g 81
Total Mothers Delivered 89
Live Infants 82 (incl. 2 sets twins)
Miscarriage 8
Stillbirths 1
Infants <37 weeks gestation 18
Infants ≥37 weeks gestation 64
Infants delivered by Caesarean Section 25
NICU admissions for NAS 14
*DLM: Drug Liaison Midwife
In 2012, 299 infants attended the Rotunda Paediatric Infectious disease clinic
(The Rainbow clinic) for follow up.The clinic is delivered solely by a paediatric
specialist (Dr Ferguson).
EDUCATION AND TRAINING 
Members of the DOVE team are actively involved in undergraduate,
postgraduate and hospital education programmes. 
The British Association for Sexual Health and HIV (BASHH) accredited Sexually
Transmitted Infection Foundation (STIF) Course continues to be held in the
Rotunda Hospital, with Dr Lambert acting as course director. The course ran in
September and December 2012 and provided multidisciplinary training in the
attitudes, skills, and knowledge required for the prevention and management of
STIs. Further courses are planned for 2013. 
The Royal College of Physicians in Ireland established a Sexual Health Policy
Group in 2010, which worked on position statements in various aspects of sexual
health. Members of the DOVE team were actively involved with the education
and prevention subcommittees and Dr Lambert was co-chairperson of the Policy
Group. The Policy Group launched its first set of position statements on
education, prevention and clinical services for STIs at the Sexual Health
Awareness Week (28 May - 31 May 2012).
RESEARCH ACTIVITIES OF THE DOVE CLINIC
There are several research projects ongoing, many in collaboration with the ID
and Hepatology teams at the Mater Misericordiae University Hospital. Areas of
interest include the emergence of drug resistance and the pharmacokinetics of
HAART during pregnancy. 
The DOVE clinic has collaborated with the obstetric, paediatric and pharmacy
departments of the Coombe Women and Infants University Hospital to
investigate the effect of methadone and maternal drug use on perinatal
outcomes. This work has resulted in two peer-reviewed publication in the
journal Addiction.
A study of universal screening for genital Chlamydia trachomatis infection in,
all sexually active women presenting for care who are <26 years old, commenced
in December 2011. This study is ongoing.
Ot her  Devel opment s
In 2012 the DOVE team produced a patient information booklet which is given to
all patients who attend the clinic and is also available to download from the
hospital website. The booklet gives information on the staff and services of the
clinic including infection specific information on what to expect as a DOVE
patient.
STAFF CHANGES
In January 2012, Dr Wendy Ferguson was appointed associate specialist
paediatrician with the paediatric infectious disease service. This affiliation is
with the national paediatric infectious disease service otherwise known as The
Rainbow Team with its members based primarily at Our Lady’s Children’s
Hospital Crumlin.
PUBLICATIONS AND PRESENTATIONS
B J Cleary, M Eogan, M P O’ Connell,  T Fahey,  P J Gallagher,  T Clarke, M J White,
C  Mc Dermott, A O'Sullivan,  D Carmody,  J Gleeson & D. J. Murphy, (2012a)
Methadone and perinatal outcomes: a prospective cohort study. Addiction, 107,
1482-1492.
B. J Cleary, K Reynolds, M Eogan, M. P O’ Connell, T Fahey, P.J Gallagher, T Clarke,
M.J White, C Mc Dermott, A O'Sullivan, D Carmody, J Gleeson & D. J Murphy,.
(2012b) Methadone dosing and prescribed medication use in a prospective
cohort of opioid-dependent pregnant women.. Addiction, doi:1111/add.12078. 
L Else, V Jackson, M Brennan, J Breiden, M Lawless, S Coulter-Smith, D Back, S
Khoo , J S Lambert. Therapeutic Drug Monitoring (TDM) of Atazanavir in
Pregnancy. 11th International Congress on Drug Therapy in HIV Infection 11-15th
November 2012 Glasgow
A. Varughese, V .Ciprike, V. Jackson, M .Cafferkey, S. Corcoran, M. Brennan, M.
Lawless , M. Eogan, W. Ferguson, S. Coulter- Smith, J. Lambert. Auditing syphilis
serology in pregnant women over a period of 7 years (2005-2011) in a large
maternity hospital in Dublin, Ireland. 2012 NDHG Inaugural Conference on
Collaborative Lifespan Research, 29th November 2012, The Rotunda Hospital,
Dublin
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A  Ali, K Glennon, B Kelleher, M Eogan, V Jackson, M Brennan, M Lawless, W
Ferguson, J Lambert. Five year retrospective review of antenatal Lamivudine
(LAM) to reduce the perinatal transmission of Hepatitis B (HBV). 2nd Irish
Congress of Obstetrics Gynaecology and Perinatal Medicine. 30th Nov - 1st
December 2012. Druids Glen .Co Wicklow.
A. Varughese, V .Ciprike, V. Jackson, M .Cafferkey, S. Corcoran, M. Brennan, M.
Lawless , M. Eogan, W. Ferguson, S. Coulter- Smith, J. Lambert. Auditing syphilis
serology in pregnant women over a period of 7 years (2005-2011) in a large
maternity hospital in Dublin, Ireland. 2nd Irish Congress of Obstetrics
Gynaecology and Perinatal Medicine. 30th Nov - 1st December 2012. Druids Glen
.Co Wicklow.
A O’Higgins, V Jackson, G Connolly, S Corcoran, J Lambert. Screening for
asymptomatic urogenital Chlamydia trachomatis infection: results of a pilot
study. 2nd Irish Congress of Obstetrics Gynaecology and Perinatal Medicine.
30th Nov - 1st December 2012. Druids Glen .Co Wicklow.
M Eogan, J Gleeson. Managing a pregnant substance misuser. Irish College of
General Practitioners Summer School, June 2012.
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STEPHANIE RYAN  FFR RCSI 
NEIL HICKEY FFR RCSI
AILBHE TARRANT FFR RCSI
The radiology department in the Rotunda Hospital performed 7,532 exams in
2012 representing a 9% increase in activity over 2011 figures. This department
images both adults and children. 7.3% of these were adult examinations and
92.7% were paediatric examinations.
We continue to train radiographers in ultrasonography and in particular in hip
sonography.   We have set up a quality improvement and audit programme and
have quarterly meetings to review progress in this area.  In 2012 we were the first
radiology department in the country to begin recording peer review.
ADULT RADIOLOGY 
The adult radiology service in the Rotunda Hospital is provided by Dr. Neil
Hickey. In 2012 a total of 710 adult radiological examinations were performed of
which 63% were hysterosalpingograms, performed as part of the fertility clinic
work up. Other examinations also include other fluoroscopic procedures such as
cystograms and plain films performed on Rotunda inpatients.
PAEDIATRIC RADIOLOGY 
A total of 6,753 paediatric studies were performed in 2012. Of these, 2,972 were
paediatric ultrasound examinations representing a 43% increase over 2011
figures.  The majority of these examinations, 1,512 scans, were hip ultrasound
examinations done on outpatient babies. The increase in hip ultrasound
scanning is appropriately associated with a corresponding decrease in the
number of hip X-rays performed to 1,144, a decrease of 30% compared with the
same period in 2011. In addition 72 fluoroscopic studies were performed
predominantly for investigation of the GI tract, often as an emergency out of
hours studies. 
The MRI unit at the Children’s University Hospital, Temple Street, which has
state of the art neonatal monitoring equipment, scanned a total of 118 Rotunda
babies from both NICU and POPD.  This is particularly valuable in the evaluation
of the newborn with neonatal encephalopathy and adds very useful additional
information to the bedside cranial ultrasound examination.  MRI scanning was
also used for the evaluation of babies with brain and spine malformations as
well as metabolic and other diseases.  Twelve paediatric patients were referred
to TSH for CT scanning.  Fetal MR imaging is also done in Temple Street for
obstetric patients at the Rotunda.
R A D I O L O G Y /
P A E D I A T R I C  U L T R A S O U N D
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Both Drs Ryan and Tarrant are actively involved in training at several levels and
in paediatric radiology research.  Dr Ryan published a book chapter on imaging
of congenital abnormalities of the gastrointestinal tract.  There were several
publications from our department as well as presentations and lectures at
national and international meetings.
TABLE 1: STAFF COMPLIMENT
WTE
Diagnostic radiographers / ultrasonographers 2.5
Secretary 0.5
Consultant paediatric radiologist 0.76
Consultant adult radiologist 0.20
Senior medical physicist As needed
TABLE 2: ACTIVITY LEVELS
ADULT EXAMS 710
HSG 450
PAEDS   (X-ray & US) 6753
TOT PAEDS US 2972
CRANIAL 1144
NICU US & CR 2130
BIBLIOGRAPHY RADIOLOGY DEPARTMENT 
Book Chapters
1. Pablo Caro and Stephanie Ryan. Normal Anatomy and congenital 
anomalies In Imaging of Gastrointestinal Tract.  Springer Verlag. Berlin 
Heidelberg 2012
PUBLICATIONS
1. Bracken J, Heaslip I, Ryan S, Chloral hydrate sedation in radiology: a 
retrospective audit of reduced dose.  Pediatr Radiol (2012) 42:349-354.
2. Hayes B, Cooley S; Donnelly J; Doherty E; Grehan A; Madigan C; McGarvey
C; Mulvany S; Ryan S; Gillian J; Geary MP; Matthews TJ; King MD. 
The Placenta in Infants more than 36 weeks Gestation with Neonatal 
Encephalopathy: A Case Control Study. Arch Dis Child   Pub on line ahead 
of print 12 Jul 2012 
PUBLICATIONS ON EURORAD: 
European Assoc Radiology On line Case studies file
Case 9584 Fatal infantile encephalopathy due to complex 1 deficiency – a
mitochondrial DNA mutation disorder.  Walshe T, Browne AM, Ryan S.  Aug 12
PRESENTATIONS
1. Audit of Micturating Cystourethrograms performed over 1 year in a 
Children’s Hospital.  Lyons K, Sorensen J, Twomey EL, Donoghue VB, 
O Riordan M, Ryan S. ECR annual meeting Vienna March 2012.
2. Correlation between MR imaging of the brain and biochemical 
abnormalities of children with oxidative phosphorylation disorders Caro P,
Donoghue V, Ryan S Monovari A. European Society of Paediatric Radiology
Annual Meeting, Athens.  June 2012
3. Audit of yield of GP referrals for Ultrasound in Children with UTI.  Pienaar
M, Donoghue V, Laffan E, Twomey E, Ryan S. Children’s university Hospital
Temple Street Audit and Research Day 29 June 2012
4. 3T Magnetic Resonance Imaging of the brain at term in growth restricted
infants.  A short –term surrogate outcome of infants enrolled in the 
Perinatal Ireland PORTO Study (StOOPS) Boyle M, Meaney J, Tarrant A, 
Ryan S, Foran A. Awarded second prize. Children’s University Hospital 
Temple Street Audit and Research Day 29 June 2012
5. Injection of submandibular gland for drooling.  Davies K, Ryan S and 
O’Dwyer T.Irish Otoloryngology Society Meeting, Oct 2012
6. Ventricular Index remains static between 24 and 34 weeks   Shim R, Boyle
M, Gnanasekaran R, Tarrant A, Ryan S, McCallion N. Irish-American 
Pediatric Society Meeting, , Belfast, Northern Ireland. September 2012
7. The relationship between Levene Index and grouped gestational ages in 
preterm infants. Gnanasekaran R, Boyle M, Shim R, Tarrant A, Ryan S, 
McCallion N. Irish-American Pediatric Society Meeting, Belfast,  Northern
Ireland. September 2012
8. Expansion of Ventricular Indices to Include Extremes of Prematurity.  
Boyle M, Shim R, Gnanasekaran R, Tarrant A, Ryan S, McCallion N. Neonatal
Society Meeting, London; November 2012.
INVITED LECTURES
1. Chest radiograph in Children.  Radiology trainee forum.  S Ryan.  Eur 
Congress of Radiology March 2012, Vienna, Austria
2. Cranial Ultrasound, technique, normal findings and intraventricular 
haemorrhage.  A Tarrant.  PVL and Beyond. S Ryan.  Cranial Ultrasound for
Neonatologist Course. Rotunda Hospital 8 June 12
3. Paediatric Imaging and the GP. S Ryan. Paediatric Study day for General 
Practitioners, Children’s Hospital, Temple Street. October 12. Paediatric 
Imaging and the GP.
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MS. MARGARET PHILBIN, DIRECTOR OF MIDWIFERY/NURSING
In 2012 the hospital again experienced very high levels of activity.  Midwives and Nurses
who continue to constitute the largest cohort of staff in the hospital met the challenges
posed by capacity and acuity issues by continuing to provide a wide range of support
and care services for women, babies and families both within the hospital and in the
community.  Headcount and financial constraints again placed further pressure on all
grades of staff and the Midwifery and Nursing team worked with skill, dedication and
enthusiasm to meet ever increasing demands. The ongoing commitment of staff to the
hospital and to those who attend for care is truly appreciated. 
STAFFING
Ms. M. Philbin Director of Midwifery/Nursing
Ms. P. Williamson Assistant Director of Midwifery/Nursing
Ms. F. Hanrahan Assistant Director of Midwifery/Nursing
Ms. M. Keane Assistant Director of Midwifery/Nursing
Mrs. B. Beirne-Moore  Part-time Assistant Director of Midwifery and 
Nursing (retired January 2012)
Ms. T. McCluskey Assistant Director of Midwifery/
Nursing (joined 10th April 2012)
Ms. M. O’Reilly Practice Development Co-ordinator
Ms. A. O’Byrne Part-time Practice Development Co-ordinator
Ms. M. Brennan Assistant Director of Midwifery/
Nursing-Infection Control
Ms. J. MacFarlane Acting Night Superintendent
Ms. M. Whelan Clinical Audit Facilitator
OTHER GRADES IN POST AT 31ST DECEMBER 2012
POST WTE in Post
Director of Midwifery/Nursing 1
Midwifery/Nursing Administration 6
Practice Development Co-ordinators 1.38
Advanced Nurse Practitioner (Neonatology) 2
CMM/CNM 3 5.85
Clinical Skills Co-ordinator 1.9
Clinical Placement Co-ordinator (BSc Midwifery) 3
Allocations Officer (BSc Midwifery) 0.5
PGDM Clinical Co-ordinator 1
Neonatal Discharge Co-ordinator 1
Colposcopy Nurse Co-ordinators 1.65
CMM 2 23.45
CMS/CNS 10.10
CMM1 29.23
Staff Midwives 143.13
Staff Nurses 75.40
Student Midwives 25.50
Maternity Care Assistants 27.39
Total 359.48
D E PA R T M E N T  O F
M I D W I F E R Y / N U R S I N G
APPOINTMENTS WTE
Midwives and Nurses        Midwifery Students
11    21
TOTAL:   33
RESIGNATIONS/ RETIREMENTS
Midwives and Nurses    Midwifery Students
22.02 25
TOTAL:    47.02
RETIREMENTS 
In total 12 staff members retired from the hospital in 2012. Mrs. Bernie Beirne-
Moore retired from her post as Assistant Director of Midwifery/Nursing at the
end of January. Bernie had been on staff for over 34 years and was a great loss to
the service. Mrs. Nuala McInerney (CMM2 Colposcopy) and Mrs. Rosemary
Hennessy (S/M POPD) also retired in January. 
In February Mrs. Mary O’Connell (CMM2 Theatre), Mrs. Annette Carroll (CNM2
NICU), Ms. Kathleen Scully (CMM3 OPD), Ms. Bridget Bourke (S/M OPD), Ms.
Margaret Sheridan (CMM2 Mental Health Services), Mrs. Nora Breen (CNM2
NICU), Ms. Margaret Brophy (CMM2 Theatre), Mrs. Jean Breen (S/M NICU) and
Mrs. Christine Sammon (CMM1 OPD) all retired from the hospital. These
colleagues were senior staff members with a combined wealth of experience
and expertise. We wish them health and every happiness in the future.
RECRUITMENT AND RETENTION
Recruitment and retention of Midwifery Students, Midwives and Nurses
continued to be a major focus for the hospital in 2012 as it has in previous years.
The HSE moratorium on recruitment continued to have an impact on our ability
to recruit staff in the numbers required for service provision. Despite this
situation we were able to introduce some new staff members into the service
during the course of the year and we were delighted to welcome them to the
Rotunda Hospital. In particular we welcomed Mrs. Teresa McCluskey to the post
of Assistant Director of Midwifery/Nursing. Teresa brings many years of
experience at a senior management level which will be of great benefit to the
hospital. 
Staff continued to provide the high standard of care for which the hospital is
renowned. Appreciation is extended to all of the Midwifery and Nursing Team
including the Midwifery Students and Maternity Health Care Assistants who
continue to work tirelessly in pursuit of excellence in the care they provide. 
HOSPITAL BASED MIDWIFERY AND NURSING SERVICES
2012 was again a very busy year with large numbers of women and babies
requiring care and the response from staff was outstanding.
Midwives and Nurses throughout the hospital assisted 11,081 women who
registered for pregnancy related care during 2012.  They attended 8,845 women
during labour and delivery and cared for 9,041 babies in the postnatal wards. 
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The Neonatal Nurses and Midwives faced another year of high activity with 1,089
babies admitted to the unit with varying requirements for care while continuing
to provide intensive and specialist care for ill newborn infants referred from
hospitals throughout the country. 
Staff in Theatre continued to work to full capacity with an increasingly complex
workload. The Midwifery and Nursing staff in the Gynaecological Department
faced a challenging environment with 4,289 admissions with a diverse mixture of
antenatal and postnatal women, high dependency and bereaved patients and
elective and day work being undertaken in that department. 
Clinical Audit
Clinical audit offers a way to assess and improve patient care and uphold
professional standards. Ms. Mary Whelan, Audit Facilitator, continued to assist and
support clinical staff to plan their audit activity.  In 2012 there was a significant
increase in the number of audit’s undertaken by midwifery and nursing staff which
will no doubt increase the quality of care provided for all of the women and babies
who utilise our services.
Maternity Care Assistants       
Maternity Care Assistants continued to play a pivotal role in assisting Midwifery
and Nursing staff in the provision of care for women and babies during 2012.  They
are important members of the team who contribute to the work of the hospital
with energy and commitment and are richly deserving of our sincere thanks. 
COMMUNITY MIDWIFERY SERVICES
The Community Midwifery Services at the Rotunda Hospital have been in place
for 7 years with the service developing over the years to meet the requirements
of those who attend for care. In 2012 the team successfully expanded clinical
services into the Ballymun catchment area. 
The aim of the service is to offer access to Midwife-led or managed care during
the antenatal, intrapartum and postnatal periods. Women availing of the
community Midwifery services are considered to be ‘low risk’ in that they have
no major health or obstetric problems. The midwifery team offer community
based booking and antenatal review clinics. The feedback from the service users
continues to be very positive. In addition, the team offer antenatal parent
education classes to women and partners twice a month.
In 2012, a total of 264 women were booked directly for care with the community
team of Midwives with a further 372 women referred from the Adult Outpatient
Department to the community services following their initial booking visit.
Women are encouraged to book into the service before 8 weeks gestation. Of
those who originally booked, 35 suffered an early miscarriage, 55 women were
referred from the community service due to the development of various medical
or pregnancy related complications and 4 women transferred their care to
facilitate a home delivery which is not available via the Rotunda service. A total
of 511 women remained with the service up to the point of delivery. Of that
number 64.4% (n=329) of women achieved a spontaneous vertex delivery. The
percentage of women who required an emergency caesarean section was 9.4%
(n=48), while 3.5% (n=18) of women underwent an elective caesarean section.
Other statistics pertaining to this group of women are reflected in Table 1:
Table 1 Community Midwifery Service outcomes
Total number of deliveries 2012 511 100%
SVD 329 64.4%
Emergency C/S 48 9.4%
Elective C/S 18 3.5%
Ventouse 95 18.6%
Forceps 12 2.3%
Ventouse/Forceps 6 1.2%
BBA 2 0.4%
Stillborn 1 0.2%
Inductions 140 27.4%
Spontaneous Onset of Labour 37 67.9%
Pain Rel ief
Entonox 279 54.6%
Epidural 252 49.3%
Entonox + Epidural 139 27.2%
General Anaesthetic 5 1.0%
Spinal 13 2.5%
CSE 34 6.7%
Tens 18 3.5%
Pethidine 31 6.1%
No analgesia 50 6.1%
A total of 4 babies were admitted to the NICU where the team continued to offer
support and assistance to the mother’s where possible.
Women continued to be offered early discharge between 6-12 hours post delivery,
with 2,812 women availing of the service. The community team carried out a total
of 8,494 post natal visits in 2012 with each woman receiving an average of 3
postnatal visits in the home. The team continued to enhance their skills to meet
the requirements of the service with staff members completing the Newborn
Discharge Course in Belfast, undertaking studies at Advanced Practice and Master’s
level, undertaking the Midwife/Nurse Prescribers programme and one staff
member receiving re-accreditation as a Lactation Consultant.
Midwifery Education/Practice Development Unit
The Rotunda Hospital and the University of Dublin, Trinity College, its academic
partner for Midwifery education have continued to work closely to ensure the high
standards of previous years were maintained and improved upon. 
The Midwifery / Nursing Practice Development Unit continued to facilitate the
development, implementation and evaluation of ongoing comprehensive student
midwifery education programmes during 2012. In addition, the unit provided
professional learning and development opportunities for qualified midwives and
nurses within the organisation. Supporting staff by facilitating access to education
and research opportunities enhances their knowledge and promotes the use of
current and evidence based practice which ultimately enables an improvement in
the patient’s experience of care.
During 2012 a total of 169 students obtained clinical experience within the Rotunda
Hospital. Students attended from a number of disciplines including undergraduate
and postgraduate midwifery and nursing programmes as outlined in Table 2:
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Table 2 Education Programmes 
Education Programme Number College Link
Higher Diploma in Midwifery 25 Rotunda Hospital
/University of Dublin 
Trinity College
Bachelor of Science in  Midwifery 20 Rotunda Hospital
/University of Dublin 
Trinity College
Undergraduate Nursing 89 Beaumont and Connolly 
Hospital/Dublin City 
University
Undergraduate Children 15 Tallaght University
and General Nursing
Hospital/University 
of Dublin Trinity College
Public Health Nursing 6 University College Dublin
In addition, a number of external students attended on elective placement from
midwifery and nursing educational centres in Ireland and the UK.
The Post Graduate Diploma in Nursing (Neonatal Intensive Care)
The Higher Diploma in Nursing (Neonatal Intensive Care) programme is run
jointly between the three Dublin Maternity Hospitals and the RCSI. This
programme continued to be successful with three Neonatal Staff Nurses
completing studies in 2012. Neonatal Intensive Care is a very challenging and
demanding area requiring continuous adaptation to new technologies and
medical advances. Ongoing support for this course is imperative in ensuring and
maintaining a highly skilled workforce.
Continuing Education and Development
During 2012, members of the Practice Development Unit, the Clinical Skills
Facilitator and staff throughout the hospital worked in partnership with the Centre
for Midwifery Education to devise and develop a number of educational courses for
continued professional development of staff relevant to their area of practice. 
Courses facilitated included: Courses provided on site included:
• Anaphylaxis Training Consent
• Productive Ward Basic Life Support (BLS)
• Preceptorship Neonatal Resuscitation (NRP)
• Diabetes update Emergency Skills (RHOET)
• 20hr Breast feeding Infection Control and Decontamination
• IV Cannulation Audit Training
• CTG workshops Leadership 
• Customer care Performance Planning and Development
• Perineal Suturing Systems analysis
• Wound care Pressure Sore Prevention
• Nursing /Midwifery care Bereavement
for the critically ill patient Clinical Risk 
in conjunction with the Infection Prevention and Control
Mater Hospital ICU IV Medication Workshop
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Staff continued to be given the opportunity to attend conferences of interest
both in Ireland and abroad with 852 training/study days allocated to staff during
the year. Additional Midwives completed the Newborn Examination programme
and the Midwife/Nurse Prescribing Programme. Thirteen staff commenced
education programmes at Master’s level with one Midwife continuing her
studies at PhD level.  Congratulations are extended to those who successfully
completed these programmes.
LACTATION SERVICES
The Rotunda Hospital remains the only Dublin Maternity Hospital to have
achieved the Baby Friendly Hospital Accreditation Award. In July 2012 the BFHI
award was presented to the hospital by Dr. Genevieve Becker, National Co-
ordinator for the Baby Friendly Hospital Initiative. We continue to protect, promote
and support breastfeeding as the optimum way for mothers to feed their babies. 
During 2012, 70% of mothers initiated breastfeeding. A total of 690 new patients
were seen by the Lactation Specialists with 530 calls to the service. 135 postnatal
women attended the support groups throughout the year and 536 attended
information sessions. 
Supports available for breastfeeding mothers and babies in the hospital include:
Antenatal Support
▪ Breastfeeding information is given on an individual basis as required in
the antenatal clinics.
▪ Pregnant women and their partners who attend antenatal education 
programmes provided by the hospital are informed of the benefits and 
management of breastfeeding.
▪ A breastfeeding workshop is provided by the Lactation Specialists and 
other midwives every Tuesday and Thursday evening.
Delivery Suite Support
▪ Hospital policies include mother friendly labour and birthing practices.
▪ Skin to skin contact is policy for all mothers including those following 
Caesarean Section.
▪ Initiation of breastfeeding is also encouraged within the first hour 
of delivery.
Postnatal Support
▪ Individual assistance and support with early breastfeeding problems is 
available from ward staff and Lactation Specialists when required.
Support Following Discharge
▪ An Outpatient service is available for mothers with breastfeeding issues
from Monday to Friday.
▪ A phone service is available Monday to Friday for counselling and advice.
▪ A Breastfeeding support group is held every Thursday from 11.30 to 12.30 hrs.
▪ Community links with Public Health Nurses, General Practitioners and 
voluntary support groups are maintained with mothers referred to these
services when appropriate.
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Breastfeeding Committee Meetings 2012
This is a multi disciplinary committee which also includes members from the voluntary
breastfeeding support groups. There were four meetings held during the year.
Breast Feeding Education Workshops 2012
Breastfeeding lectures were included in all orientation days for all new staff.
Lectures were provided for Medical Students and those attending the Higher
Diploma in Neonatal Nursing programme.
National Breastfeeding Week 
National Breastfeeding week was celebrated in a number of ways in the hospital
with information stands providing a wealth of information for mothers and
staff alike.
Breastfeeding Supportive Workplace
The Rotunda hospital continues to hold a Breastfeeding Supportive Workplace
Silver Award. 
OCCUPATIONAL HEALTH SERVICE
The Occupational Health Department endeavours to protect, maintain and
promote the health of all employees of the Rotunda Hospital. The service is
readily accessible to all employees and plays an extremely important role in
employee welfare. Many of the services provided by the Occupational Health
Department are underpinned by the Safety, Health and Welfare at Work Act
2005. The management of occupational blood and body fluid exposures is an
important occupational health role. Induction education for all employees and
in-service education is an ongoing measure to heighten awareness and reduce
exposures in the workplace.
Main Services Provided 
▪ Health assessment/ screening of all prospective employees.
▪ Sickness absence management and return to work assessments.
▪ Administration of vaccination programmes e.g. Hepatitis B, MMR, chicken 
pox, flu, and the provision of advice on travel vaccines.  
▪ Provision of First Aid treatment to employees who sustain injuries or 
accidents while at work. 
▪ Counselling of staff, post incidents e.g. needle stick, blood/body fluid 
exposure, and referral to an Infectious Diseases Consultant if required. 
▪ Provision of information to all employees on all health-related matters and 
in particular, assisting the provision of advice on measures to 
eliminate/reduce occupational ill health & injury.
▪ Protection against hepatitis B and staff carrying out exposure prone 
procedures are checked to ensure that not only do they have adequate 
protection against the disease, but that they are also not infectious carriers of
the disease.
The seasonal flu vaccine programme continued in 2012 with a large number of
staff vaccinated between October and December. 
94
MENTAL HEALTH SUPPORT
The Perinatal Mental Health Service in the Rotunda saw a change in personnel in
2012. Ms. Margaret Sheridan a pivotal member of the team retired. Margaret was the
first Perinatal Mental Health Midwife in the Republic of Ireland who worked
tirelessly in the service of women attending the Rotunda Hospital for the past
decade. The service welcomed a new staff member Ms. Kathleen O ’Donohoe.
Kathleen is a Nurse, Midwife and Public Health Nurse with many years experience
working with women with post natal depression in the community. Kathleen is also
a fully accredited member of the Irish Association of Counsellors and
Psychotherapists, her expertise will enhance the services already provided. 
There was a growing demand for the Mental Health Support Services with a total of
1,433 women giving a mental health history at their booking visit. This represented
16% of the total number of women delivered in 2012. The support Midwives saw 579
women in the health promotion clinic. Many of these women attended for
assessment, talk therapy and antenatal and postnatal support. A further 1,305 women
with a mental health history were reviewed at ward level for brief intervention,
including health promotion, mental health management and follow up advice. 
Audit featured strongly in relation to this service in 2012. An audit of the “Completion
of the Edinburgh Postnatal Depression Scale” (EPDS) was conducted in August. The
EPDS is a self reporting assessment tool to monitor mood and the audit indicated that
71% of women discharged from the hospital had completed the documentation. As a
result further collaboration between the support midwives and those at ward level has
taken place to increase the opportunity for women to complete this assessment tool. 
The team continued to provide education on the topic of Perinatal Mental Health.
They support education sessions in-house for staff, Public Health Nurses and
Students in Trinity College. In addition, they worked closely with colleagues in the
National Maternity and The Coombe Hospitals’ which culminated in a very
successful study day on Perinatal Mental Health in February 2012.
PARENT EDUCATION
The Parent Education Midwife continued to provide an extensive range of education
sessions to both in-patients and outpatients during 2012.  Parent education sessions
aim to convey positive messages to parents regarding their role in the development of
healthy children and their lifestyles.  This is achieved by woman focused sessions with
the role of the father emphasised throughout.  Education is provided to expectant
women and their birth partners on issues relating to pregnancy, labour and the
immediate postnatal period with feeding choices, baby care and the future demands
of parenthood also discussed.  Information is also provided to inform parents where
to source support and resources when they go home with their new baby. Special
education sessions were organised for groups with specific identified needs including:
• Those with hearing disabilities
• Parents with sight disabilities
• Those with language difficulties
Attendance was high with over 5,000 women attending the daytime education
classes. Ms. Margaret Merrigan Feenan deserves a big thank you for facilitating
these education sessions for so many expectant mothers.
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BEREAVEMENT SUPPORT AND CHAPLAINCY SERVICES
The Rotunda Hospital acknowledges that the loss of a baby before or shortly after
birth is one of the most painful experiences imaginable in any parent’s life and we
offered a range of services through the Bereavement, Recurrent Pregnancy Loss and
Fetal Anomaly Clinics to afford bereaved parents the necessary support to meet
their individual needs. The entire Bereavement team offered support to families
who suffered bereavement during 2012 endeavouring to provide sensitive,
compassionate and individualised care to those families.
The work of the hospital is greatly assisted by the Chaplains and Ministers who are
available to offer support to patients and staff alike. Their dedication and attention
to women, their babies and families and staff is very much appreciated. The
presence of a lay Chaplain on staff has added enormously to the service provided for
patients and staff.
Service of Remembrance
The annual Service of Remembrance was again held in the Pro Cathedral in
November 2012. This year over 1,100 bereaved families attended the event, the
largest number to date. We are extremely grateful for the continued assistance
of the Very Rev. Damien O’Reilly in facilitating this important event. The service
was led by the Chaplains from the main churches with bereaved parents, staff
members and members of the Board of Governors present. The occasion was
enhanced by the presence of soloist Mary Flynn and harpist Denise Kelly to
whom we send a sincere thanks for their involvement. Many staff volunteered to
assist on the day and our gratitude is extended to them also. 
Health Promoting Hospitals
The Rotunda Hospital is a committed member of the Health Promoting Hospitals
Network. The Smoking Cessation Service continued to focus on the important role of
support for those working to reduce or cease smoking. This was particularly
important in 2012 in advance of the Hospital becoming a Smoke Free Campus in 2013. 
CONCLUSION
I would like to take this opportunity to thank the Chairman Ms. Hilary Prentice
and the members of the Board of Governors for the support they have continued
to provide to Midwifery and Nursing in 2012.  I would like to extend my sincere
thanks to the Master, Dr. Sam Coulter Smith and Secretary/ Group General
Manager, Ms. Pauline Treanor for their support. The hospital could not run as
effectively or efficiently without the dedicated Midwifery and Nursing team
who have continued to provide such high quality care despite the many
challenges they face.  I am indebted to them for their endless enthusiasm to
work in the Rotunda Hospital for and with women, babies and families. I would
like to thank our Medical, Allied Health and Support colleagues for their
continued assistance. I wish to acknowledge and thank all of the external
agencies that have continued to support Midwifery and Nursing education and
practice and the Hospital throughout the year. I would like to add a special word
of thanks to the Assistant Directors of Midwifery/Nursing for their loyal and
endless assistance. They continue to meet the ever increasing demands on their
time and talents with patience and enthusiasm.
1. DEPARTMENT STAFF
PROFESSOR AND HEAD OF DEPARTMENT
Fergal D. Malone MD, FACOG, FRCOG, FRCPI
CONSULTANT SENIOR LECTURER
Paul Byrne MD, FRCOG, FRCPI
Fionnuala Breathnach MD, MRCOG FRCPI DCH DipGUMed
Ronan Gleeson MA MD, FRCOG FRCPI
Sharon Cooley MD, MRCOG MRCPI (covering maternity leave) 
HONORARY CLINICAL PROFESSOR
Sam Coulter Smith, MB, BCH, LCRPI & SI, FRCOG
HONORARY CONSULTANT SENIOR LECTURERS
Carole Barry MD, FRCOG
Mary Holohan FRCOG
Edgar Mocanu, MD, MRCOG
MATERNAL FETAL MEDICINE SUBSPECIALTY FELLOW
Jennifer Donnelly MD, MRCOG (to June 2012)
Karen Flood MD, MRCOG (from July to Dec 2012)
SPECIALIST REGISTRAR LECTURERS
Naomi Burke MRCOG (from July 2011)
Aoife Murray MRCPI (to July 2012)
Siglinde Muellers MRCPI (from July 2012)
Mark Dempsey MRCPI ( from July to Dec 2012)
CLINICAL RESEARCH STAFF
Claire O’Rourke (Midwife Sonographer)
Ann Fleming (Midwife Sonographer) (from Sept 2012)
Siobhan NiScanaill (Midwife Sonographer) (covering maternity leave until Aug ‘12)
Fiona Cody (Midwife Sonographer) (covering maternity leave until Aug ‘12)
Elizabeth Tully (Research Manager) 
Grainne Mc Sorley (Research Nurse)
Patrick Dicker (Epidemiologist / Statistician)
Brain Cotter (Research Assistant) (Until Feb 2012)
ADMINISTRATIVE STAFF 
Suzanne Kehoe (Administrative Assistant)
Michelle Creaven  (Administrative Assistant)
Paula Carty (Administrative Assistant)
Lorraine Harte (Administrative Assistant) (covering maternity leave) 
ROYAL COLLEGE OF SURGEONS IN IRELAND
DEPT. OF  OBSTETRICS & GYNAECOLOGY
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2.  PATIENT SERVICES
The RCSI Fetal Medicine Centre continues to provide advanced fetal medicine
services for patients of the Rotunda Hospital, as well as those referred from
throughout Ireland. During 2012 a total of 3118 fetal ultrasound examinations were
performed at the Centre. This included a total of 998 first trimester assessments for
fetal aneuploidy, based on combined nuchal translucency and serum screening.
The RCSI Fetal Medicine Centre operates a one-stop clinic for assessment of risk of
fetal aneuploidy, using the Brahms Kryptor biochemistry platform. Management
of multiple gestations contributed a significant workload to the Centre, with 46
twin pregnancies, and 2 triplet pregnancies managed through our unit. 
3.  TEACHING SERVICES
Two hundred and sixty nine students participated in the RCSI Obstetrics &
Gynaecology and Neonatology clinical rotations. The RCSI Department of
Obstetrics and Gynaecology at the Rotunda has a leadership role in providing
teaching and assessment for undergraduates at the Rotunda, National Maternity
Hospital, Our Lady of Lourdes Hospital Drogheda, Midland Regional Hospital
Mullingar, St. Luke’s Hospital Kilkenny, and Waterford Regional Hospital. One
hundred and seventy two of these students attended the Rotunda Hospital for
clinical attachments. 
These students participated as sub-interns on the hospital wards and in clinics,
contributing significantly to the mission and function of the hospital, while
providing increasingly positive feedback on their learning experiences.
4. RESEARCH OUTPUT
a) Research Grants and Awards:
• Children’s University Hospital Temple Street, Dublin
- Magnetic Resonance Imaging of Neonatal Survivors of IUGR Pregnancy
- M. Boyle, A. Foran / Perinatal Ireland and RCSI
• Friends of the Rotunda Hospital, Dublin, Ireland
- Platelet Hyper-reactivity and Recurrent Miscarriage
- A. Murray, K. Flood, F. Malone
PERINATAL IRELAND UPDATE 2012
Perinatal Ireland is a multi-centre, all-Ireland research consortium focused on
research into women's and children's health. It is primarily funded through an
Imaging Award from the Health Research Board (HRB) and links the seven main
academic obstetric units across the island, harnessing the expertise of Ireland's
leading maternal fetal medicine specialists. The consortium provides a unique,
world-class research infrastructure comprising of state-of-the-art imaging
equipment, dedicated research personnel and a central management and
governance structure. With access to large patient populations (50,000+ births pa.),
Perinatal Ireland is uniquely positioned to carry-out innovative and ground-
breaking clinical and translational research.
The National Twin study, ESPRiT was a two year research programme which
recruited over 1000 twin pregnancies. In 2012, Dr Fionnuala Breathnach (Lead
Researcher) used the results of the ESPRiT study to publish guidelines on the
management of twin pregnancies which was endorsed by the Institute of
Obstetricians and Gynaecologists Clinical Advisory Group in RCPI and by the
National Working Party in the HSE Programme in Obstetrics and Gynaecology.
The following outputs from ESPRiT were also published during 2012.
• Optimum timing for planned delivery of uncomplicated monochorionic and
dichorionic twin pregnancies. Breathnach FM, McAuliffe FM, Geary M, Daly S,
Higgins JR, Dornan J, Morrison JJ, Burke G, Higgins S, Dicker P, Manning F,
Carroll S, Malone FD; Perinatal Ireland Research Consortium. Obstet Gynecol.
2012 Jan;119(1):50-9
• Placental pathology, birthweight discordance, and growth restriction in twin
pregnancy - results of the national prospective ESPRiT Study. Kent EM,
Breathnach FM, Gillan JE, McAuliffe FM, Geary MP, Daly S, Higgins JR,
Morrison JJ, Burke G, Higgins S, Carroll S, Dicker P, Manning F, Tully E, Malone
FD. Am J Obstet Gynecol, 207:220, 2012.
The PORTO study began in January 2010 looking at the effects of Intrauterine
Growth Restriction (IUGR) on pregnancies using sophisticated ultrasound
techniques. PORTO finished recruiting a cohort of over 1200 patients in June
2012. The main objective was the study of advanced multi-vessel Doppler
changes in babies with an estimated weight <10th centile. The significance of
these changes evaluated and correlated with short and long term paediatric
morbidity. 
Preliminary results from PORTO were presented at the Fetal Growth Meeting in
Birmingham in September 2012 and a number of primary output abstracts were
submitted for presentation at the annual Society for Maternal Fetal Medicine
Meeting in February of 2013. The following paper was also accepted for
publication in 2012
• The customised fetal growth potential: a standard for Ireland – Unterscheider
J,  Geary MP, Daly S, McAuliffe F, Dornan J, Morrison JJ, Burke G, Francis A,
Gardosi J, Malone FD, European Journal of Obstetrics & Gynecology and
Reproductive Biology, Accepted Sept 2012
b) Scientific Publications – Peer-Reviewed Journals
• Donnelly JC, Byrne J, Murphy K, McAuliffe FM. Obstetric outcome with low
molecular weight heparin therapy during pregnancy IMJ 2012:105(1);27-29.
• Cooley SM, Donnelly JC, Walsh TA, MacMahon C, Gillan J, Geary MP Ponderal
Index (PI) versus Birthweight centiles in the low-risk primigravid population:
Which is the better predictor of fetal wellbeing? Journal of Obstetrics and
Gynaecology July 2012, Vol. 32, No. 5 , Pages 439-443
• Breathnach FM, McAuliffe FM, Geary M, Daly S, Higgins JR, Dornan J, Morrison
JJ, Burke G, Higgins S, Dicker P, Manning F, Carroll S, Malone FD. “Optimum
Timing for Planned Delivery of Uncomplicated Monochorionic and Dichorionic
Twin Pregnancies.” Obstetrics and Gynecology 119:50-59, 2012.98
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• Hehir MP, O’Connor HD, Kent EM, Fitzpatrick C, Boylan PC, Coulter-Smith S,
Geary MP, Malone FD. “Changes in Vaginal Breech Delivery Rates in a Single
Large Metropolitan Area.” American Journal of Obstetrics and Gynecology
206:498-499, e1-4, 2012.
• Kent EM, Breathnach FM, Gillan JE, McAuliffe FM, Geary MP, Daly S, Higgins JR,
Hunter A, Morrison JJ, Burke G, Higgins S, Carroll S, Dicker P, Manning F, Tully E,
Malone FD. “Placental Pathology, Birthweight Discordance, and Growth
Restriction in Twin Pregnancy: Results of the ESPRIT Study.” American Journal
of Obstetrics and Gynecology 207:220, e1-5, 2012.
• Hehir MP, O’Connor HD, Malone FD. “Changes in Vaginal Breech Delivery Rates:
Reply.” American Journal of Obstetrics and Gynecology 207:e9, 2012.
• Hehir MP, O’Connor HD, Kent EM, Robson MS, Keane DP, Geary MP, Malone FD.
“Early and Late Preterm Delivery Rates – A Comparison of Differing Tocolytic
Policies in a Single Urban Population.” Journal of Maternal Fetal and Neonatal
Medicine, 25:2234-2236, 2012.
• Bukowski R, Chlebowski RT, Thune I, Furberg AS, Hankins GD, Malone FD,
D’Alton MF. “Birth Weight, Breast Cancer and the Potential Mediating Hormonal
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Birth.” Obstetrics and Gynecology 120:542-550, 2012.
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• Gyamfi-Bannerman C, Gilbert S, Landon MB, Spong CY, Rouse DJ, Varner MW, et
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• Gilbert SA, Grobman WA, Landon MB, Spong CY, Rouse DJ, Leveno KJ, et al.
“Elective repeat cesarean delivery compared with spontaneous trial of labor
after a prior cesarean delivery: a propensity score analysis.” American Journal of
Obstetrics and Gynecology 206:311, e1-9, 2012.
• Johnson LH, Mapp DC, Rouse DJ, Spong CY, Mercer BM, Leveno KJ, et al.
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Obstet Gynecol 2012 Sep; 207(3):220.e1-5.
• Kent E, Breathnach FM, Gillan J et al. Placental pathology, birthweight
discordance and growth restriction in twin pregnancy: results of the ESPRiT
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• Breathnach FM, Malone FD. Fetal Growth Disorders in Twin Gestations. Semin
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• Breathnach FM, Carroll SC, McAuliffe F, Daly S, Geary M, Morrison JJ, Dornan J,
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• Ramhendar T, Byrne P. “Use of the levonorgestrel-releasing intrauterine system
in renal transplant recipients: a retrospective case review” Contraception. 2012
Sep;86(3):288-9.
c) Scientific Publications – Book Chapters and Other Journals
• Donnelly JC, Kearney M, Ni Ainle F. Obstetric haematology: Treatment and
prevention of VTE in pregnancy Hospital Doctor, Jan 2012
• Donnelly JC, Malone FD. “Early Fetal Anatomical Sonography.” Best Practice
Research in Clinical Obstetrics and Gynaecology, 26:561-573, 2012.
• Breathnach FM, Malone FD. “Fetal Growth Disorders in Twin Gestations.”
Seminars in Perinatology, 36:175-181, 2012.
• Flood K, Malone FD. “Prevention of Preterm Birth”. Seminars in Fetal and
Neonatal Medicine, 17:58-63, 2012.
• Donnelly J, Geary M, Barry C, Breathnach FM, Malone F. Monochorionic
Monoamniotic Twins- A Five Year Review.. (BMFMS Annual Scientific meeting
Glasgow April 2012)
• Aoife Murray, Karen Flood, Julia Unterscheider, Carol Barry, Michael Geary,
Fionnuala Breathnach, Fergal Malone. When identical twins are different.
(BMFMS Annual Scientific Meeting, Glasgow April 2012)
d) Invited Lectures and Oral Scientific Presentations: 
• Donnelly JC, Monoamniotic Twins – a five year review: Royal Academy of
Medicine in Ireland, Dublin, Jan 2012
• Malone FD, “Magnesium in Obstetrics – New Indications” – Irish Society of
Obstetric Anaesthesia, Annual Clinical Meeting, Dublin, Ireland, December 2012.
• Malone FD, “Obstetric Ultrasound Debate – Optimal Timing of Obstetric
Ultrasonography” – Institute of Obstetricians and Gynaecologists Annual
General Meeting, Dublin, Ireland, September 2012.
• Malone FD, “Irish Obstetric Ultrasound: What Should Happen in the Future?” –
National Maternity Hospital Annual Fetal Medicine Meeting, Dublin, Ireland,
January 2012.
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1.  SERVICE
During 2012, under the guidelines of the Medical Council, the HARI Unit provided a
full range of Assisted Reproductive Technology services to couples referred from
throughout Ireland.  The services included: IVF, ICSI, frozen embryo transfers, natural
cycles (IVF and ICSI) follicle tracking with or without ovarian stimulation (anti-
oestrogens, FSH), testicular biopsy, embryo freezing and oncology stimulation and
subsequent gamete and embryo cryopreservation .  In 2012, the Unit had on average
52 staff delivering medical care.
NURSING SERVICES
The Nursing department prides itself on recognizing each individual’s needs and
delivering tailored treatment.  HARI nursing staff provides a high standard of care
to couples attending the Unit whilst maintaining a safe, efficient and friendly
service.  The treatments and services provided range from ultrasound scanning
and hormonal monitoring, patient education and training to scheduling
procedures and intrauterine inseminations.  Nursing staff participates in
continuous professional development through regular meetings at national and
international level as well as training of new staff.  The role of the fertility nurse is
unique, delivering continual care and support for a complex reproductive
treatment journey involving two patients. 
COUNSELLING SERVICES
Our team offers a comprehensive counselling and support service at HARI both to
our ART and oncology patients.  The services range from psychological and
emotional support before, during and after treatment to mind/ body medicine, CBT
and stress management services.  Our counselling team comprise of highly skilled
individuals specifically trained in the area of infertility.  They work as an integral
part of our multi disciplinary group. 
2. ART DEMOGRAPHICS AND OUTCOMES 
ART Activity
The female age among our IVF/ ICSI patients is a key determinant of the likelihood
of conception.  In 2012 the mean ages were 35.3 years for females and 36.9 years for
males. The mean duration of infertility of those undergoing fresh cycles was 2.15
years. The main indications for IVF or ICSI therapy were male factor (39%), tubal and
endometriosis (22.5%), unexplained (23%), and others (15.5%).
In these 12 months, 1,330 cycles were undertaken - 453 IVF, 480 ICSI and 397 frozen.
Of the 933 fresh cycles commenced, 799 had oocytes collected (IVF 369, ICSI 430).
Zygotes were transferred in 1079 cases (IVF 331, ICSI 377 and frozen 371).  A total of 375
clinical pregnancies were achieved, 277 in the IVF/ ICSI cycles and 98 in the frozen
zygote transfer cycles.
TABLE 1. Overall IVF/ ICSI activity (2012)
IVF ICSI FZT
Cycles started 453 480 397
Cycles abandoned 55 41 -
Oocyte collections 369  430 -
Zygote transfers 331 377 371
Clinical pregnancies 127 150 98
PREGNANCY RATES
Pregnancy rates shown below are clinical pregnancy rates.  All types of fresh
treatments are included, namely: long protocol, antagonist, flare, natural.  The
terms used are defined below:
TABLE 3.   CLINICAL (IVF AND ICSI) PREGNANCY RATES ACCORDING TO  
FEMALE AGE (2012)
Age Overall IVF ICSI
n = 933 n = 453 n = 397
Per Cycle Started
≤ 35 34.4% (n=488) 34%    (n=223) 35%   (n=265)   
36-39 29%   (n=302) 26%    (n=155)    32%   (n=147)
≥ 40 13.3% (n=143) 12%     (n=75) 15%   (n=68) 
Total: 45 Total: 48
Per Oocyte Recovery
≤ 35 40%  (n=416) 42%   (n=176)  39%  (n=240)    
36-39 32%   (n=267) 29%   (n=132)    35%  (n=135)
≥ 40 15.5% (n=116) 13%    (n=61)      18%  (n=55)
Total: 36 Total: 43
Per ZygoteTransfer
≤ 35 44%   (n=367) 43%    (n=159)  45%   (n=208)    
36-39 37%  (n=237) 42%    (n=116)     39%  (n=121)
≥ 40 18.3%  (n=104) 25%    (n=56)      21%   (n=48)
Total: 33 Total: 37
A female of age 35 years old or younger, undergoing fresh ART treatment had a
34.4% chance of a clinical pregnancy per cycle started, 40% per oocyte recovery
and 46% per zygote transfer.
TABLE 2. Clinical pregnancy rates (2012)
Overall Overall IVF ICSI FZT
n = 1330 n=933 n = 453 n = 480 n=397
(375) (277) (127) (150) (98)
Per Cycle Started 28% 30% 28% 31% 25%
Per Oocyte Recovery N/A 35% 34% 35% N/A
Per Zygote Transfers 35 % 39% 38% 40% 26%
n= total number of patients
()= number of pregnancies
These figures are interpreted as follows: the overall likelihood to have a clinical
pregnancy after IVF/ICSI was 30% per cycle started, 35% per oocyte recovery and
39% per zygote transfer.  The clinical pregnancy rates for patients undergoing
frozen cycle transfers were 24% per thaw and 26% per zygote transfer.
Clinical Pregnancy = all cases where an intrauterine visible pregnancy sac has
been identified to include ectopic pregnancies (ESHRE definition).
Clinical Pregnancy Rate per Cycle Started = number of clinical pregnancies per
number of patients that commenced therapy.
Clinical Pregnancy Rate per Oocyte Recovery = number of clinical pregnancies
per number of patients that had an oocyte recovery.
Clinical Pregnant Rate per Zygote Transfer = number of clinical pregnancies per
number of patients that had zygotes transferred.
Delivery Rate = number of delivery episodes of babies weighing more than 500
grams (per cycle started, per oocyte recovery, per zygote transfer).
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TABLE 5. Female age related cumulative pregnancy rates 
after eSBT (2008-2012)
Day 5 transfers ≤ 35 35-39 years ≥ 40 years 
CPR 46% 44.2% 28%
Cumulative CPR
(One fresh and 
first frozen transfer) 58.5% 53.7% 39.3%
Single blastocyst transfer programme
The HARI elective Single Blastocyst Transfer (eSBT) programme continued in
2012.  Details of pregnancy rates after ICSI, IVF and FZT since 2008 are presented
in Table 4.  Pregnancy rates are expressed as positive test per eSBT and clinical
pregnancy rate per eSBT.
TABLE 4. Pregnancy rates after eSBT (2012)
ICSI eSBT All ages ≤ 35 36-39 ≥ 40
hCG+ve/eSBT 244/421 (58%) 168/283 (59.4%) 66/105 (63%) 10/33 (30.3%)
CPR/eSBT 186/421 (44.2%) 129/283 (45.6%) 52/105 (49.5%) 5/33(15%)
IVF eSBT All ages ≤ 35 36-39 ≥ 40
hCG+ve/eSBT 290/541 (53.6%) 166/294 (56.5%) 104/199 (52.3%) 20/48 (41.7%)
CPR/eSBT 232/541 (43%) 134/294 (45.6%) 86/199 (43.2%) 12/48 (25%)
FZT eSBT All ages ≤ 35 36-39 ≥ 40
hCG+ve/eSBT 96/244 (39.3%) 64/151 (42.4%) 24/73 (32.9%) 8/203 (40%)
CPR/eSBT 63/244 (26%) 46/151 (30.5%) 15/73 (20.5%) 2/20 (10%)
The introduction of the eSBT was driven by the desire to reduce multiple
pregnancies while maintaining respectable pregnancy rates from one oocyte
recovery. As shown below, this approach offers an excellent chance of pregnancy
as cumulative clinical pregnancy rates, since the commencement of this
programme, were as high as 59% (Table 5) with an average multiple pregnancy
rate of only 1.9% after fresh transfers (Table 6).  The value in pursuing eSBT lies in
the enormous savings to the public purse in terms of prevention of prematurity-
related intensive neonatal care expenses.  Such savings should be made available
for the provision of free IVF to couples attending ART services that support
elective single embryo transfers.   
TABLE 6. Multiple pregnancy rates for eSBT (2012)
IVF ICSI FZT
Singleton 97.3% 97.1% 98.2%
Twins 2.7% 2.9% 1.8%
Triplets 0% 0% 0%
Take home baby rates are always one year behind, the figures shown are therefore
purely for the year 2011, calculated from the throughput of these year alone. 
TABLE 7.         DELIVERY RATES AFTER TREATMENT IN 2011
(At least one baby 500grams+)
Total patients  IVF ICSI Frozen   
treated (clinical n=376 n=456 n=348
pregnancies) (109) (121) (77)
Deliveries 99 112 52
Per Cycle Started 26.3% 24.6% 14.9%
Per Oocyte Recovery 27.3% 25.2% -
Per Zygote Transfers 29.6% 29.5% 15.3%
n= total number of cycles
()= number of pregnancies
3. NATIONAL ONCOLOGY CRYOPRESERVATION SERVICES
The activity of the National Oncology Cryopreservation Centre includes
emergency onco-fertility consultations, counselling and gamete/zygote
preservation prior to gonadotoxic intervention, offered to all females and males
diagnosed with cancer referred by a consultant.  In 2012, 191 male oncology
patients attended HARI and 169 patients had sperm cryopreserved.  The increase
in demand for female cryopreservation services continued, with 38 referrals
being received and 25 patients proceeding to oocyte or zygote freeze.  New
cryopreservation protocols (vitrification) were introduced during the year.
Studies have shown that these lead to better survival of embryos and eggs and,
consequently, to improved success in assisted reproduction treatments.
TABLE 8. Oncology cryopreservation data
Year 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012
Males 
attended 114 142 142 158 186 174 163 173 191
Males with 
samples 
frozen 63 131 98 102 127 132 141 170 155 149 157 169
Not suitable
/No sample 11 21 15 12 15 10 17 16 19 14 16 18
Female 
attendances 5 5 5 6 14 12 23 25 32 38
Pursued 
cryopres
-ervation 3 4 0 1 10 4 7 19 22 25
Oocyte/ 
embryo 
cryopres
-ervation 3 4 0 0 5 3 5 16 22 25
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4. RECOGNITION
Training in Reproductive Medicine (RM)
HARI continues as the main RM teaching centre in Ireland.  Up to July 2012, Dr
Gbenga Oluyede filled the SpR in Obstetrics and Gynaecology position recognised by
the HARI/ Institute of Obstetricians and Gynaecologists scheme allowing SpR’s with
interest in RM to receive 12 months of training.  
The British Fertility Society continued HARI recognition for medical training in the
following certified special skills modules: Pelvic Ultrasound, Embryo Transfer/IUI,
Management of the Infertile Couple and Assisted Conception.  HARI is also certified
as the only RCOG subspecialty training centre in Reproductive Medicine and Surgery
in Ireland.
The unit is similarly recognised for training purposes by the Association of Clinical
Embryologists, UK.  Ms Ciara Hughes and Ms. Gerri Emerson are certified
embryology trainers, two embryologists have completed their training and a further
two embryologists were undergoing the ESHRE training programmes in 2012.
Staff recognition nationally and internationally
Gerri Emerson continued as the Irish Clinical Scientist National Representative to ESHRE
(European Society of Human Reproduction and Embryology). Ciara Hughes continued
her roles as Chair of the Irish Clinical Embryology Society (ICE) and executive member
on the ACE committee, appointed to update their Good Practice Guidelines. 
Mrs. Joan Hamilton continued as the Chairperson of the Irish Fertility Counsellor
Association (IFCA).
Dr. Edgar Mocanu continued as member of Board of Directors of the International
Federation of Fertility Societies (IFFS) and Treasurer of the Federation.  He continued as
chair the EUTCD ESHRE Task Force and member of the Clinical Advisory Group of the
Institute of Obstetricians and Gynaecologists.
5. QUALITY AND SERVICE IMPROVEMENTS
Quality and patient safety are the cornerstones of the culture within HARI. The
dedicated quality department works closely with all departments to provide
appropriate solutions to ensure best practices, resulting in quality patient care
and service. Using improvement techniques, departments work together to
maximize the work environment and processes involved in daily patient care
Some of the initiatives are detailed below:
• After undertaking extensive training, the patient support team introduced the
“HARI Fertility Well Being Programme”.  The one-day workshop is designed to
give patients practical help and information to maximize their chance of
achieving a pregnancy. The aim of the workshop is to give guidance and advice
on fertility issues and to help patients prepare for assisted reproductive
treatments.
• Authorisation was received from the Irish Medicines board to introduce
Vitrification. This is a specialised freezing technique, where oocytes or embryos
are frozen so quickly, ice crystals do not have time to form, thus offering patients
undertaking frozen cycles of treatment a higher success rate.
• During the year a number key improvements were introduced within the HARI
Laboratory. To improve air quality for embryo culturing, carbon filters were
installed across the entire laboratory and theatre air handling systems. A
substantial investment was also made in updating ICSI capabilities by
introducing an additional ICSI workstation.
• To ensure continuity of care, the clinic introduced a satellite monitoring service
for HARI patients who have to travel abroad to avail of treatments not available
in Ireland. Although ultimately under the medical care and responsibility of the
foreign clinic, this service allows former HARI clients who choose to attend a
foreign clinic for egg donation to benefit from blood hormone and ultrasound
monitoring locally. The results are then forwarded to the chosen clinic
• During the year the clinic undertook a major review and update of the entire
HARI website to make it more user friendly and informative to first time users
and patients.
• At the start of the year we undertook a major overhaul of the patient
administration system. Firstly, we introduce a wireless medical chart tracking
system so that the exact location of each chart could be monitored and tracked. In
tandem we updated the patient registration and scheduling systems. These
changes will support the introduction of SMS appointment confirmation and
reminders to all patients in early 2013
6.        ACADEMIC ACTIVITY
The teaching in Reproductive Medicine of students from Trinity College and the Royal
College of Surgeons in Ireland continued in the Rotunda and the HARI Unit.
Attendance at infertility clinics, theatre and ward rounds were routine during the
academic year.  The RCSI Consultant Senior Lecturer attended regular student
tutorials in HARI and participated as a final year examiner for RCSI and TCD students. 
From a scientific point of view, during a very busy and successful year HARI staff
engaged in numerous activities at national, European and international level, as
presented below.
Higher degrees and awards
Deignan, K. (2012)
Examination: ESHRE Senior Clinical Embryology Certification
European Society of Human Reproduction and Embryology (ESHRE) 28th Annual
Meeting – Turkey, July 2012
Awar ds
Cl inical  Science Awar d f or  Post er  Pr esent at ion (ESHRE 2012)
Naasan, M., Oluyede, G., Kirkham, C., Ciprike, V., Mocanu, E.
Is ovarian reserve in female cancer patients attending for cryopreservation
different compared to age matched infertile patients?
European Society of Human Reproduction and Embryology (ESHRE) 28th Annual
Meeting – Turkey, July 2012
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Scientific publications (peer reviewed Journals)
Mocanu E. 
Facts and myths in serological screening of ART couples. 
FVV in ObGyn. 2012, 4(3): 198-202.
Wong VV, Emerson G, Mocanu E. 
When no choice of embryos exists, the multiple pregnancy risk is still high. 
J Obstet Gynaecol. 2012 Oct; 32(7): 676-9.
Hayes I, Rathore R, Enohumah K, Mocanu E, Kumar D, McCaul CL. 
The effect of crystalloid versus Low molecular weight colloid solution on post-
operative nausea and vomiting after ambulatory gynecological surgery - a
prospective randomized trial. Anesthesiol. 2012 Jul 31; 12(1): 15
Naasan M, Waterstone J, Johnson MM, Nolan A, Egan D, Shamoun O, Thompson W,
Roopnarinesingh R, Wingfield M, Harrison RF, Mocanu E.  
Assisted Reproductive Technology Treatment Outcomes.  
Ir Med J. 2012 May;105(5):136-9.
Basit I, Johnson SN, Mocanu E, Geary M, Daly S, Wingfield M.  
Mode of conception of triplets and high order multiple pregnancies.  
Ir Med J. 2012 Mar;105(3):80-3.
Scientific presentations (oral and posters)
1. Emerson G, Hughes C, Mocanu E. Male  cryopreservation: clinical relevance of a
diagnosis of testicular cancer on spermatogenesis. ESHRE 28th Annual Meeting,
Istanbul, July 2012.
2. Naasan M, Oluyede G, Kirkham C, Ciprike V, Mocanu E. Is ovarian reserve in
female cancer patients attending for cryopreservation different compared to age
matched infertile patients. ESHRE 28th Annual Meeting, Istanbul, July 2012.
3. G Emerson, C Hughes, C Harrity, E. Mocanu. Elective single embryo transfer. Where
have all the twins gone? 2nd ICOGPM Druids Glen, Wicklow, November 2012.
4. S Detho, C Harrity, S Afridi, E Mocanu, G Emerson.  Initial experience of natural
cycle IVF in Ireland. 2nd ICOGPM Druids Glen, Wicklow, November 2012.
5. J McInerney, M Dempsey, C Kirkham, E Mocanu.  Quality of life among those
attending for fertility investigations and treatments. 2nd ICOGPM Druids Glen,
Wicklow, November 2012.
6. WPV Ooi, M Naasan, V Ciprike, C Harrity, E Mocanu. Outcomes of pulsatile Gn-RH
treatment in women with hypogonadotrophic hypogonadism- an Irish
experience. 2nd ICOGPM Druids Glen, Wicklow, November 2012.
7. F Sutton, E Mocanu, CA Berney, L Finnamore, S Sweeney, J Kelly. Intra-uterine
insemination-should the oocyte be kept waiting? 2nd ICOGPM Druids Glen,
Wicklow, November 2012.
8. N Abdul Aziz, C Harity, E Mocanu.  Anti-mullerian hormone: a non-invasive
screening test for the presence of endometriosis? 2nd ICOGPM Druids Glen,
Wicklow, November 2012.
9. Mocanu E.  EIM Irish Report 2009. Irish Fertility Society Annual Meeting,
Malahide, May 2012.
10. Ciprike V, Emerson G, Mocanu E. A 10-year review of live birth rates after ART in
serodiscordant couples who are positive for either hepatitis B (HBV) or hepatitis
C (HCV) infection.  IFS Annual Meeting, Malahide, May 2012, Dublin.
11. Hooper A, Emerson G, Kelly P, Mocanu E. Temperature changes in culture media
lag behind air temperature changes in the transport environment. 8th Annual
Irish Fertility Society Meeting, Malahide, May 2012. 
Peer reviewed published abstracts 
1. Emerson G, Hughes C, Mocanu E. Male cryopreservation: clinical relevance of a
diagnosis of testicular cancer on spermatogenesis. Hum Reprod. (2012) 27 (suppl
2): ii64-ii65.
2. Naasan M, Oluyede G, Kirkham C, Ciprike V, Mocanu E. Is ovarian reserve in
female cancer patients attending for cryopreservation different compared to age
matched infertile patients. Hum Reprod. (2012) 27 (suppl 2) ii248-ii261.
3. G Emerson, C Hughes, C Harrity, E. Mocanu. Elective single embryo transfer.
Where have all the twins gone? 2nd ICOGPM Abstract book, 2012, p178.
4. S Detho, C Harrity, S Afridi, E Mocanu, G Emerson.  Initial experience of natural
cycle IVF in Ireland.  2nd ICOGPM Abstract book, 2012, p180.
5. WPV Ooi, M Naasan, V Ciprike, C Harrity, E Mocanu. Outcomes of pulsatile Gn-RH
treatment in women with hypogonadotrophic hypogonadism- an Irish
experience. 2nd ICOGPM Abstract book, 2012, p182.
6. J McInerney, M Dempsey, C Kirkham, E Mocanu.  Quality of life among those
attending for fertility investigations and treatments. 2nd ICOGPM Abstract book,
2012, p185.
7. F Sutton, E Mocanu, CA Berney, L Finnamore, S Sweeney, J Kelly. Intra-uterine
insemination-should the oocyte be kept waiting? 2nd ICOGPM Abstract book,
2012, p181.
8. N Abdul Aziz, C Harity, E Mocanu.  Anti-mullerian hormone: a non-invasive
screening test for the presence of endometriosis? 2nd ICOGPM Abstract book,
2012, p262.
9. Ciprike V, Emerson G, Mocanu E. A 10-year review of live birth rates after ART in
serodiscordant couples who are positive for either hepatitis B (HBV) or hepatitis
C (HCV) infection.  IFS Annual Meeting, Malahide, May 2012, Dublin. 
10. Hooper A, Emerson G, Kelly P, Mocanu E. Temperature changes in culture media
lag behind air temperature changes in the transport environment. 8th Annual
Irish Fertility Society Meeting, Malahide, May 2012. 
11. Mocanu E.  EIM Irish Report 2009. Irish Fertility Society Annual Meeting,
Malahide, May 2012.
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Invited lectures, chairs, media appearances
Chairs
Mocanu EV:
Chair and Organiser 2nd Irish Congress of Obstetrics, Gynaecology and
Perinatal 
Medicine (ICOGPM). December, Wicklow 
Chair               Breast cancer in young women conference. European
Conference
Session VII: Fertility and adoption. November, Dublin
Co-chair; Organiser Regulation of quality and safety in ART. ESHRE Campus, 
September, Dublin
Chair                             ESHRE Annual Meeting, Istanbul: Session 23: Mystery or 
fiction: progesterone in the follicular phase.
Invited lectures:
Mocanu EV: 
1. Optimal management of fertility in pre-menopausal women.  Breast study day,
Cork University Hospital, 25th February 2012.
2. Reproductive Medicine – a true carrier in Obstetrics and Gynaecology. RCSI
Obs&Gyn Society, 23rd March 2012.
3. Female fertility cryopreservation: current options and limitations. 8th Conference
on clinical management of breast cancer. Kildare, 21st April 2012.
4. ART result in Ireland.  IFS Annual Meeting, Dublin, 11th May 2012. 
5. Ethical issues in Assisted Reproduction. Ethics IV: End of life issues, RCPI, Dublin,
22nd June 2012.
6. Human Assisted Reproduction. ICGP Summer School 2012. Kilkenny, 23rd June 2012. 
7. Assisted Reproduction-an update. Endocrine Grand rounds, SVUH, 10th
September 2012.
8. Vigilance in ART. Regulation of quality and safety in ART-the EU Tissues and Cells
Directive perspective. ESHRE Campus Symposium, Dublin 14th September 2012.
9. TCM and WM-do the roads ever meet? NRRI Symposium, Dublin, 15th September 2012
Hughes C:
January 2012 Graduate Diploma in Nursing Studies (Cancer Nursing) UCD
August 2012   Breast Care Mater Hospital  – Preserving Fertility for Breast
cancer patients
September 2013  Preserving Fertility Lecture for Post Graduate Diploma in
Haematology HOPE Directorate St James
September 2012 Preserving Fertility for the Post Graduate Diploma in Oncology
Nursing
17th November 2012 Updates in Fertility Preservation – Irish Cancer Nurses – Carton
House, Maynooth
November 2012 Visit from HOPE directorate post-graduate nurses for lecture and
tour of Hari Unit
Conference Course Attendance
January ACE Annual Conference– Leeds Ciara Hughes 
Barbara Hughes
May Irish Fertility Society Jemma Johnston
Edgar Mocanu
June ESHRE Gerri Emerson
John Furlong
Karen Deignan
Edgar Mocanu
September ESHRE – Quality Meeting Gerri Emerson
Ciara Hughes
December ICOGPM Gerri Emerson
Ciara Hughes
Edgar Mocanu
Vitrolife Workshop Gerri Emerson
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DR. EIBHLIS O’DONOVAN (DIRECTOR)  
MS. GWEN O’CONNOR (ACTING LABORATORY MANAGER, JAN-AUG 2012);
MR JOHN O LOUGHLIN (APPOINTED LABORATORY MANAGER AUG 2012 )
INTRODUCTION
The Department of Laboratory Medicine is staffed by dedicated and highly
educated professionals who are committed to providing a service of the highest
quality that is pro-active and responsive to the needs of the users of the service.
Quality is now well embedded in the culture of the department. The Laboratory
Annual Management Review, User Surveys and Users Committee meetings,
inform the laboratory management of any concerns regarding the services
provided and also any changes in the requirements of service users. Quality
objectives are in place to ensure that the needs and requirements of users are met;
these quality objectives are reviewed annually. 
D E PA R T M E N T  O F  L A B O R A T O R Y
M E D I C I N E
TABLE 1: DEPARTMENT OF LABORATORY MEDICINE WORKLOADS FOR 2012 
COMPARED TO 2011; TESTS  PERFORMED IN-HOUSE
Department Specimens
% Change
in
specimens
over 2011
Number of
Tests
% Change
in tests over
2012
Haematology 48,635 -5.4 64,199 -1.9
Blood Group Serology 23,614 2.85 69,207 -3.1
Transfusion 6,503 -5.5 7,738 -5.5
Clinical Microbiology 47,792 7.9 87,052 -6.9
Virology / Serology 13,676 -12 33,091 -33
Clinical Chemistry
Endocrinology 57,003 -2.4 203,528 -8
Histopathology
- Surgicals 4,420 -1.3 12,464 (blocks) -4.96
- Placentae 1,463 -10.4 5,056 (blocks) -57
- Autopsies 93 22.4 1909 -29.9
- Fluids 175 10.8 214 13.2
TABLE 2: REFERRED  WORKLOAD FOR 2012 COMPARED TO 2011
Specimens % Changeover 2011 Tests
% Change
over 2011
Haematology 2,706 -8 3,144 -8
Biochemistry* 3,736 -3.9 7,553 -11.4
Microbiology
serology confirmation
and otherspecialized
tests
4,533 22.3 11,186 -9
Rubella/Syphilis 10,871 -5.8 20,792 -6.7
* This includes many diverse tests such as drug, screens, metabolic screens,
ceroplastin, antenatal predictive screens, endocrinology, vitamin B12, folate, iron,
anti-Mullerian Hormone, and investigation of low glucose concentration in
neonates (Newcastle workup). 
STAFFING
Consultant posts
Dr Fionnuala Ni Ainle was appointed as Consultant Haematologist in March 2012. 
Dr John Gillan, Consultant Histopathologist retired. 
Laboratory manager
Mr John O’ Loughlin was appointed Laboratory manager in August 2012. Mr Ken
Grundy who had filled the position in an acting capacity and worked for many
years as Chief Medical Scientist in Microbiology very sadly passed away in January
2012. His tremendous contribution to the laboratory is acknowledged.
Medical Scientist posts
Mr David Le Blanc was appointed Chief Medical Scientist in Microbiology.
Ms Rosie Hickey, Chief Medical Scientist in Biochemistry retired in February 2012.
Ms Ann Downey was subsequently appointed as Chief Medical Scientist,
Biochemistry in May 2012.
Ms Niamh Cahill and Ms Deirdre Cafferty were appointed as Senior Medical
Scientists in Microbiology. 
Ms Asun McGrath vacated her position as Senior Medical Scientist in Biochemistry.
Ms Sharon Campbell was subsequently appointed to the post.
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QUALITY DEPARTMENT: 
Quality Manager: Ms Susan Luke
Deputy Quality Officer Ms Emily Forde*
Training Officer Mr. Ciaran Mooney* 
Health and Safety Officer Ms Aiveen O’Malley*
LIMS Officer (Mr Ken Grundy* January 2012)
(* These roles are in addition to the existing work and responsibilities of these individual
medical scientists and have been undertaken without the provision of additional
human resources.)
The laboratory was granted accreditation status with Clinical Pathology
Accreditation Limited (UK) - CPA in 2008. This accreditation status was
maintained until January 2013. It was agreed by laboratory management that
the laboratory would withdraw from the CPA accreditation scheme.  This
decision was made as all departments were moving to gaining accreditation
through INAB in 2012.
During 2012 all departments within the laboratory gained accreditation against
ISO 15189 Medical Laboratories –Requirements for quality and competency and
against ISO 22870 Point of Care Testing- Requirements for quality and
competency. Blood transfusion and Haemovigilance continue to comply with
the requirements of the EU directive ‘minimum requirements for Blood Bank
Compliance with article 14(traceability) and article 15 (notification of serious
adverse reaction and events). This was achieved due to the hard work and
commitment of all laboratory staff during a difficult year when faced with the
unexpected loss of a dear friend and colleague Ken Grundy.
The accreditation process was extended to Point of Care testing under the scope
of ISO 15189 and ISO 22870 for the first time. This ensured that the laboratory
provided governance and a service to facilitate evaluation of new or alternative
POCT instruments /systems, consider the end users proposals and protocols,
purchase, installation and validation of equipment, maintenance of
consumables and reagents, provide training to POCT operators and ensure the
required quality control and quality assurance. Ms Jane Halligan is
acknowledged for her work in enabling us achieve accreditation in this joint
area of providing a near patient test service.
The mortuary services were accredited with CPA (UK). The possibility of
continuing accreditation with INAB was explored against the standard ISO
17020:1998  Conforming assessment –Requirements for the operation of various
types of bodies performing inspection, however  after initially confirming that
this may be feasible,  INAB later stated that they were not in a position to assess
the mortuary services.   The Mortuary services were reviewed against the HSE
Standards and Recommended practices for Post Mortem Examinations Services
in 2012 by means of a gap analysis. These standards ensure high quality care to
service users and their families.
An up-to–date record of the status of the accreditation of the Department of
Laboratory Medicine can be found on the following website: www.inab.ie  
The laboratory is required to submit an Annual Report for Blood Transfusion to the
Irish Medicines Board (IMB). This report confirms to the IMB the Blood Transfusion
activity for the previous year, states blood usage and wastage, status of accreditation
and informs of any planned future changes. The report was reviewed and was
satisfactory. No visit was deemed necessary.
The quality management system is now embedded in the routine culture of the
laboratory. To ensure the QMS is maintained and to encourage continual
improvement, the laboratory processes are reviewed by means of a scheduled audit
calendar, assessment of user’s satisfaction and requirements, review of supplier’s
performance, monitoring and assessment of non conformances and ongoing training
and competency testing of all scientific and clinical staff involved in providing the
testing service.
HISTOPATHOLOGY DEPARTMENT
STAFF
Consultants: Dr J E Gillan, Dr Deirdre Devaney, 
Dr Eibhlis O’Donovan
Locum Consultant: Dr Emma Doyle
Registrars: Dr  A McCarthy, Dr Kate O Connor
Chief Medical Scientist: Colma Barnes
Senior Medical Scientist: Ms Phil Bateson, 
Medical scientists: Ms Miriam Hurley, 
Ms Aderanti Morenigbade, 
Mr. Michael Smith, 
Ms.Tokiko Kumasako, 
Ms Sarah Morris.
Electron Microscopist: Dr Aiveen O’Malley, 
Senior anatomical technician: Mr Bill O’Neill
Anatomical technician: Ms Karen Fennelly 
Laboratory Aide: Mr. Martin Fitzpatrick
PERINATAL PATHOLOGY
The following Tables indicate the number of autopsies (full, limited, and Coroner’s)
performed in 2012.
*This table includes 5 autopsies from infants born in another institution which are
not included in the Rotunda figures.116
TABLE 3: AUTOPSY WORKLOAD >500GRAMS
Full
Postmortem 
Limited
Postmortem
Coroners
case Total
Stillbirths 21 0 2 23
Early Neonatal deaths 3 2 10 15
Late Neonatal deaths 3 3
Total 24 2 15 41
Outside cases* 1* 0 4* 5*
% of Total PMs 23.8% 1.9% 14.9% 40.6%
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TABLE 4: AUTOPSY WORKLOAD <500GRAMS
Full
Postmortem
Limited Post
mortem
Coroners
case Total
No. of PMs 54 6 0 60
% of Total PMs 53.5% 5.9% 0 59.4%
TABLE 5: ROTUNDA PERINATAL MORTALITY FIGURES: 2012 (0-7DAYS)
No
examination
Limited
examination
Full Post
Mortem
Coroners
Cases Total
Stillbirths 20 0 20 2 42
Early Neonatal deaths 14 2 3 7 26
Total 34 2 23 9 68
The perinatal autopsy service in 2012 was busier than the previous year (101 cases
compared to 92 cases in 2011). Turnaround times (TATs) for these cases remained in
line with previous years in that the majority of cases were reported within the
recommended 8 weeks allowing the clinicians to interface with grieving parents
in a timely fashion. In conjunction with this, there were no organs retained in 2012.
A full autopsy includes external examination, radiology, cytogenetics and internal
examination of all three body cavities (Chest, abdomen and cranium) in
conjunction with placental examination.  Limited autopsy examinations are in
keeping with the wishes of the parents, as expressed on the consent form  eg,
external examination and cytogenetics only or a single body cavity – as in a case of
a known congenital heart disease, the family may only wish to have the chest
cavity opened. We endeavor to examine all placentas associated with fetal demise,
as in a large number of cases the placenta will reveal a significant pathology which
may be the cause of death.
101 autopsies were performed in 2012 (41 >500g and 60 <500g) in comparison to 92
in 2011, leading to  overall autopsy rate (AR) of 45.3% (41+60=101 / 223 cases through
mortuary) in comparison to 42.3% in 2011 and 50% in 2010. The AR (Full, limited and
coroners cases) for >500 g was 50.6% (41/81) and 42.3% (full and limited – 60/142) for
<500g. These figures take into account some external transfers and late neonatal
deaths.  The AR for the Rotunda cases (perinatal mortality figures) is 50% (34/68
cases). The reduction of the AR in the > 500g group probably continues to reflect the
improvements in antenatal diagnostic imaging and amniocentesis confirming
congenital malformations.  However 45.8% (11/24) of our congenital malformations
had a post mortem examination compared with only 20.8% last year.  We
continued to see a reduction in the number of limited examinations with only 2 in
the >500g group and 6 in the < 500g group (compared with 1 and 9 respectively in
2011 and 7 and 23 in 2010).   We saw an increase in the number of coroners cases (15)
compared to previous years (6  in 2011 and 10 in 2010). These included 4 outside
cases and 3 late neonatal deaths (i.e. not in the Rotunda figures).  The majority of
these cases were neonatal deaths (13/15).
As mentioned above, it is our policy to examine the placenta on all cases of
perinatal deaths.  There were 68 > 500g, 66 of these cases had placental
examination. In the other two cases, one baby had a known congenital anomaly,
the other however had no post mortem and no placental examination.
Tulip Classification of Perinatal Mortality:
This is a  Dutch Classification system that separates cause and mechanism of
perinatal mortality for the purposes of counselling and prevention.  The goal of the
system was to identify an unambiguous single cause system aiming to identify the
initial demonstrable pathophysiological entity initiating the chain of events that
irreversibly led to death based on a combination of clinical findings and diagnostic
tests including pathological findings. The causes of death are stratified into 6 major
categories:
1. Congenital Anomaly
2. Placenta
3. Prematurity / Immaturity
4. Infection
5. Other
6. Unknown
Cause of Death: (perinatal figures Rotunda only  > 500g)
We have used a modified version of the Tulip classification to classify our causes of
death.
68 cases:
Congenital Malformation 24 (35.3%)
Placental causes: 21 (30.9%)
Cord 6
Parenchyma 15 
Prematurity / Immaturity 1 (1.5%)
Infection 13 (19.1%)
Other 3 (4.4%)
Unknown 6 (8.8%)
The 24 congenital malformations included 11 babies with chromosomal
abnormalities (6 babies had trisomy 21 and 4 had trisomy 18), 1 baby was born
with renal malformations, 2 babies with a cardiac malformation, 1 with a
diaphragmatic hernia, 1 with a body stalk malformation, 1 neural tube defect
(anencephaly), 1 VACTERL malformation, 2 Arthrogryposis, 1 sirenomelia and 2
congenital tumours (1 saccrococcygeal teratom and 1 lymphangioma) and 1 vein
of Galen malformation. In the placental category, there were 6 cord accidents
identified. There was evidence of chronic uteroplacental insufficiency in 7 cases.
Placental abruption accounted for four deaths and four cases had a moderate to
severe villitis to which death was ascribed.
13 deaths were attributed to infection. 12 of these were ascending infection and 1
was hydrops secondary to Parvovirus infection. One baby had both ascending and
transplacental infection with toxoplasmosis. In the ascending infection group, E.
Coli and Group B streptococcus was isolated from two babies and from another
infant a bacillus species was isolated.  Nine babies had negative cultures but there
was histological evidence of ascending infection with a fetal response (i.e.
umbilical vessel vasculitis +/- a congenital pneumonia). In our use of the Tulip
classification we have modified this category – if we were to adhere to the strict
classification guidelines, these nine cases would be relegated to the unexplained
category despite the fact there is histological evidence of infection.
There was one neonate who was assigned to the prematurity category.
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The miscellaneous category included 3 cases.  There were two cases of hypoxic
ischaemic encephalopathy of undetermined cause with one case of uterine
rupture leading to fetal demise.
There were 6 cases that had no identifiable cause of death giving an unexplained
rate of 8.8% (in comparison to 14.7 % last year).  Significantly 4 of these 6 cases did
not have any form of post mortem examination.
Cause of Death (<500g)
142 cases
Congenital Malformation 13 (9.2%)
Placental: 32 (22.5%)
Infection: 30 (21.1%)
Other: 5   (3.5%)
Unexplained: 62 (43.7%)
This cohort shows a much lower rate of congenital malformation with ascending
infection and placental categories as the most prominent cause of death. The high
unexplained rate reflects the fact that a significant number of these cases only
had a placental examination (i.e. did not consent to a full post mortem
examination and also reflects the small size of the foetuses (1.22grams –
499grams) with 29 (19.7%) of these cases being 10 grams or less.
Placental Examination:
The placental work load was modified in 2012. During the year we introduced a
triage system for placental examination following Royal College of Pathologists
Guidelines. A protocol detailing which placentas should be examined is available on
the Labour ward and includes the examination of placentas from babies admitted
to the NICU, from all mothers with pyrexia, PPROM, PET, gestational diabetes
mellitus, multiple gestations and as alluded to earlier,  all cases of stillbirths and
neonatal deaths. These placentas are sent to the laboratory and are then stratified
into two groups. Group One placentas are those that require both gross and
histological examination. Whereas Group Two placentas are those cases that gross
examination only is deemed as sufficient. Should the clinician specifically require a
microscopic examination of these cases, it is available on request. 1463 placentas
were referred to the laboratory for examination in 2012. 488 (33.3%) fulfilled the
criteria for gross examination only. The remaining 975 had both macroscopic and
microscopic examination.  The introduction of this triage system has been very
beneficial in that it has succeeded in reducing the histology workload of placental
examination by approximately one third, affording us extra time to devote to the
cases that require a more detailed examination.  Placental examination continues to
reflect a significant workload for the department.
Surgical pathology: 
The Histopathology department continued to provide a diagnostic service to the
Colposcopy clinic, supporting the activity generated by the NCSS programme.
Multidisciplinary team meetings for the colposcopy service were held on a
regular basis.
TABLE 6:  ANALYSIS OF THE SURGICAL PATHOLOGY WORKLOAD 
FROM 2009 - 2012
Surgical data
2012 (no. & 
% increase
from prev
year
2009
n0.
2010
no.
2010
%
Incre-
ase
from
2009
2011
no.
2011
%
Incre-
ase
from
2009
2011
%
Incre-
ase
from
2010
2012
no.
2012
%
Incre-
ase
from
2009
2012
%
Incre-
ase
from
2010
2012
%
Incre-
ase
from
2011
Surgicals (inc
llletz & colcb)
Total no. of
Cases: 3140 4030 28.3 4476 42.55 11.07 4420 40.76 9.68 -1.25
Total no. of
Specimens 4025 5454 35.5 5571 38.41 2.15 5467 35.83 0.24 -1.87
Total no. of
Tissue Blocks 8765 11661 33 13114 49.62 12.46 12464 42.2 6.89 -4.96
LLETZ
Total no. of
Cases: 536 783 46.3 914 70.52 16.58 752 40.3 -4.08 -17.72
Total no. of
Specimens 826 1160 40.4 1175 42.25 1.29 910 10.17 -21.55 -22.55
Total no. of
Tissue Blocks 2954 4906 66.1
6045 104.6
4
23.22 4906 66.08 0 -18.84
Colcb
Total no. of
Cases 264 732 177.3
991 275.38 35.38 1014 284.09 38.52 2.32
Total no. of
Specimens 285 915 221.5
1214 325.96 32.68 1242 335.79 35.74 2.31
Total no. of
Tissue Blocks 345 916 165.5
1216 252.46 32.75 1246 261.16 36.03 2.47
TABLE 7:  LLETZ & COLPOSCOPIC BIOPSY GRADING 2012
2011 CIN 1 CIN 2 CIN 3 CGIN/AIS SCC inclmicroinvasion Adenoca
Cases
LLETZ 209 188 285 6 10 1
COLCB 411 227 131 4 2 0
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A new digital recording system improved workflow. The department continues to
participate in the National Quality Assurance programme in Histopathology with
data submitted centrally to NQAIS. The department was awarded INAB
accreditation following a full assessment in October 2012. The hard work and
dedication of all staff is acknowledged.
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Creatinine measurements on both plasma and urine are now performed using the
enzymatic method only replacing the traditional Jaffe method which is subject to
interference by a number of substances including bilirubin and some drugs.
Spectrophotometric measurement of plasma haemolysis and lipaemia was
introduced midway through the year. These measurements feed in to
manufacturer-specified cut-offs which have been optimised and verified by the
laboratory.
There were some initial difficulties due to the not unexpected increase in the
incidence of the reporting of lipaemia, particularly with neonates on TPN. The
reflexive reporting of a plasma triglyceride in these instances has aided the
interpretation of these findings. Indices measurement has improved the quality of
reporting from the laboratory which no longer relies on subjective notation of
sample quality.
Reflex testing for anti-thyroxine peroxidise antibody on samples from adult females
with a TSH greater than 2.0 mU/L as per HSE guidelines was also introduced.
The Point of Care Testing (POCT) Steering Committee met on a number of occasions
during the year.  Glucose HemoCue units are provided to the Gynae and prenatal
wards and NICU. PSNT commenced using the Haemoglobin HemoCue in March
2012. This has improved discharge times on the ward.
The department including POCT experienced it’s first inspection for accreditation by
INAB for compliance with ISO 15189 in 2012. All staff are to be congratulated on a
successful outcome and thanked for their hard work throughout the year.
BIOCHEMISTRY:
Consultant: Prof Philip Mayne 
Chief Medical Scientist: Ms Rosie Hickey, 
Ms Ann Downey (commenced May)
Senior Medical Scientist: Ms Asun McGrath, 
Ms Sharon Campbell (commenced September)
Medical Scientists: Ms Lorna Pentony Mr. Damien Lally, 
Laboratory Aide: Mr Paul Reilly
POCT manager: Ms Jane Halligan
The overall workload for general biochemistry showed no major change on the
previous year and for endocrine testing we saw an increase in tests performed.
The overall pattern suggests that there may be a tendency towards opportunistic
screening with a 75% increase in lipid testing and a 150% increase in Vitamin D
testing.  The numbers associated with these investigations are relatively small at
present but the adoption of national guidelines and further screening could
significantly impact on the workload in future. 
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Test – marked increase Change%
Amylase 36
CSF Protein and Glucose 25
Cholesterol 73
Total Bile Acids 30
Vit D 155
Marked decrease
CK -23
Gent -26
Ferritin -21
Progesterone -25
TABLE 8: SUMMARY OF BIOCHEMISTRY WORKLOAD 2012
Specimen % Difference Test Numbers % Difference 
Numbers over 2010 over 2010
General Biochemistry 40450 -4 195894 No change
Endocrinology (in house) 16553 No change 34073 9
Referred work 3867 No change 8533 -10
TOTAL 60870 -2.4 238500 4
TABLE 9:   BIOCHEMISTRY WORKLOAD (TESTS) 2005-2012
% Difference  
Total Specimens 2005 2006 2007 2008 2009 2010 2011 2012  2005-2012
General Biochemistry 166,818 162,079 180,945 179,892 178,939 178,135 193,228 194,201 16%
% Difference over 
previous year 34% -2.8% 11.6% -0.6% 0.4 -0.4% 8.47% -4%
Endocrinology 24,625 23,106 29,382 32,449 29,137 30,008 31,192 34,073 38%
% Difference over 
previous year -16.1% -6.1% 27.2% 10.4% -10.2% 3.0% 3.9% 9%
Referred work 2,701 3,690 3,320 2,846 3,334 5,427 4,545 8533* NA
% Difference over 
previous year -55% 36.6% -10.0 -14.3% 17.1 62.77 -16.3% -10% -24.6%
TOTAL 236,807
*Some screens i.e. metabolic screens were counted per test as each of these screens
were made up of individual tests. These are not fully comparable year-on-year.
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HAEMATOLOGY and BLOOD TRANSFUSION:
Consultant: Dr. Melanie Cotter, Dr Fionnuala Ni Ainle 
Chief Medical Scientist: Ms. Deirdre Murphy 
Senior Medical Scientists: Mr Ciaran Mooney; Ms Deirdre O’Neill 
Ms Emily Forde
Medical Scientists: Ms Liliana Rasidovic, Ms Edel Cussen; 
Ms Noreen Brady; Ms Deirdre Corcoran, 
Ms Aileen Carr
Laboratory Aide: Ms. Karen Fennelly
1.  In- house workload
Numbers of FBC samples processed during 2012 were broadly similar to those
processed in 2011. Of note, FBC samples received from the paediatric OPD
department and from the postnatal ward were significantly reduced compared
with the previous 12 month period. Coagulation workload was reduced overall,
with a ~50% reduction in samples received from the emergency department and
a ~30% in samples received from postnatal ward and delivery suite. This likely
reflects improved implementation of criteria for coagulation testing by clinical
staff. Haemoglobinopathy screening requests rose, likely due to improved
identification of target groups. Thrombophilia testing was reduced by 24%
following introduction of evidence-based guidelines during the latter quarter of
2012. Further reductions are anticipated, with significant continuing cost
savings to the laboratory
2.  Referred workload
Overall a 14% reduction was observed, with significant predicted associated
cost savings. Of note, new Anti-Xa testing guidelines reflecting contributed to
an approx. 50% reduction in requests. 
3.  Serology
Workload remained broadly similar to last year’s. Minor reductions were
observed in blood products transfused, samples received for blood grouping,
antibody screening and direct Coombs test. Conversely, there was a minor
increases in samples referred for flow cytometry. These observations are in line
with general hospital activity.
4.  Blood Transfusion
A 100% traceability of all blood components issued was again recorded,
reflecting a continuing high standard of haemovigilance in the Rotunda
Hospital.
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TABLE 10: HAEMATOLOGY: IN-HOUSE WORKLOAD 2012
TEST 2012 2011 CHANGE % CHANGE
FBC
Total 43735 45041 1306 -2.9
Adult 38291 39953 1662 -4.2
Paeds 5443 5090 -353 6.9
NICU 4066 3927 -139 3.5
POPD 334 383 49 -12.8
OPD 14906 14066 -840 6.0
ER 2133 2129 -4 0.2
DS 1134 1314 180 -13.7
GW 3556 3435 -121 3.5
LILS 1409 1745 336 -19.3
GPN 3038 3714 676 -18.2
PSNT 2341 3951 1610 -40.7
PC 3045 3283 238 -7.2
COAG
Total 3373 4168 -795 -19.1
Adult 2940 3764 -824 -21.9
Paeds 433 403 30 7.4
NICU 338 323 15 4.6
POPD 18 23 -5 -21.7
OPD 203 246 -43 -17.5
ER 85 187 -102 -54.5
DS 246 365 -119 -32.6
GW 711 849 -138 -16.3
LILS 154 179 -25 -14.0
GPN 451 648 -197 -30.4
PSNT 321 434 -113 -26.0
PC 121 142 -21 -14.8
Theatre 50 66 -16 -24.2
Thrombophilia Screens
Total 219 287 -68 -23.7
Adult 214 284 -70 -24.6
Paeds 5 3 2 66.7
COAG Clinic 32 32 0 0.0
PC 25 57 -32 -56.1
HARI 25 17 8 47.1
Mocanu 79 95 -16 -16.8
OPD 31 43 -12 -27.9
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TABLE 13:    BLOOD GROUP SEROLOGY WORKLOAD 2012
% DIFFERENCE 
TEST TYPE NUMBER OVER 2011
ABO Groups 20527 -10%
Rh Groups 20527 -10%
Antibody screens 17120 -11%
Direct Coomb’s Test 3125 -2.6%
Antibody Identification panels 1232 -31%
Genotypes-5.1 426 -24%
Titres74 -50%
T Activation 0 -----
Elutions 51 4%
Weak/Partial D Typing 30 -46%
Flow Cytometry 885 9%
Total Tests 63,997 -10%
TABLE 11: REFERRED WORKLOAD 2012
Referred Tests
Test 2012 2011 Change % Change
Immunology 1225 1561 -336 -21.5
Prothrombin 2 279 294 -15 -5.1
mutation + PS
Lymph Subsets 143 81 62 76.5
Cytogenetics 678 613 65 10.6
Mol Genetics 78 51 27 52.9
Ddimers 14 12 2 16.7
Haptoglobins 4 5 -1 -20.0
Factor Assays 221 193 28 14.5
Xa 64 130 -66 -50.8
TABLE 12: HAEMATOLOGY IN-HOUSE WORKLOAD, 2005-2012
TESTS 2005 2006 2007 2008 2009 2010 2011 2012 % 
CHANGE 
OVER 7
YEARS
Tests inhouse 43,113 48,276 52,137 56,016 58,149 63,749 65,469 58565 51.8
%  Change
over 
previous 
year -13.6 +12.0 +8.0 +7.5 +3.8 +8.59 2.7 -3.9
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DETAILS OF ANTIBODIES DETECTED 2012
Antibody No of patients
D+C 3
Auto e 1
c 1
C 1
Cw 7
Cw+ Jka 1
D 12
D+C+Fya 1
D+E 1
D+G 1
E 7
e 2
E+c 3
Fya 1
Jk3 1
K 6
Lea 3
Leb 1
M 14
s 1
TOTAL 68
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TABLE 15:    BLOOD TRANSFUSION WORKLOAD 2012
% DIFFERENCE 
TESTS 2012 OVER 2011
Group/save 5894 -5.9
X-match performed; units 1844 -4
Patients x-matched(Adults) 609 -1
Units Transfused(adults) 517 -16
Patients Transfused 199 -14.6
X-match transfusion ratio 2.6:1 -0.5
IUT blood 8 units Small Nos
Pedipacks 142 babies rec’d 439 units No change
Specimen 5894 -14
Wastage
Red cell (concentrated) 3.5 % 1.4%
Platelets 11.1% -15%
Plasma 7.5% +7.5%
Transfused Components
Plasma Adult 187 186%
Plasma Paediatric 55 12.2%
Platelets-Adult 9 -60% (Small Nos)
Platelets-Paed 46 142%
Fibrinogen-Adult 27 No change
Fibrinogen-Paed 38 192%
Novo seven Adult - -------
Novoseven-Paed - -----
Factor 8 0 -------
Anti-D 1560 No change
Total tests 7738 -5.5%
Total Specimens 6503 -5.5%
TABLE 14: BLOOD GROUP SEROLOGY FIGURES OVER LAST 7 YEARS
Tests 2005 2006 2007 2008 2009 2010 2011 2012 % 
Difference
7-year
Tests 48,220 51,648 57,245 66,429 65,108 69,708 71,483  63,621
% Change from 
previous year -10% +32%
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CLINICAL MICROBIOLOGY
Consultant: Dr. Suzanne Corcoran 
Prof Mary Cafferkey (locum cover for leave)
Specialist Registrar: Ciara Keating & Sarah Bergin
Associate Paediatric Specialist in
Infectious Diseases: Dr Wendy Ferguson
Chief Medical Scientist: Mr David LeBlanc
Senior Medical Scientists: Ms Niamh Cahill (Feb-Dec), 
Ms Deirdre Cafferty (May-Dec)
Medical Scientists: Ms Ita Cahill (0.5), 
Ms Patricia Baynes, 
Ms Ann Lamont, 
Ms Bernadette Lennon (0.5), 
Ms Ellen Lennon, 
Ms Gemma Tyrrell (Jan-April), 
Ms Anne Dalton (Jan-May), 
Mr John Williams (Jan-March), 
Mr Michael Hennessy (July-Sept).
Laboratory Aide: Ms Grainne McDonald 
Assistant Director of Midwifery/Nursing,
Infection Prevention and Control: Ms Marian Brennan 
Infection Prevention and Control Midwife: Ms Alva Fitzgibbon
Infectious Diseases Liaison Midwife: Ms Mairead Lawless.
TABLE 16: Overall Microbiology Workload in 2012 compared with 2011
2012 % change
Tests Specimens Tests Specimens
Testing in-house
General Microbiology 87,052 47,790 7.63 7.62
Virology/Serology 33,091 13,676 -32.57 -14.84
Total tested in-house 120,143 61,466 -7.55 1.66
Referred 
Rubella 10871 10871 -5.31 -5.31
VZG 9568 9568 *** ***
Treponemal tests 10273 9921 -5.53 -4.94
Confirmation and other 
specialist tests  referred 
externally** 11186 4533 27.91 23.99
Total Referred 41898 27075 19.11 0.54
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GENERAL MICROBIOLOGY WORKLOAD
The increased activity and increased complexity of the hospital workload and that
of the Neonatal Unit contributed significantly to continuing high workload.
The numbers of swabs at first instance appear down by 11.41%, but this is due to the
fact that screening swabs (Rectal & MRSA) were removed from this category and
put in a category of their own. Screening swabs are up by 37.37% on the previous
year. Urine specimens are slightly down by 2.6%, with also a reduction in
pregnancy testing by 4.55%. There is a big increase in both CSF (26.5%) and Blood
Culture (11.36%) testing, however the cultures for placenta are significantly down (-
64.95%) due to the fact that these numbers were reduced during the course of 2012
as a cost saving initiative. Specimens for testing for Chlamydia trachomatis PCR
increased significantly as did N. gonorrhoea PCR analysis. These tests were up by
98.53% on the previous year. There was a new category of tests introduced in 2012
called IQA (Internal Quality Assurance), which is a required standard for ISO: 15189
Accreditation. Overall there has been a 7.62% increase in clinical Microbiology
specimens and a 7.63% rise in clinical Microbiology tests.
General Microbiology was inspected by INAB in early 2012 and again in late 2012
and was fully compliant. These inspections were an extension to the existing scope
for the department and resulted in full ISO: 15189 Accreditation been awarded in all
areas examined.
SURVEILLANCE SCREENING
In line with best practice and in the interests of patient safety, screening for multi-
drug resistant organisms (MDRO’s) including MRSA, VRE, ESBL’s and CRE in
identifiable ‘at risk’ groups in adults continued in 2012.
2012 saw continued surveillance screening for the entire hospital. This included
figures for adult & paediatric blood cultures, figures for Chlamydia and N.
gonorrhoea PCR, and screening of the NICU for resistant Coliforms, VRE,
pseudomonas, Candida and MRSA. All these figures are presented at the NICU and
infection control meetings, which take place quarterly. 
Also presented at these meetings are any infection clusters (Influenza, Norovirus
etc), all EARSS data and resistance patterns on various antibiotics.
Surveillance of the adult blood cultures saw a continuation of contamination
among the positive blood cultures (4.15%) although this was a marked reduction
from 2011 (8.04%). A contamination rate of <3% is desirable. This had led to the
infection control team to look at novel ways of reducing these numbers and so
preventing unnecessary treatment.
The Laboratory works as part of a multi-disciplinary team and provides the
surveillance data to the Neonatal Infection Prevention and Control group, which
helped to enable the group to identify changes and practices, which were required
in order to reduce the incidence of contaminated samples and healthcare
associated infection (HCAI). 
During 2012 the rectal screening of the NICU yielded 7 Gentamicin resistant
Coliforms, 10 AmpC producing Coliforms, 4 ESBL producing Coliforms, 12 P.
aeruginosa and 69 Candida sp. This was the first year that the resistant Coliforms
were grouped as either AmpC or ESBL producers and so it is difficult to compare
with 2011, which had 13 Cefotaxime resistant Coliforms. Candida was cultured in 69
patients (11.3%), compared with 7.8% in 2011. There was a total of 12 P. aeruginosa
isolated from the NICU in 2012 representing a 1.97% isolation rate compared with
0.36% in 2011. There was no VRE or CRE isolated in 2012.
Screening for MRSA continued, yielding a total of 33 positives in 2012, 5 of which
were in the NICU. These results are similar to previous years and the Rotunda
continues to enjoy low rates of MRSA among patients due to its policy of ‘seek
and destroy’. Occupational health continues to yield high numbers of positive
MRSA, highlighting the continued need to screen all new staff at clinical areas.
Quarterly reporting of EARSS organisms continued in 2012 and results were as
follows. 18 E. coli, 2 E. feacalis, 6 S. aureus (No MRSA), 1 P. aeruginosa and no K.
pneumoniae, E. feacium or S. pneumoniae. All positive isolates were isolated
from Blood Cultures and not from CSF cultures.
There was no case of invasive infection with multiple antimicrobial resistant
Gram-negative bacilli in the Neonatal Unit throughout 2011 and this continued
in 2012.
TABLE 17: CLINICAL MICROBIOLOGY WORKLOAD IN 2012 COMPARED WITH 2011
BY SPECIMEN TYPES AND TEST NUMBERS
Specimens 2012 % Difference over 2011
Urine 21792 -2.6
Swabs 10206 -11.41
CSF 296 26.5
Blood Cultures 2509 11.36
Placenta 375 -64.95
Semen 1912 -4.02
Pregnancy Tests 126 -4.55
Screening 6539 37.37
Chlamydia trachomatis
NeisseriaG PCR 3109 98.53
Total specimens 47790 7.62
Tests
Urines 35926 1.39
Swabs 20412 -11.41
CSF 643 31.22
Blood Cultures 2509 11.36
Placenta 375 -64.95
MRSA Screen 5720 -15.36
Rectal Screen 7358 166.4
Semen 4600 -4.66
Antimicrobial Cards 2254 9.15
Pregnancy Tests 126 -4.55
Chlamydia trachomatis 3109 98.53
GC PCR 3094 551.37
IQA 926 No figures
Total Tests 87052 7.63
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VIROLOGY/SEROLOGY WORKLOAD
The virology/serology for the HARI Unit continues to be performed in the
virology/serology section of the Microbiology laboratory. Under the EU Tissue
Directive, it is a legal requirement that this testing can be only performed in a
laboratory that is fully accredited to ISO. The laboratory was again inspected by
INAB in 2012, and continues to enjoy ISO: 15189 Accreditation. Following the
November inspection, serology reports were changed from ‘Negative’ to ‘Not
Detected’ and ‘Positive’ to ‘Detected’.
The number of antenatal booking bloods tested is similar with the number for
2011, however the overall in-house virology testing is down on 2011. Overall
virology testing is down by 21.96% and this reflects a large decrease in virology
testing from the HARI unit, due to new national policy in blood screening for IVF
patients. CMV IgG testing is down by 44.76% and best reflects this drop in HARI
blood testing. The number of specimens referred for testing at outside laboratories
increased by 0.54% with an increase of 19.11% in lab tests. This is best represented
by the fact that testing for Varicella Zoster IgG which was traditionally done in-
house, is now been sent to the NVRL for analysis.
COMMENTS ON REFERRED SEROLOGY WORKLOAD
The situation whereby for historical and financial reasons outside our control,
bloods for screening for Rubella, Varicella Zoster IgG and Treponema pallidum
(syphilis) are referred to two outside laboratories continued in 2012. This situation
exists because it has not proven possible to secure the budget from the funding
agency (the HSE) to perform this testing at the Rotunda. Of note, there is no direct
electronic link with these outside laboratories, and all data has to be entered on the
computer when the results are received, which can cause delays in reporting. To
reiterate from the 2011 report, it would be both time-efficient and cost-effective to
perform Rubella, VZ IgG and the Treponema screening tests in-house, with only
problematical samples referred and those testing positive on screening for
confirmatory and/or additional testing. It is important to note, that the analyser
for performing all these tests is already in operation in the Rotunda performing
other vital tests and is fully ISO: 15189 compliant, something the referral
laboratories do not enjoy.
CHANGES IN LABORATORY EQUIPMENT AND TESTING PROCEDURES
INTRODUCTION AND VALIDATION OF A NEW SYSTEM FOR BATCH ACCEPTING OF
REAGENTS
From January 2012 all reagents, kits and media (agar etc) were recorded
electronically on the LIMS using a unique identifier and assigned a laboratory
specimen number (MQ number). The purpose of this was to record electronically
internal quality assurance of these reagents. Previously the IQA was recorded on
paper, which was cumbersome and time consuming and accumulated excessive
paperwork. This has all been eliminated now and records are much tidier and more
readily available to view. It has also meant that the work put in by the staff can be
quantified and compared yearly. IQA or batch acceptance is a standard required by
ISO: 15189 for accreditation.
INTRODUCTION OF NEW QUALITY CONTROLS FOR TRAINING ON URINES AND CSF
2012 saw the introduction of internal quality controls for both urine microscopy
and CSF microscopy for the purpose of training both new microbiology staff
members and also non-microbiology scientists for on-call. These controls are an
important tool in not only training but also to control the counting chambers in
which these tests are performed. The introduction of these controls eliminated the
need to make up mock samples for the purpose of training and quality. These
controls have a multi-purpose use and are also employed as a positive and negative
control to QC pregnancy tests.132
TABLE 18:  WORKLOAD IN VIROLOGY/SEROLOGY 2012
Tested  in-house 2012 % Change over 2011
HIV 11738 -16.74
HbsAg 11736 -16.88
Hepatitis B Core 2527 -39.15
HepC Antibody 4849 -20.00
CMV IgG 2067 -44.76
Hep B core - vidas 81 -24.30
VZ IgG - vidas 93 -497
Total 33091 -32.57
Specimens Referred 
Referral laboratory 1
TPE 9921 -5.53
RPR 144 12.5
TPEM 64 28.0
TPPA 144 13.39
Sub Total (a) 10273 -4.94
Referral laboratory 2
Rubella 10871 -5.31
VZ IgG - Liason 9568 13.89
Sub Total 20439 30.81
Confirmation and other specialist
tests referred externally 11186 27.91
Total referred 41898 19.11
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VITEK 2 
The VITEK 2 compact software was upgraded during 2012 and is now fully compliant
for both CLSI and EUCAST susceptibility testing. Although CLSI was still used during
2012 it is hoped that validation of both the Vitek and Disc diffusion for EUCAST will
begin in early 2013.
A number of new Vitek antimicrobial cards were introduced during 2012, which
contained new antibiotic formulas and concentrations, which replaced older
concentrations. These were all fully validated and implemented into the working day.
SEMEN ANALYSIS 
The SQA-V semen analyser was upgraded to the new WHO recommendations for
semen analysis. This was fully validated, tested and implemented during the
middle part of 2012. This involved retraining of all staff members on the new
recommendations and reference ranges provided by the WHO. It involved
rewriting procedures and methods and informing the users of the change over and
rewording of specimen report forms. It is hoped that semen analysis will be added
to the scope of accreditation for 2013.
COMPUTERISED INFECTIOUS DISEASES REPORTING (CIDR)
Reporting of all notifiable diseases continued in 2012 using the CIDR link and the
list of notifiable diseases was updated in early 2012.
Group B Streptococcus
A new chromogenic agar media was validated in 2011 for the isolation of
Streptococcus group B. This has increased our turnaround time (TAT) in reporting
of GBS isolates in patients. All vaginal swabs on pregnant patients will now
routinely be screened for GBS using the chromogenic agar, and other specimens on
request. This was introduced in 2012 as a cost saving initiative and to improve TAT.
It has reduced the need to perform costly manual grouping on these isolates. It is
hoped that this will ultimately reduce the numbers of paedriatic sepsis with GBS.
Blood cultures
The recording of blood volumes of paediatric blood added to blood culture bottles
was introduced in July 2012 to estimate if volume has an impact on rate of
positivity. This continued throughout 2012. 
Chlamydia Study
The Chlamydia study took place in 2012 on all patients <27 years of age. It involved
testing first void urine for both CT and GC PCR. There was about a 50% uptake in
the study and the DOVE team headed by Dr Jack Lambert are due to publish the
findings in 2013.  For 2012 the rate of positive CT among the patients tested at the
Rotunda was roughly 3% and 0.3% for GC. These figures are roughly in line with
national figures.
New Equipment
A new fridge for storing of agar and growth media was procured in 2012; it replaced
an over 10-year-old fridge, which consistently failed calibration tests, leaving it no
longer fit for purpose.
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CLUSTERS OF UNUSUAL INFECTION AND INVESTIGATION OF THESE
OUTBREAKS 
MRSA   
The VITEK 2 compact software was upgraded during 2012 and is now fully
compliant for both CLS
595 neonates (NICU) screened yielding 5 positives = 0.84%
673 adults (including staff) screened yielding 18 positives = 2.7%.  Ten further
patients cultured positive for MRSA from routine clinical specimens. This means
a total of 33 patients or staff members were found to be either colonized or
infected by MRSA in 2012.
PSEUDOMONAS AERUGINOSA   
There was a total of 12 P aeruginosa isolates from the NICU in 2012. This marked
a large increase from previous years (2 in 2011). February yielded 3 with
November and December yielding 5 in total. All the isolates were sent out to the
HPA Colindale for typing and results revealed that all strains were genetically
distinct. The laboratory remains vigilant to identify any isolates in clinical
specimens from the NICU, and the situation is being kept under review. 
INFLUENZA & NOROVIRUS
Influenza and Norovirus continue to be a challenge for hospital staff and
patients throughout the country. Fortunately there were no major clusters of
either within the Rotunda. There were a total of 2 positive Norovirus results for
the whole of 2012, both in October and unrelated. There was a total of 18 Positive
Influenza A and 5 Influenza B in 2012. 16 of the Influenza A positive results were
in the months of January and February, when national numbers are at their
peak. Influenza B numbers peaked in December 2012 with the Rotunda reporting
4 cases. 
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TABLE 19: SEROLOGY TESTING
2012 tests 2011 tests Diff nos % change
VZGL 9568 4144 5424 130.89
VZDR 0 6203 -6203 -100.00
VZVR 93 590 -497 -84.24
Total VZ 9661 10937 -1276 -11.67
TPE 9921 10502 -581 -5.53
RPR 144 128 16 12.50 
TPPA 144 127 17 13.39
TPEM 64 50 14 28.00
Total TP 10273 10807 -534 -4.94
Rubella 10871 11481 -610 -5.31
Rubella & VZ total (VRL) 20439 15625 4814 30.81
Tested In-House
HIV 11738 14098 -2360 -16.74
Hep B 11736 14120 -2384 -16.88
Hep B core 2527 4153 -1626 -39.15
Hep C 4849 6061 -1212 -20.00
CMV 2067 3742 -1675 -44.76
HBCVR 81 107 -26 -24.30
Total  32998 42281 -9283 -21.96
NVRL (confirmatry tests) 1398 985 413 41.93
Total Serology In-House 33091 49074 -15983 -32.57
Total Samples In-House 13676 16059 -2383 -14.84
Referred Tests (others) 9788 7760 2028 26.13
Referred Specimens (others) 4533 3656 877 23.99
Total Reffered Tests 41898 35177 6721 19.11
Total Referred Specimens 27075 26929 146 0.54
Total Tests 74989 84251 -9262 -10.99
Total Specimens 40751 42988 -2237 -5.20
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TABLE 20 MICROBIOLOGY TESTING
2012                           2011 Difference               % 
numbers Change
Tests Specimens Tests Specimens Tests Specimens Tests Specimens
MSU 27674 13761 28490 14129 -816 -368 -2.86 -2.60
First visit 8252 8031 6944 6740 1308 1291 18.84 19.15
Total Urine 35926 21792 35434 20869 492 923 1.39 4.42
Pregnancy 126 126 132 132 -6 -6 -4.55 -4.55
Tests
Blood 2509 2509 2253 2253 256 256 11.36 11.36
Cultures
Placenta 375 375 1070 1070 -695 -695 -64.95 -64.95
Total Blood 2884 2884 3323 3323 -439 -439 -13.21 -13.21
culture
CSF 643 296 490 234 153 62 31.22 26.50
Semen 4600 1912 4825 1992 -225 -80 -4.66 -4.02
CT PCR 3109 1566 1543 98.53
NG PCR 3094 475 2619 551.37
Total PCR 6203 3109 2041 1566 4162 1543 203.92 98.53
IQA 926 926 9 9 917 917 10188.89 10188.89
MRSA 5720 2860 6758 3379 -1038 -519 -15.36 -15.36
Rectal 7358 3679 2762 1381 4596 2298 166.40 166.40
Total Screens 13078 6539 9520 4760 3558 1779 37.37 37.37
Swabs 20412 10206 23042 11521 -2630 -1315 -11.41 -11.41
Antimicrobial 2254 2065 189 9.15
Sensitivities 
cards
Total 87052 47790 80881 44406 6171 3384 7.63 7.62
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INTRODUCTION
Infection control is about maintaining an effective programme for the prevention of
hospital acquired infections and the containment of infections brought into the
hospital by staff visitors or patients. The core Infection Prevention and Control and
Team (IPCT) comprises a temporary Consultant Microbiologist (CM), 1 WTE Assistant
Director of Midwifery/Nursing (Infection Prevention and Control) and 1 WTE
Infection Prevention and Control Midwife/Nurse Specialist (both referred to as
IPCM/N). The IPCM/N visits all clinical areas daily and participates in ward rounds
in the Neonatal Unit once/twice weekly and as required. The CM participates in
ward rounds in the Neonatal Unit on a weekly basis and more often when required
as well as other areas where indicated.  This IPCT liaise daily with the Microbiology
departmental staff and the CM.      
Meetings of the Infection Prevention and Control Committee
Formal meetings of the Infection Prevention and Control Committee take place
quarterly and also as required. Much additional work relating to Infection Prevention
and Control was progressed through the Property Committee, the Quality Committee,
the Hygiene Services Committee the Neonatal Infection Prevention and Control
working group and the Decontamination Committee. 
INFECTION PREVENTION AND CONTROL PROGRAMME FOR 2012
The Infection Prevention and Control programme for 2012 included the following:
Education 
Monthly in service education programmes for midwifery and nursing 
staff were undertaken by the IPCMs in collaboration with others e.g., 
Decontamination Co-ordinator, Occupational Health, Infectious Diseases 
Liaison Midwife, and Health and Safety.
•   Hand Hygiene
•   Standard Precautions
•   Aseptic non-touch technique
•   Transmission Based precautions
•   Blood/body fluid exposure awareness and management
•   “Sharps” injury awareness, prevention and management
•   Use of Personal protective equipment 
•   Segregation of Waste and Waste management
•   Management of Laundry
•   Decontamination of patient equipment.
•   Decontamination of Reusable Invasive Medical Devices.
•   Prevention of mother-to-child transmission of blood-borne viruses
•   Management and prevention of Influenza
A similar study day for maternity care assistants was undertaken by the IPCMs in
conjunction with the Decontamination manager. 
I N F E C T I O N  P R E V E N T I O N  A N D  C O N T R O L
Attendance is recorded, however due to staffing level difficulties the numbers
of people who attended these study days remained suboptimal. 
Hand hygiene Education
The importance of hand as the most important contributor to preventing
healthcare associated infections is well documented. The IPCMs continued their
efforts to impress this fact upon all staff. 
Education sessions were offered to all new staff at induction, at the monthly in
service days for midwifery and nursing staff at the breakfast meetings for
Consultants and for non consultant hospital doctors  and on visiting clinical
areas. On three occasions (in February, May and September) open days were
held for all. Here staff was educated about the WHO 5 moments for hand
hygiene and given demonstrations on the correct technique for performing
hand hygiene. They were also assessed on their technique using the ultra violet
“glo germ box”. 
Records of staff attending hand hygiene education are maintained with the
support of the HR department. Non attendees can be identified and targeted.
The number of staff who had hand hygiene education in 2012 increased to 71%
from 43.6% the previous year.
Since June 2012 attendance at hand hygiene education is reported to the
Hygiene Committee per discipline per quarter.
Hand Hygiene Audits
Hand hygiene audits are carried out throughout the Hospital on a regular basis
in all departments, with twice monthly audits in the NICU.
During the months of June and October 2012, the IPCMs were required for the
National Hygiene Audit, to measure healthcare worker compliance against 30
hand hygiene opportunities for each of the seven randomly selected wards,
resulting in 210 opportunities per hospital.   
The WHO methodology for undertaking hand hygiene observational audits was
used.  Healthcare workers were observed for their compliance against the WHO
'5 moments of hand hygiene':
The HSE set a target of achieving >85 % compliance in 2012.
Compliance rate in June was 83.3% and in October 86.1%.  
Auditing of decontamination of medical equipment 
During the first half of 2012 the decontamination and infection control teams
developed an electronic database which facilitates the auditing of all pieces of
medical equipment in each department. Auditing commenced in the September
2012. Ward managers, infection control link midwives and care assistants are
involved with the IPC/decontamination team when carrying out the audits. 
Audits are carried out in high risk areas monthly: NICU, Delivery Suite, ER,
Theatre and CSSD.
All other areas are considered low risk areas and are audited at 3-monthly intervals.
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Results are available on a traffic light system and can be downloaded on the intranet.
These results are presented at CMM meetings and at the Decontamination
Committee Meeting.
Ongoing Surveillance and Audit of Infection with multiple   antimicrobial
resistant organisms 
In line with best practice and in the interests of patient safety, screening for multidrug
resistant organisms (MDROs) including MRSA, VRE, ESBLs and CRE in identifiable at
risk groups in adults was continued. 
The surveillance screening of infants in the Neonatal Unit for carriage of MRSA or
aerobic Gram negative bacilli resistant to aminoglycosides and/or third generation
cephalosporins was carried out weekly. The findings were reviewed at meetings of
the IPC Team and the Neonatal Unit IPC team, and reported to the IPCC. 
In 2012, MRSA was detected in 5 babies. All instances of infection and/or carriage with
MRSA were documented, reviewed at meetings of the IPCT and the Neonatal IPC
bimonthly team meetings, and reported to the IPCC. Review of the cases did not find
an epidemiological link, i.e. there was no evidence of cross infection.
There were 7 babies with gentamicin resistant and 4 babies with extended spectrum
B-lactamase producing Gram negative bacilli isolated on rectal screening. 
The incidence of colonization with Pseudomonas aeruginosa increased significantly
during 2012. There were 12 cases in 2012, compared with 2 cases in 2011 and 3 cases in
2010. Results from the specialist laboratory in Colindale, UK found that all strains
from either clinical or environmental samples were genetically distinct i.e. there was
no evidence of an outbreak.
In early 2012, in light of recent P. aeruginosa outbreaks in the North of Ireland and an
alert from the HSE to all neonatal units in the Republic, to remain vigilant and
investigate any potential clusters of infection with this organism, the IPC team
undertook an investigation to look for any potential environmental source including
water samples, disinfectants etc. with negative results. All practices surrounding the
use of sinks, respiratory ventilation and humidification were reviewed and are in
accordance with best practice. Surveillance of all ventilated infants’ secretions was
reintroduced on a weekly basis in the unit. Staff awareness was increased. In addition,
a waterless system milk thawing/ heating was introduced.
REVIEW OF THE HIQA NATIONAL STANDARDS ON PREVENTION OF HCAIS
The IPC team in conjunction with the Quality and Safety committee carried out a
full review of the HIQA National Standards on the prevention of healthcare
associated infections. This was a lengthy project which involved the development
of appropriate self assessment teams for each standard. For each criterion, the self
assessment team considered: 
➢ Structures and processes currently in place
➢ How well the current system and processes are operating i.e. are the desired
outcomes being achieved through the monitoring of national performance 
indicators as outlined in the National Service Plan
➢ Any unique or innovative practice which would be of benefit to share as 
good practice
➢ Any inadequacies / inefficiencies within the current system / processes and
any outcomes which are not being achieved. 
➢ The overall gaps, deficits or barriers which are impeding progress and 
improvements being made in a particular area
A quality improvement plan required to improve compliance with the standard was
developed. 
The report created included a score for each criterion. The overall score was 92%.
This report was presented to the Hospital Executive Management Team at the IPC
Committee meeting. It was also returned to the HSE DNE.
Work continues on the quality improvement plans to increase compliance with the
standards.
National Point Prevalence Study
In May 2012, The Rotunda Hospital was one of  50 acute Irish hospitals (42 public
and eight private) that participated in the voluntary European Centre for Disease
Prevention and Control (ECDC) point prevalence survey (PPS) of hospital‐acquired
infections (HAI) and antimicrobial use (AMU). 
The survey was coordinated in Ireland by the Health Protection Surveillance
Centre (HPSC). The HPSC is the national centre for the surveillance of infections
in Ireland. The survey has been carried out across the European Union. 
During April 2012, staff members went to a training day, where they were taught
how to perform the survey.
The survey was done for the following reasons: 
1. To count the number of patients with an infection, which may have 
occurred as a result of being admitted to hospital, i.e. a ‘hospital‐acquired
infection’ (HAI). 
2. To count the number of patients in the hospitals who were prescribed 
antibiotics. 
At the Rotunda Hospital the prevalence of HAIs was 4.59%, which is slightly
below the national average of 5.17%.  However, the rate was higher than in the
other two maternity hospitals (see table below)
The prevalence of patients receiving antimicrobials was 18.88% which compared
favourably to a 34.42% rate at national level and was similar to results from the
other maternity hospitals.
Performance targets were developed and are being worked on by the IPC team.
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Table 1: National Point Prevalence Study
Total patients Number/Prevalence Number/Prevalence
surveyed of patients with HAI of patients receiving 
antimicrobials
National 
(all hospitals 9030 (100%) 497 (5.2%) 3108(34.4%)
surveyed)
Rotunda 
Hosptial 196 (100%) 9 (4.6%) 37 (18.9%)
Coombe 
Women’s 195(100%) 8 (4.1%) 43 (21.8%)
Hospital
National 
Maternity 920 (100%) 4 (2.3%) 31 (18.1%)
Hospital
Antimicrobial Stewardship
Antimicrobial stewardship refers to coordinated interventions designed to improve
and measure the appropriate use of antimicrobials by promoting the selection of
the optimal antimicrobial drug regimen, dose, duration of therapy, and route of
administration.  The antimicrobial stewardship team seeks to achieve optimal
clinical outcomes related to antimicrobial use, minimize toxicity and other adverse
events, reduce the costs of health care for infections, and limit the selection for
antimicrobial resistant strains.
The antimicrobial stewardship team was set up in the Rotunda Hospital in May
2011 and has members from Infection Control, Microbiology, Infectious Diseases
and Pharmacy. The team currently takes part in twice weekly antimicrobial rounds.
There is a Pharmacist present on all rounds who is also responsible for collecting
data for antimicrobial audit purposes. In 2012 the team reviewed approximately
1138 patients receiving antibiotic treatment and approximately 160 interventions
were made. About 60% of interventions related to issues with the choice of
antibiotic or deviations from the hospital guideline. The remainder of interventions
related to a combination of issues involving antimicrobial frequency, dose, and
route as well as poor recording of indications and duration of treatment. The
Pharmacy department contributes antimicrobial consumption data to a national
surveillance system coordinated by the Health Protection and Surveillance Centre.
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2012 was another busy year in the Ultrasound, Fetal Assessment (FAU) and
Prenatal Diagnosis (PND) clinics. 
The core ultrasound services in The Rotunda Hospital in 2012 were provided by
midwife sonographers Irene Twomey, Deirdre Nolan, Gemma Owens, Hilda
O’Keeffe and radiographers Marie Finnerty and Mabel Bogerabatyo and Fiona
Cody. Once again their dedication, hard work and commitment are recognised.
All patients are offered a departmental fetal anatomic survey at 20 weeks. Serial
scanning services were provided for patients attending the Diabetes, Twin and
Medical Clinics. Non routine or emergency ultrasound requisitions are
accommodated in addition to the scheduled workload.  
Fiona Cody and Hilda O’Keeffe of Perinatal Ireland contributed enormously to
the FAU this year. The PORTO Trial ended in May and the Genesis Study
commenced in October. 
A total of 1,103 serial scans were performed.
U LT R A S O U N D, F E TA L  A S S E S S M E N T  &
P R E N ATA L D I AG N O S I S  C L I N I C S
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DEVELOPMENTS IN 2012
• Sonographer Gemma Owens completed her Masters in 
Obstetric & Gynae Ultrasound.
• Dr. Karen Flood completed her Fellowship.
NUMBER OF OBSTETRIC SCANS
20 Week Scan 8,821 
Growth Scan 7,435
Echocardiogram  139    
Others 1,238
NUMBER OF GYNAECOLOGICAL SCANS 1,306
Total 18,939  
FETAL ASSESSMENT UNIT
Drs. Holohan, Gleeson, and Gaughan with CMM2 Nollaig Kelliher and S/M Joan
O’Beirnes  provided longitudinal follow up for women with high risk pregnancies in
the Fetal Assessment Unit. These were a diverse group of patients including women
with obstetric cholestasis (34), preterm pre-labour rupture of membranes (36), IUGR
(26), multiple pregnancies (113) and breech presentation (53). Fetal biometry,
biophysical score (674), CTG (534) and serial laboratory evaluation facilitated
outpatient management.  Altogether there were 1,520 attendances.
PRENATAL DIAGNOSIS CLINIC
In 2012 1,212 new patients attended for Prenatal Diagnosis.  Drs. Geary, Barry,
Breathnach, Cooley and Prof. Malone with CMS Jane Dalrymple, CMM2 Nollaig
Kelliher and S/M Joan O’Beirnes operated 7 clinics per week.
There were 2712 attendances as some patients were followed longitudinally. All
patients had an ultrasound scan.  In addition the following tests were performed:
Combined First Trimester Screening 1,113
Second Trimester Screening (Intmark) 72
Amniocentesis 163
Chorionic Villus Sampling 120
Of the 283 diagnostic procedures performed, there were 56 abnormal results
representing 19.8 % of invasive tests.
Abnormality CVS Amnio Total
Trisomy 21 14 14 28
Trisomy 18 8 5 13
Trisomy 13 2 2 4
45X 3 1 4
Triploidy 1 - 1
Klinefelters - 1 1
Zellweggers - 1 1
Pallister Killian - 1 1
Myotonic Dystrophy 1 - 1
Sickle Cell - 1 1
Osteopathia Striata 1 - 1
Total 30 26 56
Failed Culture - 2
- .7%
Forty eight invasive procedures other than amniocentesis or CVS were
performed. These included: 
Fetal Bladder Shunts 4
Cordocentesis 16
Intrauteine Transfusion 12
Laser Ablation (see Note Below) 16 16
Total 48
Dublin Fetal Surgery Group:
Since 2010, the fetal surgical teams at the National Maternity Hospital Dublin,
and the Rotunda Hospital Dublin have collaborated jointly for the management
of all cases of twin-to-twin transfusion syndrome referred to either centre. This
has resulted in a single team approach to all such cases, regardless of which of
the two hospital locations at which such patients are seen. Professor Fergal
Malone, Professor Fionnuala McAuliffe and Dr Stephen Carroll jointly perform
all such procedures.
During 2012, a total of sixteen cases of severe TTTS were managed by the Dublin Fetal
Surgery Group by means of fetoscopic laser ablation of placental vessels. In nine of
the sixteen cases (56%), both fetuses survived with normal paediatric outcome. In five
of the sixteen cases (31%), both fetuses died shortly after the procedure or before
reaching viability. In two of the sixteen cases (13%), the donor fetus died shortly after
the procedure and the recipient fetus survived with normal paediatric outcome. In
total therefore, overall neonatal survival was 63%.  These results are in line with
international published experience for this complex condition.
This approach to a complex, but relatively rare, fetal problem is an excellent
example of a joint collaborative management strategy that successfully
optimises care for these patients. Patients are currently referred from obstetric
units throughout Ireland for fetoscopic laser ablation and, where appropriate
expertise is available, patients are referred back to their original obstetric centre
for subsequent fetal surveillance and delivery. It is hoped that, as referral
pathways become more established, the number of cases of fetoscopic laser
ablation will increase further.146
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Major Fetal Structural Abnormality:
Excluding soft markers and chromosomal abnormalities, 154 cases of major
structural abnormalities were detected and followed.  These include:-
Cardiac 20
CNS 28
Renal 37
Abdominal 7
Skeletal 15
Multiple 17
Head / Neck incl. Cystic Hygroma 10
Thoracic 17
Other 3
Total 154
Targeted fetal echocardiograms were performed in women deemed high risk
according to a specific departmental protocol or where a routine structural scan
was suspicious for a cardiac abnormality.  Dr Fionnuala Breathnach performed the
majority of fetal echocardiograms. A total of 139 targeted fetal echocardiograms
were performed within the Department in 2012. 
Where fetal congenital heart disease was identified or suspected, women were
seen at our Combined Fetal Cardiology clinic based at the Coombe Hospital, staffed
by Consultant Paediatric Cardiologist Dr. Orla Franklin and by consultants in
Maternal Fetal Medicine Prof. Sean Daly and Dr. Fionnuala Breathnach.  
Established in 2009, this collaborative clinic offers a seamless transition from
prenatal to neonatal care for infants diagnosed in-utero with congenital heart
disease.  This approach allows for individualized care, to include prenatal
counseling and formulation of delivery and perinatal care plans. This clinic
continues to expand, and caters for referrals from all maternity units in Ireland. 
In 2012, 297 patients were referred for targeted fetal echocardiogram at our
combined service. 
The table below illustrates the group of patients seen at the Combined Fetal
Cardiology clinic in 2012 who had a prenatal diagnosis of a fetal cardiac
abnormality, and therefore includes patients who delivered in the Coombe
Hospital, and those referred from other hospitals. 
Major Cardiac Lesions seen at Combined Rotunda-Coombe Fetal Cardiology Clinic:
Cardiac Lesion 2011 2012
Atrioventricular septal defects 20 28
Hypoplastic left heart syndrome 12 7
Hypoplastic right heart syndrome 2 9
Outflow Tract Abnormalities 28 11
Isometric Heart Lesions 3 2
Others 4 8
Total 69 65
There were also 11 cases of fetal cardiac arrhythmia identified and followed
through this clinic.
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Multiple Pregnancy:
Seventy one multiple pregnancies were referred to the Prenatal Diagnosis
Clinic in particular high risk circumstances.  These include:
Multiple Pregnancy
Monoamnionicity 2
MCDA with Normal Ultrasound 21
Twin to Twin Transfusion 18
MCDA with Discordant Growth 10
MCDA Discordant for Structural Abnormality. 1
DCDA with Discordant Growth 4
DCDA  Discordant for Structural Abnormality 7
MCTA Triplets with Normal Ultrasound 1
DCTA Triplets with Normal Ultrasound 3
DCTA Triplets Discordant for Structural Abnormality 3
TCTA Triplets with Normal Ultrasound 1
Total 71
Excludes women undergoing laser therapy for TTTS In the Dublin Fetal Surgery
Group
MCDA = Monochorionic Diamniotic;  DCDA = Dichorionic Diamniotic
MCTA = Monochorionic Triamniotic;  DCTA = Dichorionic Triamniotic
TCTA = Trichorionic Triamniotic
Additional Cases Followed in Prenatal Diagnosis Clinic:
PPROM 1st & 2nd Trimester 9
IUGR (Severe 2nd trimester) 23
Polyhydramnios 4
Rhesus 5
Antibodies 20
CMV 2
Toxoplasmosis 2
Parvovirus 12
Soft Marker Normal Outcome 33
High Risk Screen Normal Outcome 69
Total 179
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DR GERALDINE CONNOLLY
DEBORAH BROWN RM
Antenatal care is provided to all teenage pregnant mothers up to age 17 in the
Rotunda hospital in the teenage pregnancy clinic.  Girls who are older and
deemed vulnerable, such as those with special needs, may also attend the clinic
as we feel they may benefit from continuity of care. Comparative figures for the
past 6 years for the clinic are presented.
Number booked
2007 120
2008 132
2009 145
2010 116
2011 124
2012 110
Primiparous Multiparous
2007 113 7
2008 123 9
2009 131 6
2010 109 7
2011 115 9
2012 100 10
Onset of Labour
Spontaneous % Induction %
2007 72 26
2008 70 30
2009 68 30
2010 69 27
2011 66 24
2012 68 31
Mode of Delivery %
SVD Instrumental C Section C section 
Emergency No labour
2007 64.7 20.7 12 2.6
2008 59.8 28.8 11.4 0
2009 64.2 23.3 10.9 1.6
2010 58.4 19.7 17.9 3.7
2011 63.6 20 10.9 5.5
2012 61.1 21.3 15.5 1.9
T E E N A G E  P R E G N A N C Y  C L I N I C
Epidural rates %
2007 78.5
2008 71
2009 74.4
2010 66.3
2011 68
2012 66
Premature delivery % low birth wt %
2007 5.8 3.3
2008 7.8 6.8
2009 7.6 6.5
2010 4.7 2.8
2011 7.3 9.1
2012 2.9 4.8
Chlamydia positive (%) Third degree tear (n)
2007 15 1
2008 6.4 1
2009 16 3
2010 12.2 3
2011 9.6 3
2012 14.1 2
Adverse baby outcome (n)
intrauterine neonatal
2007 0 1
2008 1 0
2009 2 2
2010 0 1
2011 0 2
2012 0 1
Attendance at
Antenatal Classes % Postnatal Clinic (%)
2007 52 50
2008 66 67
2009 55 37
2010 48 48
2011 54 41
2012 45 55
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Comment
The caesarean section rate in the teenage population is 17.4%. All of the
emergency caesarean sections were performed in those being induced and the
figure is a reflection of the increased induction rate this year.  On reviewing the
inductions 13 were performed for post dates, 5 for PET, 3 for IUGR, 3 for
oligohydramnios, 6 for prelabour SROM and 2 for reduced fetal movements.
Attendance at the postnatal clinic increased and we inserted a mirena IUS into
28% of those who attended. Chlamydia positive rate was 14.1% which is high in
this young population. 
There was 1 neonatal death due to anencephaly. Three babies weighed above
4.5Kg and 3 babies had IUGR at term.
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DR JOHN SHEEHAN
MARGARET SHERIDAN RM
KATHLEEN O’DONOHOE RM
LOUISE RAFFERTY RM
In 2012, a number of significant changes occurred in the mental health service.
Ms. Margaret Sheridan retired at the end of February after working for over 25
years in the Rotunda, 11 of which were as a Support Midwife in Mental Health.
She was a pioneer in developing the Support Midwife service, the first of its kind
in Ireland. Along with Dr. Sheehan, she oversaw the introduction of postnatal
screening in the Rotunda using the Edinburgh Postnatal Depression Scale (EPDS)
and she established the Health Promotion Clinic.  She promoted awareness of
mental health through the education of trainee midwives.  She had a positive
effect on the lives of many mothers and their babies attending the Rotunda and
was held in high esteem by all.
Ms. Sheridan was replaced by Ms. Kathleen O’Donohoe who commenced work as
a Support Midwife in the Rotunda in August 2012.  Previously, Ms. O’Donohoe
trained as a general nurse, midwife and public heath nurse.  She has a degree in
Counselling and Psychotherapy and brings considerable skills and experience to
the mental health service.
An audit was conducted by Ms. Louise Rafferty on the use of the EPDS on the
Postnatal and Lillie wards.  The audit highlighted areas for improvement which
have been implemented.  Ms. Rafferty also presented at the Royal College of
Midwives and INMO international conference in Armagh. 
In March, a woman in late pregnancy with twins and depression died tragically.
At the Inquest, the Coroner delivered an open verdict.
During the year, all team members were involved in the education and training
of medical students, midwifery students, midwifery interns and public health
nurses. 
Finally, in  2012, Dr. Sheehan saw 97 new patients and 208 review patients in the
OPD. The midwives saw 579 patients in the Health Promotion Clinic and 1305
patients on the wards.  The number of patients seen is very large and reflects the
need for mental health services in the patient group attending the Rotunda.
M E N T A L  H E A L T H  S E R V I C E S
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AILBHE MC CARTHY CNM1 Research
PREGESTATIONAL DIABETES MELLITUS
Rotunda Hospital  2012
Type 1 Diabetes (n=27)
Pregnancies 27
Spontaneous Abortions 4
Preterm deliveries 10
Term deliveries 11
Live Infants 23 2 sets twins
IUD 1 *Case Study 1
PND 0
Delivered Elsewhere 1
Maternal Data (Type 1) (n=27)
Age 31.4 ± 5.9
DM Duration 14.9 ± 9.0
DM Complications
Retinopathy 3
Nephropathy 0
Neuropathy 1
Hypertension 5
PET 3
Gestation at OPD Booking 7.8 ± 4.3 *Footnote 1
Booking HbA1c 7.8 ± 2.0
Delivery HbA1c 6.4 ± 0.5
Booking Fructosamine 351 ± 67
Delivery Fructosamine 256 ± 26
Caesarean Section 15 i.e. 68%
C O M B I N E D  S E R V I C E  F O R
D I A B E T E S  M E L L I T U S
Infant Data (Type 1) (n=23  live births)
Gestation at Delivery 37.1 ± 1.9
Birth Weight 3.3 ± 0.7
<4kg 18 Note -1 pt t/fd, 1 not 
pregnant = 21).
Macrosomia (4.0-4.449kg) 3
Macrosomia (4.5-4.99kg) 0
Macrosomia (>5kg) 0
Shoulder Dystocia 0
IUD 1 *Case Study 1
Congenital Abnormalities 0
Type 2 n=22
Pregnancies 22
Spontaneous Abortions 5
Preterm deliveries 10
Term deliveries 8
Live Infants 18
IUD 0
PND 0
Delivered Elsewhere 0
Maternal Data (Type 2) n=22
Spontaneous Abortions 5
Age 35.7 ± 6.1
DM Duration 5.2 ± 3.6
DM Complications
Retinopathy 0
Nephropathy 0
Neuropathy 0
Hypertension 5
PET 2
Gestation at OPD Booking 7.6 ± 3.9 *Footnote 2
Booking HbA1c 6.7 ± 1.4
Delivery HbA1c 6.4 ± 0.8
Booking Fructosamine 266 ± 43
Delivery Fructosamine 239 ± 29
Caesarean Section 15 i.e. 83.3%
Infant data (Type 2)  n = 18 live births 1 set twins
Gestation at Delivery 37.4 ± 1.7
Birth Weight 3.2 ± 0.7
<4kg 15
Macrosomia (4.0-4.449kg) 3
Macrosomia (4.5 - 4.99kg) 0
Macrosomia (>5kg) 0
Congenital Abnormalities 0154
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GESTATIONAL DIABETES MELLITUS Pregnancies n = 216
Rx with Insulin                107
Rx with Diet                     109
GDM Total Group  Rotunda Births 216
Live Births 221 8 sets twins
Age 33.0 ± 5.6
Gestation at delivery 38.2 ± 1.9
Birth Weight 3.37 ± 0.7
Caesarean Section 83 i.e. 38%
IUD 0
Spontaneous Abortion 2
Delivered Elsewhere 1
Congenital Abnormalities 0
Rx with insulin n = 107
Rotunda Live Births 109 4 sets twins
IUD 0
Delivered Elsewhere 0
To Insulin 26.6 ± 7.6
Gestation at delivery 38.4 ± 1.7
Birth weight 3.38 ± 0.6
Caesarean Section 45 i.e. 41%
Spontaneous Abortion 2
PET 0
Hypertension 0
Birth weights
<4kg 90
4-4.499kg 14
4.5-4.999kg 5
>5kg 0
Rx with Diet n= 109
Rotunda Live Births 112 4 sets twins
Age 33.0 ± 5.5
Gestation at delivery 38.0 ± 2.0
Birth Weight 3.33 ± 0.7
Caesarean Section 38 i.e. 34%
Spontaneous Abortion 0
IUD/PND 0
Delivered Elsewhere 1
Congenital Abnormalities 0
Birth weights
<4kg 95
4-4.499kg 14
4.5-4.999kg 4
>5kg 0
One abnormal value on OGTT n=172
Rx with Insulin 8
Rx with Diet 164
Total Group
Birth Weight 3.44 ± 0.6
Caesarean Section 69 i.e. 40%
Diet Group
Gestation at Delivery 38.7 ± 1.6
Birth Weight 3.43 ± 0.6
Caesarean Section 65 i.e. 39%
IUD 2 *Case Study 2&3
Delivered elsewhere 1
Spontaneous Abortion 1
Congenital Abnormalities 0
Birth weights (Diet Group)
<4kg 139
4-4.499kg 25
4.5-4.999kg 3
>5kg
Insulin Group
Age 33.9 ± 3.4
To Insulin 33.3 ± 2.3
Gestation at Delivery 39.1 ± 0.7
Birth Weight 3.7 ± 0.5
Caesarean Section 4 i.e. 50.0%
Birth weights (Insulin Group)
<4kg 6
4-4.499kg 1
4.5-4.999kg 1
>5kg 0
*Case Study 1
35 year old lady with Type 1 DM x 24 years. Booked at 8 weeks gestation with
Hba1c 9.7% and fructosamine 420. Delivery HbA1c 7.1% and fructosamine276.
Unanticipated IUD. Examination showed fetal scalp oedema with overlapping
skull bones. PM declined. See perinatal mortality report for further details.
Pathologist raised possibility that inflammation of uncertain significance was
identified and possibly related to an intercurrent maternal infection.
*Case Study 2
42 year old lady with IGT diagnosed at 18 weeks and controlled by diet.
Presented at 34 weeks with flu-like illness and decreased fetal movement.
PM declined. See perinatal mortality report for further details.
*Case Study 3
32 year old lady diagnosed with IGT at 28/40 controlled on diet. HTN prior to
delivery. PM says retroplacental haemorrhage with early organisation and
secondary inflammation as well as early ascending infection focal acute
chorioamnionitis. Any congenital malformations were excluded at autopsy.
*Footnote 1
2 x late bookers i.e. >12 weeks gestation. If removed would read 6.9 +/- 2.7.
*Footnote 2
1 late booker @ 17 +2 weeks gestation. If removed would read 7.0 +/- 3.1.156
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LAURA HARRINGTON, RD, MINDI- SENIOR DIETITIAN
In 2012 the dietitian held a total of 1177 patient visits, 667 new patients and 510
reviews. This is a decrease of 8.6% from 2011. The types of patients cared for can
be classified in the table below:
Referring Service Number of Patient Percentage of
Visits (Combined in- Total Patient
and outpatients) Visits
Antenatal 221 18.8 %
Diabetes 740 62.9 %
Gynaecology 41 3.5 %
Neonatology/Paeds 158 13.4 %
Postnatal 17 1.4 %
The number of diabetic patient follow-up visits decreased over the last year, due
to redistribution of patients into the midwifery-lead breakfast club. The number
of gynaecology referrals declined as well. However, there was a rise in the
number of antenatal, postnatal and paediatric patient referrals. 
The majority of dietetic referrals are for the following conditions:
. Antenatal: Overweight or obesity, maternal underweight, poor weight 
gain, hyperemesis, multiple gestations, anaemia, history of eating 
disorder, Crohn’s disease and other conditions that impact on nutritional
status 
• Diabetes: Gestational diabetes, type 1 and 2 diabetes in pregnancy and 
impaired glucose tolerance
• Gynaecology: Gestational diabetes, type 1 and 2 diabetes in pregnancy 
and impaired glucose tolerance
• Neonatology/Paeds: Poor weight gain, faltering growth, food 
intolerances and allergy
The dietitian gives presentations in the antenatal classes every week and in
study days on diabetes for midwifery yearly. 
Service expansion is planned based on the balance between resources and local
needs assessment. 
Links are maintained with the dietitians at The Coombe Women and Infants
University Hospital and The National Maternity Hospital to create best practice
guidelines, contribute to the National Clinical Guidelines, create and update
patient education materials and encourage continuing professional education.
C L I N I C A L  N U T R I T I O N
DR MARY HOLOHAN
At the Epilepsy Clinic in 2012 there were 166 patients seen.  For all of the patients a delivery
plan was determined and if on treatment, medication  optimised in conjunction with the
Epilepsy Specialist Nurse.  Monitoring of the therapeutic drug levels especially of
Lamotrigine and Carbamazepine significantly assisted in patient care.  
During 2012, 125 of these patients delivered in the Rotunda Hospital. 57 had not
required anti-convulsant treatment for some time before pregnancy and 48
patients needed anti-epilepsy drug treatment for the duration of the pregnancy.  8
patients had discontinued treatment shortly before this index pregnancy.  In late
pregnancy symptoms suggestive of subtle seizure activity were determined in 3 of
these. All declined to re commence treatment. 2 patients had first seizure during this
index pregnancy with 1 starting treatment (Levetiracetam). Seizure activity in 10
patients were associated with use of Benzodiazepines.
There was 8 complications in the group of 57 patients not on treatment. There were
3 deliveries at 26 - 27 weeks. Two term babies were admitted to NICU. Shoulder
dystocia with PPH occurred in one case and placenta percreta occurred in a further
case. One baby had Trisomy 21. One mother had some jerking movements after
delivery but recommencement of treatment was not deemed necessary.
Of the 48 patients  on anti-epilepsy treatment regimes, 38 were on mono-therapy and
9 required 2 medications.  One patient was on 3 medications.  2 of the patients had
monotherapy with Sodium Valproate (not Irish born).  There were 4 pregnancy
complications in patients using anti-epilepsy medications.  In 3 patients on
Levetiracetam pregnancy was complicated with hypertension and intra-uterine
growth restriction, fetal arrhythmia and a case of PPH. One patient on Topirimate had
mid trimester pregnancy loss. One patient in this group had a marked increase in
seizure frequency after delivery as medication regime was not continued.
There were 6 pregnancy complications in the 10 patients whose seizures related to
Benzodiazepine use. Intrauterine growth retardation occurred in 2 cases and
placenta praevia occurred in 1 case.  One infant was delivered at 26 weeks and
placental abruption complicated one case in a setting of pre-eclampsia. Extremely
high levels of Anti-D led to one fetal loss in mid trimester.
The Irish Epilepsy Association (Brainwave) Nurse Specialist, Sinéad Murphy,
continues to attend the Epilepsy Clinic on alternate weeks.  Sinéad had an individual
consultation with each of the patients on anti-epilepsy medications. Changing from
Sodium Valproate is actively encouraged even after first trimester in view of the
developmental challenges now linked to treatment with Valproate. The support and
advice offered by Sinéad and her close liaison on behalf of these patients with their
neurologist is hugely beneficial and is reflected in the very low number of problems
for patients attending the Epilepsy Clinic.  This model of care for pregnant women
with epilepsy has become the national standard operating procedure template.
I am very grateful to the neurology service in the Dublin hospitals for their support
in assisting with the care of the patients attending this clinic and in particular to Dr.
Norman Delanty and Nurse Specialist Sinéad Murphy.
E P I L E P S Y  C L I N I C
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MS CINNY CUSACK, PHYSIOTHERAPY MANAGER
The Physiotherapy Department’s mission is to provide patient centred,
innovative and evidenced based practice in the management and treatment of
obstetric, gynaecology and paediatric conditions.
In September 2012, Cinny Cusack was appointed as Physiotherapy manager and
a department plan was drawn up to implement the Rotunda’s strategic plan
within the physiotherapy department. A review of the clinical services was
commenced, which included:
• New adult and paediatric referral forms were introduced to facilitate 
improved triaging of referrals.
• Bleeps for all physiotherapists to improve communication with 
inpatient services. 
• Reducing waiting times from referral to outpatient appointment of 0-
2 weeks for urgent, 2-6 weeks for soon and 6-8 weeks for routine. 
• To reduce the amount of hospital based cancellation of appointments 
by appropriate management of annual leave and diary scheduling. To 
reduce the DNA rate by implementing a DNA policy
• To review all patient information leaflets and these have been sent for 
printing.
o  Post natal leaflets (immediately post natal, return to exercise)
o  Information following 3rd and 4th degree tears
o  Pelvic girdle pain 
o  Paediatric information leaflets and assessment form
OBSTETRIC PHYSIOTHERAPY - ANTENATAL 
Preparation for parenthood classes are currently run jointly with the parent
education midwives. 
There are day time and private evenings/Saturday classes.
• The physiotherapy classes 
•  (Class 1) includes advice and education to alleviate the 
musculoskeletal problems in pregnancy e.g. Pelvic girdle pain 
(PGP) carpel tunnel, low back pain. 
•  (Classes 2 and 6) Coping skills for labour, baby handling and 
development, Post natal advice and exercises. 
• The classes promote a healthy life style, recommended exercising regimes
and relaxation which will improve the women’s well being during 
pregnancy.
• Early attendance for the class is recommended and any special needs are
catered for on an individual basis. Refresher classes are provided for 
multigravida mums.
• Partners are welcome to attend classes 2 and 6.
•  Mothers attending  : Class one- 1,663, Class two- 1,218, Class six- 1,037
•  For the evening classes, Class one -143, Class two- 91,Class six- 91
•  For the Saturday classes a total of 289 attended.
•  Refresher classes: 130 attended.
P H Y S I O T H E R A P Y
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POSTNATAL PHYSIOTHERAPY
• 6,397 Mothers were seen as Inpatients for post natal advice and 
exercises, Pelvic girdle pain, mobility issues.  Our focus is on the high risk 
mothers who have anal sphincter tears, an operative delivery or have a 
baby over 4kg.
• The post natal class time has been changed to the morning to 
accommodate mothers with school going children. This has 
improved the attendance and  249 patients plus babies attended 
the classes held during 2012
GYNAECOLOGY PATIENTS
• The Continence promotion Clinic is led by Dr. Mary Holohan and Cinny 
Cusack. 207 new patients were given appointments in 2012 and 142 
attended. A review of the clinic was carried out in 2012 to ascertain the 
patient profile, primary diagnosis and treatment outcomes.74% of 
patients were referred for physiotherapy. Of those who completed the 
treatment, the outcomes were very positive. 
• A poster presentation on “The profile of assessment and treatment 
outcomes in a multidisciplinary clinic in the Rotunda Hospital”  was 
accepted as a poster at the IUGA conference to be held in Dublin 2013.
• Gynaecological patients are also referred from outpatient 
clinics. However, we are no longer accepting Gynae referrals from GP’s 
due to an increase in overall referrals from within the hospital and a 
reduction in physiotherapy hours.
• In patients are seen following all major surgery for advice, exercises and
chest physiotherapy if required.
•  A total of 126 patients were treated. 
PELVIC GIRDLE CLASS
• Over 600 referrals were received in 2012 for pelvic girdle pain. A pelvic 
girdle class is held to provide advice on ergonomics, management of 
activities of daily living, pacing and specific stabilising abdominal and 
pelvic floor exercises.  Patients who may require further treatment 
triaged through this class and assessed for use of support garments and
walking aids.
• The new referral form has a validated pelvic girdle questionnaire on the
reverse. When the patient fills out the form, the functional disability can
be calculated in order to triage the urgency of the referral. Those with 
severe pain/disability can then be offered an individual appointment.  
Unfortunately many forms are incomplete and all patients are not being
given the questionnaire.
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• Physiotherapy assessment and treatment follow the HSE guidelines 
published in August 2012. Management of pelvic girdle pain in 
pregnancy and post partum.
INCONTINENCE AND OBSTETRIC ANAL SPHINCTER INJURIES 
• Ante and post natal patients are treated for urinary and faecal 
incontinence. Post partum mothers may self refer for incontinence up to
six months post natal but are encouraged to come to the post natal class.
• All third and fourth degree tears are seen as an Inpatient (unless 
discharged at a weekend) and a follow up appointment is made for 
physiotherapy for 2 weeks post partum. A further appointment is made
for 6-8 weeks and ongoing appointments given as necessary. This 
follows the HSE guidelines into the Management of OASI published in 
April 2012.
PAEDIATRIC PATIENTS
•  Babies are referred to physiotherapy as inpatients for the following 
conditions
•   Torticollis, Talipes, Erbs and Plagiocephaly. 
•  73 babies were reviewed as inpatients requiring 104 attendances. 
Currently there is no routine physiotherapy input into babies in NICU. 
•  A further 620 babies were referred as outpatients for the above 
conditions and for developmental delay requiring 1,139 attendances
• A Talipes referral pathway was been written in conjunction with Dr. 
Adrienne Foran and Dr. Hilary Lane. This has reduced the number of 
inappropriate referral to physiotherapy and has ensured the correct 
pathway of care is provided.
DEPARTMENT ACTIVITY
In 2012 there were 4,557 outpatient attendances to the physiotherapy
department NOT including the preparation for parenthood classes or the
inpatients seen on the wards. This represents an increase in attendances of 37%
from 2011. I would like to acknowledge the hard work and dedication that the
Physiotherapy staff has put in over the past year in increasingly difficult
circumstances. The smooth running of this extremely busy department could
not happen without the significant contribution of the physiotherapy secretary. 
DR MAEVE EOGAN
Introduction
The Rotunda unit is now one of 6 HSE supported SATUs around the country, with
units established in Cork, Waterford, Mullingar, Galway and Letterkenny. In 2012
the SATU at the Rotunda Hospital provided care for 318 men and women after rape
or sexual assault, a decrease of 33 patients (9%) from 2011..
Most patients (84%) presented within 7 days of an incident of sexual assault, with
4 patients disclosing long-term abuse.  Early presentation is optimal in terms of
provision of appropriate care as well as collection of forensic evidence. In 10 cases,
the incident had occurred outside of Ireland. Of the 308 cases where the incident
was reported to have taken place in the Republic of Ireland, 258 of these took place
in Dublin city or county. 11 other counties were also represented in the figures.
December was the busiest month and Tuesday was the busiest day. 199 (63%)
patients were seen between the hours of 9pm and 8.59am, which underpins the
need for a round-the-clock service.  
The age and gender profiles of all patients is shown in Figure 2, the age range was
from 13 to 78 years. Although the remit for the Adult SATU services is for patients
over 14 years, in 2012 the unit provided care for 5 girls less than 14 years. These were
instances where acute care in a paediatric service could not be arranged.
Considerable developments in paediatric services are underway which will mean
that such patients can be appropriately accommodated in the future. 
103 (32%) patients were students, 97 (31%) were in employment and 113 (36%) were
unemployed. The majority of patients (267, 84%) were single. 255 (80%) patients
reported a single assailant, and 116 (36%) patients reported that the assailant was a
stranger. In 29 cases the alleged assailant was reported to be an intimate (or ex-
intimate) partner, and in an additional 12 cases reported to be a family member. 235
patients (74%) had consumed alcohol in the 12 hours prior to the assault, 12 units of
alcohol being the mean number of units ingested. That being said, many patients had
an imprecise recall of the amount of alcohol ingested. 59 patients were unsure if a
sexual assault had taken place, due to memory loss associated with alcohol ingestion.
S E X UA L  A S S AU LT  T R E AT M E N T  U N I T
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Emergency contraception (EC) was given to 143 of 209 women seen with 72 hours
of an incident. There were a range of reasons (including previous effective
contraception, hysterectomy) why the remaining patients did not require EC.  All
SATU attendees were offered follow-up screening for sexually transmitted
infections. 282 men and women accepted this offer, but only 212 actually
attended for screening. Such low return rates are not uncommon, both
nationally and internationally, and have encouraged continued provision of
routine prophylaxis for Chlamydia at the time of the patient’s initial attendance.
The rates of identification of Chlamydia have fallen precipitously since the
introduction of routine prophylaxis. All patients are also offered a course of
Hepatitis B Vaccination. This policy was introduced in 2009 and I would like to
acknowledge the ongoing support of the ID Services at the Mater University
Hospital. Since 2009 we have also been in a position to offer HIV prophylaxis on-
site if required. In 2012 44 patients received post-exposure prophylaxis for HIV,
no patients tested positive for HIV for the first time after their SATU attendance. 
Since 2009 we have been providing care for men and women who have
experienced sexual violence but who preferred not to report the incident to An
Garda Siochana. Of the 318 patients that attended the SATU, 63 (20%) patients
attended without reporting the incident to An Garda Síochána. It is a welcome
development that patients seek care and attention following an incident which
will hopefully have a positive impact on their recovery.
The SATU Liaison group (which includes Dublin Rape Crisis Centre, Garda Liaison
Officer, Medical Director, Sexual Assault Forensic Examiners, Nurses and
Administration Support Staff and a member of the team from the Forensic Science
Laboratory) met quarterly during the year.  These meetings are a valuable
opportunity to discuss relevant issues pertaining to SATU facilities and care and
ensure that all staff from the various agencies are aware of changes and
developments as they arise.  
The Royal College of Physicians in Ireland established a Sexual Health Policy
Group, which worked on position statements in various aspects of sexual health.
Members of the SATU team were involved with the prevention subcommittee, and
the work of this group was launched in 2012. It is hoped, with the support of the
Minister for Health, that these position statements will provide a framework for a
national Sexual Health Policy. 
Aideen Walsh completed a Masters in Science programme in Advanced
Nurse/Midwife Practice at RCSI. This will provide her with the academic
qualification to develop advanced nursing practice within the SATU. Deirdra
Richardson continues to offer the risk reduction programme to schools in the
Dublin area. SATU staff were all very involved in the Sexual Health Awareness
Week at the RCPI in May 2012 and also actively involved in outreach education
within Emergency Departments & General Practice, Mental Health Services, Prison
Services, An Garda Síochána and Dublin Rape Crisis Centre to raise awareness and
increase understanding and recognition and to equip people better to respond to
incidents of sexual violence. The strong Interagency Links that have traditionally
existed, particularly with An Garda Síochána, Forensic Science Laboratory and
Rape Crisis Centre were maintained over this year.  The Annual Interagency Study
Day for all those involved in delivering the service took place in the Pillar Room of
the Rotunda in October 2012. This was attended by delegates from a range of
agencies involved in taking care of men and women after sexual violence. We
acknowledge both the Manuela Riedo Foundation and The Friends of the Rotunda,
the study day would not have taken place without their significant and much
appreciated support. 
As is highlighted annually, the SATU has, yet again, outgrown its physical space. As
a service we are confident that we will be considered for relocation in conjunction
with any on-site hospital developments.
Similar to every health care setting in this country, we remain limited by both head
count and funding restrictions. As the longest established SATU in Europe, we are
proud of our heritage and are ambitious for the future. Nevertheless, we rely to a
significant degree on the support of the Master, Director of Midwifery,
Management and Board of the Rotunda Hospital, and for their ongoing and
unwavering support, even in these times of immense budgetary restrictions, we
are extremely grateful. 
As we face these challenging times, I acknowledge the assistance of all SATU staff
over the past year. Maintenance of a responsive 24 hour service was possible
throughout the year, due to the dedication of the unit staff. All staff are extremely
committed to providing exemplary care at all times and but for them the SATU of
the Rotunda Hospital would not be a centre of excellence. This report highlights
the significant amount of work done by a very committed team, and their
availability to provide holistic care to patients at a time of crisis is acknowledged.
The commitment of staff to ongoing service development despite so many
pressures is also very much appreciated. 
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SINEAD DEVITT  (ACTING HEAD MEDICAL SOCIAL WORKER)
INTRODUCTION
During 2012, the Rotunda’s team of social workers continued to provide a
comprehensive social work service to patients, their partners and their families.
Those who used the service had a broad range of needs and issues of concern.
These included: bereavement, domestic violence, addiction, relationship issues,
mental health issues, underage pregnancy, the birth of a baby with special
needs, child protection issues, concealed pregnancy, crisis pregnancy and
intellectual disability.
The Rotunda’s social work service is exceptionally proactive and broad in its
remit.  It operates from the rationale that addressing problems in a timely
manner can prevent their escalation and can serve to minimise the distress
experienced by patients.  To exploit the potential of preventative interventions,
there is a social worker attached to each of the hospital’s four obstetric teams
and to all the larger specialist clinics and units.  Patients are typically met during
pregnancy so that issues of concern can be identified and alleviated.
CHILDREN’S REFERENDUM
In November 2012, the Irish people voted to amend the Constitution to strengthen
the rights of children.  This potentially provides the state with the necessary tools
to develop more effective adoption and child protection legislation.  Unfortunately,
in Ireland a minority of children are not safe in their own home or the child’s
family is unable to care for the child.  There are currently over 6,000 children in
care and 91 per cent are in foster care, often with relatives.  Only in exceptional
cases do children not return home with their parents following discharge from the
Rotunda Hospital.  The hope is that the changes to the constitution will provide a
platform to increase protection for all vulnerable children in the future. 
HOUSING CRISIS
In 2012 the number on the housing waiting lists in Ireland reached a high of 98,000
households.  Given the continuing economic difficulties and the rising number of
people in mortgage arrears, the numbers are likely to grow.   Simultaneously, there
has been an increase in demand for private rented accommodation, which has led
to a lack of availability and an increase in rents.  Many patients attending the
Rotunda Hospital are struggling to find suitable places to live prior to the birth of
their baby.  This is a major source of stress when many families find themselves
living in poor and inappropriate housing conditions. 
M E D I C A L  S O C I A L  W O R K
ASYLUM SEEKERS
The number of asylum seekers accommodated by the Reception and Integration
Agency (RIA) since the introduction of Direct Provision in 1999 exceeded 51,000
people by 2012.  Asylum seekers in the direct provision system spend on average
of three years and eight months accommodated in conditions that are often
overcrowded and bleak.
While waiting for their application to be processed, people exist on food and
clothing provided for them directly by the State and an allowance of ¤19.10 per
adult and ¤9.60 per child.  At the end of December 2012, 4,841 people – including
more than 1,000 children – lived under such circumstances in 34
accommodation centres run by private contractors spread across 17 counties. The
medical social workers continue to provide support to families undergoing such
difficult experiences.
Indeed, the social and economic changes which have taken place in Ireland over
recent years have given rise to many challenges for patients attending the hospital.
This has led to an increase in the number of referrals to the social work department
and has rendered the nature of our work more complex and varied.  The following
reports of social work involvement in the hospital’s specialist clinics and units
during 2012 provide a summary of the services offered by the department.
TEENAGE PREGNANCY CLINIC
In 2012, 110 teenagers booked into the Teenage Clinic.  This figure was 124 in 2011.
This reflects an overall drop in the number of births to teenagers in Ireland.  In 2012,
the Rotunda’s Teenage Clinic continued to meet teenagers aged 18 or 19 who
required additional support, whereas traditionally the Teenage Clinic was for
adolescents aged 17 years or under.
For many young people, their pregnancy is unplanned and the medical social
worker provides support and counselling to the young person to assist them to
come to terms with the news and to provide ongoing support and assistance
throughout the pregnancy.  Becoming a mother at any age can be a daunting
experience and young people, in particular, can feel overwhelmed about becoming
parents.  Attendance and participation in the antenatal classes is also encouraged. 
The medical social worker offers psychosocial support to the young person and
their family and completes referrals to community services if necessary.  The Teen
Parents’ Support Programmes in the young person’s local area offer continued
support for the mother and baby following delivery.
The medical social worker attached to the Teenage Clinic works closely with the
Clinic’s specialist midwife in order to provide a holistic and consistent service.  
FETAL ASSESSMENT AND PRENATAL DIAGNOSIS CLINICS
2012 was a very busy year for these clinics which provide care for women with high
risk pregnancies or who have received the diagnosis of chromosomal and major
structural abnormalities.  Fetal Medicine Midwives - Nollaig Kelleher, Jane
Dalrymple and Joan O’Beirnes - work closely with the medical social worker in
identifying patients who have been given difficult news about their baby and who
may need additional emotional and practical support at the time of a diagnosis
and in the weeks and months that follow. 
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Getting the news that an expected baby may have a problem changes everything
for parents.  As part of the team caring for and supporting parents during this
difficult time, the medical social worker offers a confidential counselling and
support service to all patients attending the FAU.  Patients are informed of this
service around the time of their first attendance and invited to meet with the
medical social worker if they are open to doing so.  Meeting with the medical social
worker, even briefly at this time, allows patients to identify another source of
support available to them throughout their pregnancy and after their baby’s birth. 
The range of supports available to parents includes:
Crisis Counselling and Support during the Pregnancy: Crisis counselling is made
available to parents around the time that they are being given bad news or trying
to make a decision about the pregnancy. This early intervention can help parents
to begin to come to terms with a diagnosis, adjust to their new reality and prepare
for the emotional impact of their baby’s birth.
Continued emotional support is provided by the whole multidisciplinary team
during the remainder of the pregnancy - patients often report how comforting it is
for them to meet with the same midwives and doctors at each visit, as well as it
being invaluable to have a quiet space to meet with the medical social worker and
explore their feelings in confidence.
Advocacy and Liaison: The medical social worker ensures that parents have up-to-
date and relevant information about supports available in their local community
and makes direct links for parents with organisations where appropriate, e.g.
Down Syndrome Ireland, Spina Bifida & Hydrocephalus Ireland, A Little Lifetime
Foundation.  
Practical Supports: The medical social worker can give information and advice in
relation to financial assistance where appropriate, e.g. Maternity Benefit, Illness
Benefit, Bereavement Grant. They can also directly link with a local Community
Welfare Officer or the Department of Social Protection on behalf of parents when
necessary.  
Follow-up Support and Counselling: The medical social worker meets with FAU
patients following their baby’s birth and continues to be available as a support to
them, e.g. where a baby is in our neonatal Unit. 
When a baby sadly dies, bereavement counselling and follow-up support is offered
to all parents. All bereaved parents are invited to attend the Hospital Bereavement
Support Programme that takes place annually yearly and is organised by the Social
Work Department.
Grateful appreciation is expressed to Midwives Nollaig Kelleher, Jane Dalrymple
and Joan O’Beirnes for their invaluable support and assistance during the year.
BEREAVEMENT SOCIAL WORKER
In 2012, the bereavement social worker offered a service to all women who had
experienced the loss of a baby through miscarriage, ectopic pregnancy, stillbirth or
neonatal death. The role of the bereavement social worker was to visit these
patients and their partners while they were in hospital or to contact them when
they went home. They were offered emotional and practical support, counselling,
advice on explaining the death of a baby to children, and follow-up care. They were
also offered counselling and support during subsequent pregnancies and after the
birth of their new baby. The follow-up care was offered both in the Rotunda and on
home visits if requested. 
The bereavement social worker represented the hospital at remembrance services
organised by A Little Lifetime Foundation and the Miscarriage Association. During
2012 we also welcomed a newly established organisation for bereaved parents,
Felieacain, (Stillbirth and Neonatal Death Association of Ireland). These support
groups offer invaluable assistance to our bereaved patients and we aim to continue
to build strong links to them in the community.
SUBSTANCE MISUSE
The medical social worker attached to the DOVE team met with all women who
misused substances.  The main emphasis was on opiates and cocaine but also
includes other drugs. 
81 women in 2012 who delivered the babies in the Rotunda Hospital were on a
methadone maintenance programme.  Methadone maintenance is the most
common treatment for opiate dependent pregnant women.  It is used to help
people stabilise their drug intake and associated lifestyle. 17 women were
commenced on methadone treatment secondary to their pregnancy.
The medical social worker liaises with the Drug Liaison Midwife throughout the
woman’s pregnancy, sharing relevant information.  The Drug Liaison Midwife
introduces the role and availability of the medical social worker to all women and
this normalises the referral and decreases anxiety and apprehension for the women.  
It is important for the medical social worker to meet with the patients as early as
possible to begin the psychosocial assessment.  Assessment is an ongoing
process and includes identifying both risk factors and strengths.  64 women in
2012 were referred (79%) to HSE Child and Family Social Workers. This is an
increase in comparison to the previous year when 57.7% of women were referred
to the community social work services.
Drug-related child protection concerns were reviewed and shared with other
professionals involved with the family at 19 discharge meetings and 19 case
conferences.  9 babies did not return home with their parents as a result of
concerns in relation to their on-going drug use.  17 babies returned home with
their parents as an agreement was reached whereby a non drug using relative
would live with them, and be the primary carer for the baby.
Relapse prevention work is a hugely important part of the child protection plan for
families.  This is part of the support provided by the medical social worker.168
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INFECTIOUS DISEASES
In 2012, 341 people were newly diagnosed with HIV in Ireland (Health Protection
Surveillance Centre, Annual Report, 2012).  The annual number of newly
diagnosed HIV infections had been decreasing since 2008.  However in 2012,
there was a slight increase of 7% as compared with 2011.
7 women in the Rotunda Hospital were newly diagnosed with HIV at antenatal
screening.  31 women overall with HIV delivered babies in the Rotunda Hospital
in 2012.
The medical social worker on the DOVE team offers pre- and post-test
counselling to women who receive a new diagnosis.  Women express fears and
anxieties regarding their health, their baby’s health and partner disclosure.
Counselling is provided to the women to begin to process these concerns and
worries, and to deal with the psychological consequences of their new diagnosis.
The medical social worker liaises closely with the Infectious Disease Midwife to
effectively meet the needs of many women.
NEONATAL UNIT
The role of the medical social worker attached to the Neonatal Unit is to help
families cope with the stressful experience of having a premature or sick baby.  The
social worker provides emotional support, information and practical assistance to
parents while their baby is in the hospital and also after their baby has been
discharged home.  In addition, bereavement support is offered to parents if their
baby dies while in neonatal care.
The social worker liaises closely with medical and nursing colleagues to ensure
that parents receive holistic family-centred care.  There is particularly close
collaboration with the NICU Discharge Co-ordinator and with community-based
services and support agencies to promote continuity of care from the hospital to
the home environment.
At a time when many families are experiencing financial difficulties, the social
worker is involved in informing parents of their welfare entitlements and in
enabling them to secure financial assistance with medical and other expenses.
Grateful appreciation is expressed to community welfare officers and to HSE
offices throughout the country for their co-operation.  A welcome development
in 2012 was the centralisation of the medical card application process.  This has
rendered the application process more efficient, thereby ensuring that parents
have access to the equipment and medication which is required by their babies
on discharge.
During 2012, there continued to be an increase in the number of babies transferred
from hospitals outside Dublin to the neonatal unit in the Rotunda.  These families
had to cope with the practical and emotional difficulty of commuting long
distances or of finding somewhere to stay in Dublin.  The lack of accommodation
for parents, the high cost of car-parking in the city centre and the absence of
adequate financial supports for such families constitute major problems.
A very positive development over the past year was the introduction of a monthly
parents’ support group which is facilitated by the medical social worker in
conjunction with representatives from the Irish Premature Babies Support
Organisation.  These representatives are parents who have previously had
premature babies in the Rotunda’s neonatal unit.  The objective of the group
meetings is to give parents the opportunity to support each other through the
difficult experience of having a baby in neonatal care.  They provide a safe
environment in which parents can express their feelings and share their
knowledge.  Sincere gratitude is expressed to the representatives from ‘Irish
Premature Babies’ who provided invaluable support and advice.
TRAINING - STAFF
Training Day on Stillbirth and Neonatal Loss, Centre of Midwifery Education –
26.01.2012
D. Kirk
In-service training for administration, household and catering staff on
Miscarraige,Stillbirth and Neonatal Loss - 27.06.2012
D.Kirk
In-service Training for Midwifery Staff on Miscarriage – 03.08.2012
D. Kirk
‘Mental Health and Homelessness’ College of Psychiatry - Oct 2012 
N.Rodgers and H.Lydon
‘Progressing the New Model for Disability Services: Social Work – Managing the
Change’ – Irish Association of Social Workers (09.03.2012)
P. Forster
PROFESSIONAL DEVELOPMENT
D.Kirk, Bereavement Social Worker attended training on The Impact of Caring for
Infants and Children who Die-Helping Staff to Cope and Build Resilience, Irish
Hospice Foundation- 18.04.2012
D.Kirk, Attendance at Stillbirth, Causes, Prevention and Management
Conference, Public Health Agency, Belfast- 22.11.12
D. Kirk, Bereavement Social Worker, continued to attend quarterly meetings of
the Irish Association of Paediatric Palliative Care in 2012 
N. Rodgers - Social Work Student Placement, Trinity College - Sept- Dec 2013 
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ACKNOWLEDGEMENTS
The Medical Social Work team would like to acknowledge their grateful
appreciation of the following:
• The Friends of the Rotunda and the Samaritan Fund for their financial 
support;
• The various charitable organisations which respond so generously to our
requests for assistance for families in need;
• All the voluntary community-based agencies which provide invaluable 
services and expertise;
• The lab staff in the Rotunda who generously donate hampers for 
families every Christmas;
• All our co-workers throughout the hospital, especially the midwives in 
Bereavement Liaison, DOVE, Drugs Liaison, Teenage Clinic, FAU and the 
staff of NICU and POPD
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CONSULTANTS: Dr Sam Coulter-Smith, Dr Sharon Cooley (locum)
ADMINISTRATOR: Ms Anne Hession; Ms Olivia Boylan
Midwifery: Care and support was provided by the midwives attached to
the Antenatal Clinic on a rotation basis.
Registrars: January to December 2012
Dr John Kennedy Dr Allan Varghese
Dr Feras Abu Saadeh Dr Denis Vaughan
Dr Nikhil Purandare Dr Pooja Sibartie
Dr Tom O Gorman Dr Nadia Ibrahim
Dr Tasneem Ramhendar Dr Sarah Campbell
Dr Nedaa Obeidi Dr Noha Bozreiba
Dr Sanchila Talukdar Dr Majda Almshwt
Since its establishment in 2008 the Early Pregnancy Assessment Unit (EPAU) has
provided individualised medical care to patients experiencing pain or bleeding
in early pregnancy. Patients are referred primarily from the emergency room or
their general practitioners. In cases where there was a prior pregnancy loss or an
ectopic pregnancy a direct referral is made.
Communication and explanation of scan findings, arrangements for repeat
ultrasound scans, explanations of tests and treatment options available are
provided to patients so they can make an informed decision regarding the best
treatment option for them. Care and support is provided to all women and their
families by staff in the unit, the bereavement services and social work. 2012 saw
the retirement of Staff Midwife Brigid Bourke who provided invaluable support
and care for our patients. She is greatly missed by staff and patients alike and we
wish her well in her retirement. 
ACHIEVEMENTS 
In 2012, in line with recommendations from the Directorate of Quality and Clinical
Care in the Health Services Executive, the Royal College of Physicians of Ireland and
the Institute of Obstetricians and Gynaecologists the following changes were
instigated:
• Provision of a new Volusson E8 in the EPAU with transabdominal and
transvaginal ultrasound capabilities to aid accurate assessment of 
early pregnancy complications.
• Provision of Registrar training in Viewpoint® and early pregnancy 
undertaken by Dr Sharon Cooley.
• Standardisation of diagnosis and reporting of early pregnancy 
findings.
• Development of local counselling and support documentation.
E a r l y  P r e g n a n c y
A s s e s s m e n t  U n i t
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• Provision of Senior House Officer training in basic ultrasound in 
conjunction with the Royal College of Physicians Basic Specialist 
Training by Dr Fionnuala Breathnach.
• Provision of training for University College Dublin Graduate 
Certificate in Obstetric Ultrasound Module 1 for Dr Noha Bozreiba and
Dr Nadia Ibrahim by Dr Sharon Cooley.
• Participation in regular clinical auditing of early pregnancy key 
performance indicators.
Clinical activity:
2011 (%) 2012 (%)
Total number of appointments in 2012 5709 5221 
Total number of patients seen 3116 3106
Repeat EPAU reviews 2214 (71%) 2315   (80%)
Failure to attend for first appointments 114 (4%) 200       (7%)
Failure to attend for follow-up appointment 178 (8%) 144       (6%)
Miscarriages 605 (19%) 1551     (30%)
Surgical management of miscarriage 247 (41%) 590       (38%)
Expectant or medical management 358 (59%) 961       (62%)
Ectopic pregnancy or pregnancy of 
unknown location 51 (2%) 123 (4%)
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CONSULTANTS: Dr Edgar Mocanu
Dr Sharon Cooley
MIDWIFE: Patricia Fletcher
The recurrent pregnancy loss service allows for investigation and follow-up of
couples with recurrent miscarriage. It links closely with the counselling service,
radiology and other clinics in the hospital and provides a support for couples in
future pregnancies. It also provides rapid access to review and ultrasound for
women from early pregnancy until their booking appointment.
2012 (%)
Total number of patient visits 376
Return visits 292 (78%)
Failure to attend for first appointments 18       (21%)
Failure to attend for follow-up appointment 39       (13%)
Total number of pregnant women seen 55
Livebirth rate 43 (78%)
R e c u r r e n t  p r e g n a n c y  
l o s s  s e r v i c e
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MS CLAIRE O’MAHONY, CLINICAL RISK MANAGER
INTRODUCTION
2012 was another busy year for the Clinical Risk & Claims Department who
participated in 19 different internal and external Committee meetings during 2012.
During 2012 there was a change to the structure of the Clinical Risk Committee
with the introduction of a written Risk Report. The Risk Report tracks the progress
on Incident Reviews and the implementation of actions arising out of reviews. It
also records incident trends noted from the STARS web system and risks escalated
from the Departmental Patient Safety Groups. The escalation of risks or incidents
to the HSE is also recorded. In recognition of the risks associated with ongoing high
activity in the hospital, an Activity Report was introduced at the request of the
Master and is tabled at the Clinical Risk Committee for ongoing monitoring. 
RISK MANAGEMENT TRAINING  
155 staff members were trained in Risk Management & Documentation in 2012.
The Risk & Claims Managers also participated in a joint initiative “Legal Study Day”
organised by the Centre for Midwifery Educuation. The team gave lectures and
provided materials contributing to the overall success of this one day course. A
lecture was also provided on the clinician’s perspective on medico-legal claims at a
Medical Negligence Litigation Conference in September.
INCIDENT REPORTING
Statistics on incident reporting continue to be shared with the Clinical Managers
in an annual report and prior to each Departmental Patient Safety Meeting.
Risk Management Policy
A Checklist for Communication with Patient/Family following a Serious Adverse
Event was introduced in order to streamline communication between the Risk
Department and the Master’s Office in respect of the progress on incident reviews
and communication with patients/NOK involved in an adverse event.
The Rotunda provided representation on an external incident review team
commencing late in 2012. This experience, along with the introduction of the HSE’s
National Incident Management Policy, provided us with feedback for use in
updating and informing our own current review processes.  Learning from 2012
will be carried into our improved risk review processes for 2013.
“ACTIVATE”
The Department introduced the “ACTIVATE” Consent Tool as part of the hospital’s
Consent Policy. ACTIVATE is a training tool introduced in a drive to assist clinicians
to recognise and meet their responsibilities in respect of the Informed Consent
Process.
Clinical  Risk Management &
Claims Department Activity
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STAFF PATIENT SAFETY AWARENESS CARDS
The Department welcomed and supported the introduction of cards for all staff, led
by Teresa McCluskey, ADOMN, promoting awareness of the WHO International
Patient Safety goals:
• Improving the accuracy of patient identification
• Making communication more effective
• Improving the safety of using high-alert medications 
• Ensuring correct-site, correct-procedure, correct-person surgery
• Reducing the risk of health care-associated infections
• Reducing the risk of patient harm resulting from falls.
PATIENT SAFETY INITIATIVES
Following trends identified or proactive risk identification monitored by the
Clinical Risk Committee, the following measures were implemented by various
disciplines across the hospital and supported with the help of the Practice
Development Unit. Gratitude is expressed to all those who were involved in the
following improvement initiatives:
• Training on the Identification and Management of Hypoglycaemia in 
Infants led.
• Standard Operating Procedure for the Counting of Swabs.
• Formal Triage System introduced in Emergency & Assessment Department.
• Incorporation of multi-disciplinary note-keeping in the Obstetric and 
Gynaecology charts. 
• Education to highlight awareness of Sudden Unexpected Neonatal Death 
Syndrome. 
• Introduction of the Rotunda Escalation Policy
FAIR REVIEWS/FOLLOW UP REVIEWS:
15 recommendations were made in 2012 out of reviews into clinical incidents. Of
these, 11 actions are complete and 4 are ongoing with regular monitoring through
the Clinical Risk Committee.
Recommendation Made: Number Actions Actions
complete ongoing
Promotion/Training of Existing 
Guidelines 1 1 complete
SBAR/Communication 1 1 complete
MEWS 1 1 complete
Update to existing guideline 
required 3 2 In consultation
New guideline/SOP required 3 2 In consultation 
Amended process 2 2 complete
Clinical Audits 1 1 complete
Documentation 2 1 National Guidance 
introduced and to be
followed.
IT improvement 1 0 Awaiting new IT 
system before 
progressing
Totals 15 11 4 in progress
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CLAIMS/LEGAL:
Significant work has been achieved in the use of a newly introduced Discovery
Template to support us in managing Discovery Requests which can be lengthy and
time-consuming. The Discovery Template has assisted in offering a standardised
structure to these requests.
The department adopted the Voluntary Hospital Group’s “Updated Guidance
preparing staff for attending Inquests” and this guidance is available for staff on
the intranet site and also in hard-copy as routine practice where a statement is
requested from the Coroner. A DVD is also available for use from the Clinical Risk
& Claims Department and is offered to all staff involved in attending an inquest as
a means of support and information.
Legal claims continued to be managed through the Clinical Risk Department, and
a Claims Database was introduced with the objective of improving internal
management of claims data in 2013. A survey was conducted in August 2012 to
gather information and feedback in respect of clinicians’ experience of the claims
process and the information is used on a regular basis to provide us with
heightened awareness particularly of the need for support for staff involved in the
legal process.
STAFF MEMBERS
The complement of the department is 3.6 whole time equivalents. I would like to
thank the team for their ongoing commitment to Patient Safety initiatives, claims
Management and incident reporting.
178
4
Friends of
the Rotunda
179
The Friends of the Rotunda is the official fundraising arm and registered
Charity (CHY20091) of the Rotunda Hospital.
Its main objective is to provide a sustainable funding base for research into
aspects of Maternal and Child Health; additional and vital equipment and
support services for the Hospital’s Specialist Units, Services and Clinics and
improved amenities for Patients, their families and Staff.
The Friends of the Rotunda actively encourages participation in fundraising
activity by Rotunda Staff, Patients and their families and friends. Donor Giving
provides funds for additional vital equipment, services and amenities within the
Hospital that are otherwise, not paid for by the State. 
Since its formation in 1971, the organisation has become highly focused and
strategic in its approach and now contains over 1,700 registered Subscribing
Members. The Charity is managed by Sheila Thompson who is responsible for
administration and overall marketing & development.
The Friends’ Council is the Charity’s governing body and meets quarterly to
discuss matters relating to policy, finance and governance of the organisation.
The Council is Chaired by Dr. Frances Gardiner. Directors: Marie Malone
(Honorary Secretary), Dr James Gardiner and Professor Alan Johnson. Officers:
Josephine Black, Dara Walsh, Sylvia Graham, Joan Dillon, Judith Woodworth and
Dr. Michael Geary. Representation from the Rotunda Hospital’s Management
Team includes the Master, Dr. Sam Coulter-Smith, Pauline Treanor, General
Manager/Hospital Secretary and Margaret Philbin, Head of Midwifery.
The F.O.R Research Sub-Committee reports to the Friends’ Council and meets
regularly each year to consider applications for F.O.R funding. During 2012, over
€44,570 was awarded to fund the following projects and research submissions:
1. Extension of a Part-time Research Psychologist Post for Rotunda 
Neonatal Research.
2. RCSI / Rotunda Study entitled ‘Platelet Reactivity and Pregnancy Loss. 
Follow on series of further research studies. Funding also supported the 
establishment of an advanced platelet research laboratory at the RCSI 
Unit within the Rotunda Hospital in collaboration with Professor Kenny 
of the RCSI.
3. Bereavement Support for Rotunda Families. 
4. Continuation of the National Volunteering Initiative (Knit-a-thon Project).
5. Continuation of the Hospital’s ‘Reach Out and Read’ Project.
6. Christmas Appeal for Rotunda Families in Need.
7. Additional training and teaching aids in support of the Hospital’s 
Lactation Service.
FUNDRAISING EVENTS TAKING PLACE DURING THE YEAR INCLUDED:
• Rotunda Golf Classic – The Masters’ Cup
• Christening Party Fundraisers
• Coffee Morning Fundraisers
• Birthday Party Fundraisers
• Sponsored Walks
• Flora Women’s Mini Marathon to Fundraise for Rotunda Neonatal 
Intensive Care180
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• Dublin City Marathon
• NY City Marathon
• Sale of Easter Eggs
• Coin Box Collections and Raffles
• Sale of Publications gifted to Rotunda Hospital by Artists / Authors
• Sale of Football Shirts in aid of Rotunda Research Fund 
• Sale of Christmas Cards
• Sale of Art illustrating the Rotunda Hospital
• Sale of Designer Silver Jewellery Collection
• Sale of  Memorabilia of the Rotunda Hospital
• Tango Fiesta Fundraiser
• FUNdraising Awareness – The Rotunda Masters Bake Off Competition
• Arts & Craft Christmas Fair
• The ROS Tapestry and Fine Art Presentations in the Pillar Room
• Young European Strings Chamber Orchestra Performance in the Pillar Room
• The Bartholomew Mosse - 300th Anniversary Ball – Raffle
• Christmas Swim Fundraiser
• Sky Dive Fundraisers
• Friends of the Rotunda Annual Membership Subscriptions
DONATIONS
On-line payments facility for Donations was introduced in September 2009 on
the Friends’ Web Site (www.friendsoftherotunda.ie ). Revenue has since been
collected to support each of the following areas:
• Bereavement Support
• The Delivery Suite
• The Early Pregnancy Unit
• Rotunda Families in Need
• Fetal Assessment Unit
• Maternity Day Care Unit
• Neonatal Intensive Care Unit
• Rotunda Research Fund
• Sexual Assault Treatment Unit
• Essential Equipment Wish list
Additional essential equipment purchased by the Friends during the year
supported the Rotunda’s Neonatal Intensive Care Unit and included electric and
manual breast pumps.
www.MyCharity.ie now hosts the Friends of the Rotunda Charity registration on
its website. Fundraisers can set up a Fundraising Page with links to mobile and
social media connections.
CAFÉ ROTUNDA
The Hospital Shop is located within the Main Reception of the Hospital and
provides a Café and retail service to all in the Hospital. Annual rental income
from the Shop provides extra revenue for the Friends’ Administration. The
Friends of the Rotunda Charity Merchandising including Christmas Cards and
Sterling Silver Designer Jewellery Collection are also on sale.
Pictured above is the striking contemporary bar facility within the Pillar Room
Complex. The facility now offers a new range of Conferencing Suites that are
equipped with IT and Broadband services and audio sound.
The Council of the Friends of the Rotunda wishes to extend its gratitude to all
those who organised and supported fundraising activities during 2012.
Sheila Thompson
Marketing Manager
www.friendsoftherotunda.ie
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THE HIRE OF THE PILLAR ROOM
Another substantial source of revenue in aid of Rotunda Research is generated
each year through the hire of The Pillar Room Complex as a facility for private
and corporate functions. It is also used by the Hospital as a teaching &
conference centre. Bookings are managed by the Friends of the Rotunda office
on 01 872 2377 or email friends@rotunda.ie.
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Clinical Audit Team:
DR SHARON COOLEY Clinical Audit Lead
MARY WHELAN Clinical Audit Facilitator
VALERIE JACKSON Surveillance Scientist
COLIN KIRKHAM Statistician
The Rotunda Hospital Clinical Audit Department was established in June 2011
under the quality and safety initiative of the Rotunda’s Strategic Plan 2011-2013.
Clinical audit offers a structured approach to evaluating our care against national
and international standards.
The Clinical Audit Department functions include:
• Hospital database of clinical audit activity.
• Education and support at all stages of the clinical audit pathway. This 
includes topic selection, researching standards, the application process, audit
tool design, data analysis, report writing and formation of action plans.
• Assistance in maintaining clinical audit experience which is an 
essential element of professional competence. 
• Creation and maintenance of the clinical audit strategy within the hospital.
• Monitor all clinical audit activity within the hospital to include the 
implementation of action plans.
• Monitor local and national audit standards and appraise hospital 
performance against these standards where appropriate. 
• Promote a high standard of practice amongst clinical staff and all 
healthcare workers undertaking clinical audit.
• Provide a forum for the sharing and dissemination of clinical audit work in the 
Rotunda, which is facilitated by the use of the clinical audit database and the 
Biannual Rotunda Audit and Research Day and the quarterly audit results meeting.
• Encourage clinical areas to prospectively plan their clinical audit activity on 
a clinical audit calendar which is disseminated to all departments.
• Link with other clinical audit units nationally and address key areas in 
clinical audit.
Clinical Audit Group Weekly Meeting
The core group within the Clinical Audit Department meet weekly to discuss and
approve audit applications.
Clinical Audit Steering Group
The Clinical Audit Steering Group meets quarterly. Membership of the steering group
includes the executive management team, clinical risk department, departmental
patient safety representatives, heads of departments and allied health professionals. 
Clinical Audit Database
Valerie Jackson, our Surveillance Scientist maintains a hospital database of clinical
audit activity in the hospital and produce weekly and quarterly reports on topics
audited; departments and clinicians involved, action plans and dates for re-audit. 
C L I N I C A L  A U D I T
D E PA R T M E N T
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The database also facilitates storage of electronic copies of audit applications
and audit tools. All clinical audits conducted in the hospital are registered on the
database. All health professionals who participate in completed clinical audits
that have been registered with the hospital receive a certificate of participation
in conjunction with their supervisors. 
In total 60 clinical audits were undertaken in 2012. This included 38 new clinical
audits in eight clinical areas which were completed within the hospital in 2012,
in conjunction with 10 ongoing clinical audits and five re-audits.  
Clinical Audit Training
In 2012 there were 11 information sessions held and two Rotunda Audit and
Research Days. This is an increase of eight teaching and training sessions since
2011. In total 120 staff members have attended our training sessions to date with
representatives from all clinical areas attending.
The department also encourages clinicians to complete the HSE e-learning
programme on clinical audit available at www.hseland.ie before embarking on
a clinical audit. 
Clinical Audit Intranet Page
The department has developed a designated page on the hospital intranet where
the application forms, guide to clinical audit, key steps to audit success, draft
action plan and report template are available to download.  Monthly and
quarterly reports on clinical audit activity within the hospital are forwarded to
relevant staff members.
New Initiatives in 2012
The vital role of the supervisors in the success of clinical audit was highlighted
by the introduction of supervisor reports and quarterly reports and the
stratification of elements of the individual audit reports into areas requiring
immediate, medium and long-term actions.
There were fourteen immediate actions identified in 2012, and in only one case
was the action not met. In this individual case the action was partially met due
to constraints on resources and the same was highlighted to the Executive
Management Team.
Another new initiative in 2012 was the introduction of a quarterly hospital wide
meeting on clinical audit activity in each area of the hospital. This has increased
awareness of the importance of clinical audit in provision of care and
acknowledged the hard work of the Rotunda staff involved.
It has led to a change in practice in many instances, for example the use of the
Hemocue© system for neonatal bloods and the provision of a midwifery-led low-
risk adolescent antenatal clinic.
Current plans for 2013 include a further expansion in activity, involvement with
Clinical Audit Departments in other hospitals (as has already happened with St.
James’s Hospital and Temple Street Hospital) and a focus on health equity in the
months to follow.
Conclusion
In 2012, Professor Tom Clarke stepped down as Clinical Audit Lead and Dr Sharon
Cooley took up the post. We wish to acknowledge the vital work of Professor
Clarke in formalising clinical audit in the Rotunda. The team would like to
commend the clinical staff for their enthusiasm for clinical audit and look
forward to working with them towards their clinical audit goals in 2013.
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MASTER
Dr. S. Coulter-Smith
Secretary/ General Manager Ms P Treanor
Director of Midwifery/Nursing Ms M Philbin
MIDWIFERY
Senior Staff
Ms P Williamson (Asst Director) Ms B Beirne Moore (Asst Director)
Ms F Hanrahan (Asst Director) Ms T McClusky (Asst Director) 
Ms M Keane (Asst Director) Ms M Brennan (Infection Prevention and 
Control)
Ms J MacFarlane   (Night Superintendent)
Ms M O’Reilly (Practice Development)
Ms A O’Byrne (Practice Development)
Ms M Whelan (Clinical Audit Facilitator)
Clinical Midwife Manager III 
Ms O. O’Byrne      Ms A Keenan        Ms K Scully        Ms. J. Hickey
Ms C Cannon      Ms M Deering      Ms S Finn Heaney
PARAMEDICAL HEADS OF DEPARTMENT
Chief Pharmacist Snr Physiotherapist Snr Radiographer Laboratory Manager
Ms A  Frankish Ms C Cusack Ms S Gibson Mr J O’Loughlin
Acting Head Medical Social Worker Senior Dietitian
Ms S Devitt Ms L Harrington
ADMINISTRATIVE HEADS OF DEPARTMENT
Patient Services Manager Ms C Ryan Hyland / Ms N Moore
Financial Controller Mr C Kenny
Human Resources Manager Mr K Slevin
Information Manager Ms L Sibley
Materials Manager Mr S Williamson
Head Librarian Ms A O’Byrne
Quality Manager Ms Sheila Breen
Clinical Risk Manager Ms. C. O’Mahony 
Information Technology Manager Mr. N. Carberry 
SUPPORT DEPARTMENT STAFF HEADS
Support Services Manager Mr R Philpott
Technical Services Mr B Memery
Catering Officer Ms P Ryan Mohammed
Clinical Engineering Mr H Gelera
Household Services Manager Ms C L’Estrange
Head Porter Mr P Shields
CHAPLAINS
Ms A Charlton Fr D O’Reilly
Rev D Gillespie Rev A Boal
Rev J Stephens Ms G Stephens
Ms S Dawson The Dominican Community
196
   
    
     
    
       
      
D       
D     
    
    
    
  
  
    
     
     
    
      
D   
  
  
  
      
  
  
       
  
   
     
    
    
  
           Dr M Byrne
D   
   
     
  
   
    
  
  
     Sheehan
C    NEPHROLOGIST
D      
  
    
  
  
   
    
    
      Mr K O’Malley Mr T Creagh
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Specialist Registrars /Registrars in Obstetrics & Gynaecology
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